MZP@ !L!This program must be run under Win32 $7PELN 8P`@`Ț.text 56 `.itextP: `.data`<@.bssx+pD.idataD@.relocH@B.rsrcȚN@@`@@%d@%`@%\@%X@%T@%P@%L@%H@%D@%@@%<@%@%8@%4@%0@%,@%(@%$@% @%@%@%@%@Sļ $DTD$,t\$0ÃD[Í@% @%@%@ZFastMM Borland Edition (c) 2004 - 2008 Pierre le Riche / Professional Software DevelopmentAn unexpected memory leak has occurred. The unexpected small block leaks are: The sizes of unexpected leaked medium and large blocks are: bytes: UnknownAnsiStringUnicodeString Unexpected Memory LeakÍ@ H@JBÍ@ HJHJH @J BÍ@ HJHJH J HJH@JBÍ@(hhhH J zzz:Í@(hhhh H(J(z zzz:Ð(hhhh h(H0J0z(z zzz:Í@(hhhh h(h0H8J8z0z(z zzz:Ð(hhhh h(h0h8H@J@z8z0z(z zzz:Í@ y,l|<x,<DDÍ@,<xÐH9щJtÐz@ָ!(z@u!$z@Ë0 !ʁ ըz@Q9ʉPAtÐz@ָ (z@ $z@Ã= z@uÐz@@u%H z@)ЍJHT0 gÐ#P0 rz@#P z@)ÐSjhhjtMz@ z@z@Qȁу+Ӊ z@+ˋz@Ѓ[3 z@3[Ð=9p@t=)=x@u j@3tj l@3uÐSVWU荵NjhVj#؅t0ow }@@@G@]_^[ËSVWU܋CƋ$PT$P uhjVt3?:ދ3jD$ PS9hjSut$;v+υuD$$$T$P@ǃ$]_^[ÐSVWUǃ؃;;v׃Љ$jD$PD$P|$upd$+ӋD$;s\+ӁJ;sjh SD$ Pt-jhSD$ PtǃpZ Z wz؅tj, vÃpǃ@Ӌϑ?;r ߃w/2؅t", vǃpӋNjà ]_^[ÍP=, S 9p@Hx@@`@uVSB9tB #HJPt([ÐSK;C wvB KP[ÐJYK[Ð#t #t #t@=x@ujH#_j 2VW=9p@t9%z@t*=x@uj%z@t j s#5$z@tpƍ4 (z@ɍ <ͨz@wVW:9u!(z@u$z@#~` rl{)7JHTUK= z@9r&5z@K0 9r))= z@5z@!Cƅuz@_^[Àd7ON1z@FF sF KS)ω{ p_^[Ð%z@tK=x@uj%z@t*j ǐ=,  0u #(z@t  ^#$z@tЋ(z@ȉ 5 z@)rz@)أz@ z@Xz@[VW<ͨz@wFG89u!(z@u$z@#~)t3JHT0 rd7KNz@_^[[+1ËPS9p@ۋuaj Bt,J@At1[ÐKZJQS1[ÐtBJHA19SuC ЋR9p@#t=x@uQRjZY#oQRj ZYÐ%z@tB=x@uj%z@t!j ǐۉVuD3L3u5L3Fu@tPCF\3Yz@1^[Ð3ˁ0 r뻐N)ˁ0 r먁= z@u,VPz@hjV^[Ð9C z@z@z@1^[Ð[ËHSVK9r7@9r^[ÐӉOtى‰É^[ÐL W1)у!t$, vxK‰ljSw_^[Ðg˃W<9U,9r]_^[Ð, s, 9vۍ0)=9p@tF%z@t/=x@uQjdY%z@t Qj LYÐ#^ ^ˋWu Wׁ0 r_CD.0 r .z@]_^[É׉tʼn‰G]_^[ËG,9=9p@t[%z@t3=x@uQRj{ZY%z@tQRj aZY뿐#^Gt~,9wt=0 r QRZY1)Ѓ!%0U)w $.T.z|0Ł0 r ݉nz@]_^[Ðz@1)Ѓ!ЉʼnRZtс, vPʼn‰]_^[Ð^[%1ËSX`ɍ ˁ, sx [Ëȋуы‹Ѓu3Í@= z@tz@;rЁ;z@sÁ= z@tz@3Í@S؃ ;BuZ;Z v؃B+؉[ËBH[Í@W׃A_pс‰ȃ0Ѓ 0 0 0 0 0 0? 0 00G_Í@SVڋӋ= ^[ËSڅtȋ@[á,`@Iȋӡ,`@[ÐUSЁvhucUR;w]]S;sU3ɉJjURPExrExuE@t E@t3[]3[]ÐUSVW؁}eEPÃdYtREPÃQYt?ÃЋ0Ã;u't'EP-YtEPWYu33_^[]ËUS3EU3ҋhYu3ۋ[]Ë=9p@t=)=x@u j@3;tj @3"uŃ=@ujhhj@=@ËSt)@8?}@@\@3@[SVW𿼚@3ۃ?t?6t6J|&B3;tuT @Ju@_^[ËUSVWEE@`@UHMԍU؋EyaEZQEƀG3ۋEbE}E؁xE؋@EE@E}t }E@m E}E@;EE}uKE؃ EE~"EЀ}tE8 s3EEMu}E8uxE؃ EE~$EЀ}t Ef8 s3E߃EMu߀}t>Ef8u5.;Et<t C~E3DE@E؋u;u{_^[]ËUP'PHuESVWH3ɺ/3ɺ@3GƅG=z@؅trÃ0uVt UYCG}7G5u ƅGGGG.؅u z@r@7Ãu&ƅGs GG[@t G|GƅG3G`@ȍ܇`@FDžG7DžGB`@OGGGƅGG;,>Gu! `@Xȋӡ `@ƅGGuV C CG@ C-C CӋGgء(`@ȋӡ(`@iƅG,C Cǃrt!Ht:T,`@ȋӡ,`@0D0`@ȋӡ0`@(4`@ȋӡ4`@ F CxC COGGGG GwG~Gt C C C C$`@ȋӡ$`@a؋GNrAF3Gt,C CG؍;w GGNuΡ8`@ȋӡ8`@h <`@P܇Pj_^[]Í@VW33B`@= z@tu:;v x@@;wF 7u_^ËSVW7\`@;u@CCCC3CCC@%0=0 s0  vȲS f0 fC{Nj I00ss0s0v0 ׋3fff%f0fC N0 z@ z@z@ z@z@‰@Nu@@@@_^[Í@SVWU z@@{ohjW;u7@`@ȉHȉH@3ɉH Ju[z@@Ju^{hjSh;u6v]_^[Ã=Ě@tĚ@PX3Ě@=x@t=@thj@P3@ Í@t $g@uðStX3҉P=p@t p@3ۋ[Í@`@y SV؀=p@t ֋p@u w 8g@Ë^[Í@UQEE$UBY]Í@S4[9t1 w|$.@,(~h~hzz:<Ð-@r.@x.@.@.@.@.@.@.@R(DL (QكL Z,<|:Z:~.9w)9ЍvȃQ,(у),<Y:< f f@f BË Ë@ BËf@ fBË@ B(:Í@SV3Cf=r/f=w)f%f=uSuS$t@p@t g^[Ë |?ffHfHfHT)T|Ð~PLڍU/@␐fHfHfHfHfHfHfHfHfH fH fHfHfHfHfÐ- `@ËtQÀ= `@vjjjhp@Ð= `@tPPRTjjhp@XÍ@Tjjhp@XÍ@= `@vPSÍ@tA9t 9u AAË= `@vPRQQTjjhp@YYZXÐ= `@vRTjjhp@ZPR= `@vTjjhp@ZXËD$@8PHtn p@҅T$ L$9t7= `@v)= `@w L$PQX‹D$H 0‹D$H = `@v= `@wPD$RQPYZXtpHS1VWUdSPRQT$(jPh1@Rp@|$(Oo_G1@f"AËD$@S1VWUUhd2@d3d#dPHSPRQ|$4OoGd2@1ZYYd]_^[ #zA8ËD$T$@tJB2@SVWUj]_^[ËD$0@3@ B `8t B1dY]_^[Í@ BZd$,1YdX]7UU=,t\=tW-t\-t=HtN`q?r6t0R=t=-t.HtHt$:-t/=t&,*&" R R]D$@= `@wD$P4tqD$T$jPh.4@Rp@\$;SCt p@҅S 6 p@tыL$Q$B1Í@P1ҍEd d@3@hYAÍ@@1҅td 9udË t9uËUSVWК@tSԚ@x3Uh5@d0d ~KԚ@tt>tօ3ZYYd_^[]ÐUQSVWК@tV83ۋ@E3Uh5@d0d ;~E4CԚ@t>t;3ZYYd)<+z_^[Y]QSVWȚ@} |@ލ} C CCkCSM C,C1Ƀ} uK 0@p@8@p@zE @C(HYS$t<}QL$tE UYE <|= p@u (p@= `@E H+ËSVWZg@5`@ƹ 0È ƙKuܳ5`@ƃxg@ӈ3Ku_^[ÉNj_oww 7 _^1`@@ ÐQ=8p@tWf=s@u=s@v s@,s@jD$PjhZg@jPjD$Pjh7@jPZÀ=`@ujhTg@hZg@jZ SVWUȚ@4p@=`@tO3`@=@t!;$@u@@~(u?t3Ӄ?u~(u=`@u3F ؅t؅u~(v =`@t&ntAFxF;xt tW>~(uV$~(tP>u=p@tp@`@PV ^E]_^[ã`@Ð`@ËtJI|Ju PBXÐt!P1:t:Ht:Ht :Ht@@@Y)Ëih5@fN@d%4@=4@tNh9@h9@P(@h9@h9@P,@h:@h9@P0@GetThreadPreferredUILanguageskernel32.dllSetThreadPreferredUILanguagesGetThreadUILanguageh5@ÐUSVWE`@E}t93Uh[:@d0d ]ES3ZYYd XEE}u_^[YY]Ë`@`@ËUQE3Uh:@d2d"E@t3ZYYdh:@E;`@u E`@`@t;Uu UuY]ËTD$$Í@Ё%usv x@x@ Ë%@%@%@%@UUE M?]ÐUM EU]USVujj@؅uVjjhvsg@g@^[]UUg@8t;u;u R`]UE+E y]UE3B8u]UE@<]US]SYPu S" []UE@]UE U;B4u3]USVWuj$jEP E$uԋU U؋NM܋^v u <EEF@ƒUt E M3=g@tEPjg@t[=g@tURjg@؅u u ؅uC)E=g@tEPjg@؅u EЉEURjjh~E hP@~u VY^ S^hP@d]=g@tEPjg@uS~tB~t?PEu,W^;Fu!SW_tvv F UBE=g@tEPjg@uEЉEURjjh}E 8=g@t3҉U]}MQjg@_^[]USVW]t3Cxt*s~vv qW3FSY3_^[]USVug@hP@t3tCpVYuuSzY3lY;uhP@^[]UhP@]Uj}hP@]Í@U3Uh?@d0d x@u7@p@)s@u@h`@3ZYYdh?@]Ð%@%|@%x@%t@%p@%l@Pj@Í@ËS؅t6=g@u u t Pg@P[øtzg@g@Put@Í@t+=g@t"g@POtP-jg@P@Í@t=g@t g@P Ð h@g@u&d,g@Ptát@Ptøg@JÐg@} u0PRh@M l@JBB @BZX5p@g@%A@A@D@P@p?@A@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@g@SysInitSystem-x@6`@p@0@p@8@:p@Vn£̣أ̡ء &4JZl~¢Тܢ&>Vn£̣أuser32.dllMessageBoxAkernel32.dlllstrcmpiALoadLibraryALocalFreeLocalAllocSleepVirtualFreeVirtualAllocGetACPGetSystemInfoGetVersionGetCurrentThreadIdVirtualQueryGetStartupInfoAGetProcAddressGetModuleHandleWGetLastErrorGetCommandLineWFreeLibraryExitProcessWriteFileUnhandledExceptionFilterRtlUnwindRaiseExceptionGetStdHandleDeleteCriticalSectionLeaveCriticalSectionEnterCriticalSectionInitializeCriticalSectionCloseHandlekernel32.dllTlsSetValueTlsGetValueTlsFreeTlsAllocLocalFreeLocalAlloc0 000"0*020:0B0J0R0Z0b0j0r0z0000000000033 4,4F4\4k4r4}444445 5/585K5V5a5p55555567 88888889!9.9K9T9999999:':>::::::::::;;];;;;9w>>>?O?_?i?? 0'000011223334(4C4I4a4n4v44444477778!8<88888)979E9S9a9o99:^:l:{::::::;;;;;;;;; <<3<^<<<<<<<<<=%=6=K=X=x=====>>> >>>>j??????00"0V0r0~00000 11G1P1111122223#4*4B4d444444@5V5m5555556C6L6S6p6x66666 777!7/7J7_7i7n77777777786888888%919G9M9U9Z9j9o9t99999:-:>:~:::::::6;A;N;V;^;f;;;;<==*=L=[=====3>B>n>>>>7?L?b?w????????????@0*0T0o0y00000000011)151C1M1q1v1111111111111111111111111222 22222 2$2(2,2024282<2@2D2H2L2P2T2X2\2`2d2h2l2p2t2x2|222222222222222222222222222222222333 33333 3$3(3,3034383<3@3D3H3L3P3T3X3\3`3d3h3l3p3t3x3|333333333333333333333333333333333444 44444 4$4(4,4044484<4@4D4H4L4P4T4X4\4`4d4h4l4p4t4x4|4444444444444444444444444444444P000%0)0/03090D0J0N0Z0c0l0x000000`@00 0$0(0,0004080<0\0|000001<1 7$7(7,707477777N>8X pPhN>XrN>N>(@"X6p`Jp0H` x: V      N>, 8N>PN>hN>xN>N>N>N>N>N>N>N>N>N>N>(N>8N>HN>XN>hxN>N>N>N>(N>8N>H@xB6y P ` . z, 0 Y> 2 N$ :_ 5 1 ICS4!df̬2 j.x/`TzАԑr|H ?WW PMOLOGIN2BMPPMOTOOL2DVCLALERRORCOLLAPSEDXSLERROREXPANDEDXSL PACKAGEINFO PMODATAXSD PMOHIDESCREEN PMOLOGIN2PMOSICKLISTXSL2005_1PMOSICKLISTXSL2007_1PMOSICKLISTXSL2011_1PMOSICKLISTXSLCOMP2005_1PMOSICKLISTXSLCOMP2007_1PMOSICKLISTXSLCOMP2011_1PMOSTANDARDTOOLBARPMOTALONASSISTTYPEPMOTALONEPISODETYPEPMOTALONINSURANCEPMOTALONMANIPULATIONSPMOTALONPATIENTGROUPS PMOTALONPAYERPMOTALONSPECIALITYCODEPMOTALONTERRITORYPMOTALONUNITTYPEXSL_MIMS_DETAIL XSL_MIMS_GMXSL_MIMS_INTERACTIONMAINICON(|Xx  ñ{gQt?t>u?v@v@w@x=v?TgwɱԽeyBd-a*c)i,k.k/l2l3l3m4m4m3o4o5o7k6i5i1c.j7|Mjǫnooopp}~~vww|}}tuunoonoo}~~noonoonoonoorssoppݢͺmq?g+_ag(k+n-m.n0m2k2l4m5l4l4n5m6m3o5o4o3q3p3r7o5k/f,c(i3{Irnoo𲳳noo|}}nooںnoo䧨noonoonoo󶷷noonooݟͽzEe!`b"f(k/l/l.k1k2m1n1n0m/m1o3o3m1n2n5l8m8m6o6p7p8p9p9p9ro;p9p9p9q:p9p9s=rr?q?r>s=uAk6m;yĻeEGqNRpOSrMRpNQoMQmNQuMRgDG}ޢüǖsF[gh&i)i*f(f)g+i,j(l)b"]"b"LͼкSk:f0i1q8s>q>m>pDsGqDrDt=q7g5wR$4 3 7 31/: &eGIzKɸϿtEűc%^h#i)j)k*g(g)g+j+n*g ]k3hīxIc.l6s=vAq=p@qCqBt=t:t=m9j?ǵ5 DCGCA?I7 qTWo?̻̻o?鴖oWcmh.f/h(f$g)l.f*f%^p8ƴ˽{Pf0p3u6t9rw>v>u=rH6 pSVѠW}R~Sh](_*ǔqBߔqBɷpBʹo?zN\&l<ɷe3h7fWƴn@zN~SuHξwKvY#b.ʸ^[%eqCŲp@{PY#uHߚuGUdj!i$g*g*j)f&i*f'\k4ǵʺ~Mg.q;o:sm9W4CBFB@>H6 pSVyLo?~Tn>o?İîo?{PwJo?ʹ̻o?o?Ƴo?{o?Y#ewJUf4qB_rDzNξo?yL[zNo?_*qA~Tgo?\qCo?ǵo?qCf4o?νʸo?d1cp@k;tB\e'i(g%f#k(j)h*h%f"b)k«sLk9t9s>tBtEuGtBu?t:oH6 pSV\o?ɷ`,\'~SrDͼo?o?̺o?o?Ǵo?ƂX!tF]|PVzNk;_+vI ]wJvIvH kƳo?o?Ǵp@to?̋n/_e g&h%gj#h#k)d$^}Bҽмqm:n:u?s?sAtBtCtDwFp=xBο4CBFB@>H6 pSV^)](uHwJsDbϿo?Ƴİo?io?o?⦈ao?҂X!wKe~So?g](o?^)zN\&](Y#Ͽo?Ǵo?o?Ͽǵo?ɷqCuG Ոj2_eg%h$d#e&j'idc"ʸmCj3wH6 pSVb.X!~So?o?X!ʸo?yLo?vI ](o?p@o?xKp@o?fyMrD^zMo?[sxxKvH qBqvI o?o?e3￪o?o?ͽƳo?wJo?o?ފj9`jgf%h!j&g*d(^h-̵̼Wj3r:vCuDxGtCuEvFq9uI4CBFB@>H6 pSVlo?İͼνϿʸɷϿʹɷa-sDɷʸͽͽɷp7_gj!f#e%g#i"g$Y!qF̨mi7uArAtCwFtCuDu;o:}X4CBFB@>H6 pSV_*o?](~SqAvI o?b.Vo?Ǵ{L\ih$d%g(g'h'gZM川{h5r@uCwFuDvEu@wAnH6 pSV빢n?qBիkj9qCl[b cj$d e'h'f[Wn:s>u?xDtFuGvDxBj;{4CBFB@>H6 pSV`!ad h%b e"i$eYV콧p@s9wAsCuJtCv@vBmAп4CBFB@>H6 pSVˍm(Zfgbe%b"e^R歓qn:u>vBtFwFyCxAr;tG4CBFB@>H6 pSVZ_e$e eg d c"Z~L䪍hm?uBwDvCwAyDw?m8c4CBFB@>H6 pSV̽[bge"d#hj_d5Ҿ|Xr?w?xCtAvExIwDk7Ͽ4CBFB@>H6 qTWޗp-Zc!if"f'fh_ƲԚuFs@sCxIvGuGvEr?wK4CBFB@>H6 lMQyUe f!f"ee!h#]qlBwIxGvCuCvFvHp;s4CBFB@>H6 oPTɹ²ɸم_#ag"de e b_wIcl8u?u>wEvIwItAmD4CBFB@>H6 pSVǽyzyUZV-3G#F DFI H!CE V*/kMR~¹úŹ´ĹϿɷŷ뺬µƶxyoMPT+0G#G!FEG I!DG!R'-hFJ~km{}aWdch#f!e hc uA§ЗqCt?w?vDtGyHwEoBn4CBFB@>H6 jKOy|Y9=G#: 9: ; @BCFDA BA<= :9 J#(nNQ\=B: EDED=><9q\`9 DDDDEEB* B!BDDDDEF4 hLQͿce[7;E 8< = : =AADFCBD>= D ? : Q+/tVY܊c be"f!g!de fe e!]__`cccddcddd e e e!e g!f"g!f$g%g&g&h&h'g*g+h,h,i-h.h0h0h0h0f-b+ʷk=u=wDvHvDxFwDqD4CBFB@=H7 jKOioF7 = FIL?@ABBDDED@?FMIC < = O,1]4;> HGGG>BF=mQW> GGGGGCD+FD GGGGDA5 lGM޵W4:: < =FNMA=>@CDCDDB?EPJHA:9 L&+qunU gbd d!g"f!e!h!iff!g#f#h#h$h$i%i%i(i(h(j)j)i*i+i+i+j,j,h/h0i0h0i1i0m/m/n/m-n.o1m2m2m2m2k/h,л}Xo9wBvGxGxFt@uBz4CBE@@AI5 iLOûG"(9 ?CB>B@>BCEFEDFDDDCA@BED; +`AEZ7<7BAA@AGHGrRY8 AAAAACJ1 ƯH=AAA@AE9 lFL껯O+20F FEC@B?>ABBCDFGECB@==<@AHD 0 ?nrn'Z edd%b'd$fe#e#e#e$e$d%e)e*f*f*f*f*e+e+f,f,f,h,h-h.g/i.i/j0j0i0j1k1k1l2l3k1l/o/o1m3l3l3m4k1h/Ҽ­h3w?uFwIwDv@yIwP4CBF=?IK-fKNnq4 : E?>@CCEHGGFFFDDABDA?CGDEF@4B_9=9DCCDEA?CrSX: CCCCBDH.EACCCC@E= hIMpCI,5 DCA?@=<=@AADGDFIGCBA>>>BBFGF; 1X)/Qdcfh%e$cggfg g!g h!f#f"g#g$g#h$h$h$i&i%i%i'j)j)k*j)k*l,l,l,l,m-m-k-l/k-n1o3k0k3l3l3m4k1h/ѼwKm6wHvGwEzEwHqF4CBE>AGK,tWZ|fi. AH@EEGHIA 8 128 6 03; DC>@ABDFG>AJ> . uwa9=<GFFGF?>CrSX= FFFFDDH.H"CFFFEAF> gJMC#3@DDCBAEGBHJB 8 /.4 2 //4 A EGFFEECABGB9 5kOS~OXhce!dedfff!f!f!g"g"h#h#h#i$i$i%i&j'j&j'k(k*i,j+j-k-k,k-k-k-k.l.l/n0m0k2l5k8j8l3l3l3m4k1h/ѼŰi7xFyHvEwGxIvHb4CBF@BEF5 iGK~[_=CJC?EIG; / J!&bCG{aekn{y}hlvY\[8=:3 ECB@ABE>>HK@ 1 qu`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMuY_/ < C@BCBBHHDD= 6 O$)qKO~ackl}ps}dhlJPU069 :BEFEEDBCFDE 8ZCA@AFEGF. `9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMhGM5BF@DB@BG@=6F"&gix{S374 7 ?CEGCCBHG4M.4ʰXgfb!eibj,T`__`a`__````bbccdfgiiiiklllmnppjkPm3k3l3l3m4k1h/Ѽpn8u@xIwMwJxBs=Ƴ4CBFAAA@ABEC@@C;=eJNC9>DCHGB=@CG8`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMeHM6 EHECADCBC: J',rs[=A5< AEECEAFC6J$+G[eddbe~WprCh/l3l3m4k1h/Ѽn9vByIwJwIzHv@r4CBEBDADDDD?B=8K#ĮD!&7 B>DGABB@IAT16`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJM]b0 DFCEEA@EA6 qTXξx_b>; D?AFACFF7Y.4n%]bdeb!``˞t@h.l3l3m4k1h/Ѽ|Ks@wGwGxHxHtDxO4CBEAEFEEEDBE7 O*.Z8>5EDDFEFDAI> oq`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMy}9 BG@E@CGH= 8高C 5 CCAEEEFF4oHOǯf`acde!\r5Ϝs?h.l3l3m4k1h/Ѽ췙tl9xHwGxHxHuDtH̼4CBEBEEEEEEE> E ȻJ#*@HDEEEE@G< H,/`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMȺ<= HDDHB>GD/ ?? FEEEEEEF/z]bd"edbY[Ϝs?h.l3l3m4k1h/Ѽ¯k;wFwGxHxHxGvF˸4CBEBEEEEEDA?: GEEEFC@DC1 tv`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMiKO:ECDGEBBF.{acz}>DEEEEEDH= :_^ cd#ef_ZͿϜs?h.l3l3m4k1h/ѼќuEtBwGxHxHxGr@4CBEBEEEEEH8 ybdjn2 GEEEFE:F@ R/3`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJM5 DEEGCCHG2 X;?w\`<@DEEEFDB2 X_K` ec ee_]Ϝs?h.l3l3m4k1h/ѼߥSp=xGxHxHxHuBj4CBFAEFEEDDF#N*/: GDEFB@BJ?`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJM_@D7GCEFEFHB 5 A $?EEEEFC?? JܞzD\hha b"cf/Ϝs?h.l3l3m4k1h/Ѽשco:xDyEzKxKtCX4CBE@EDGFD? y]a1G?>EDDCD> rv`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMAC GEEEEED3 oNTlp@ IDEEECCB,tyϗs8`ffc!a _xBϜs?h.l3l3m4k1h/Ѽ跛wo=xExFwGxJuE|Q4CBECDBFCD<E=C<DFECH= [17`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMwbd1GEEEEEE==ɸCEEEEFBDA8 U27Ƒj)dcddbY VϜs?h.l3l3m4k1h/Ѽ̶o@wEyEvEyJwDyM4CBEBFFDDA[8>jLO9 C?FGFECCL%`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMS154 HDEEEEF6V5:qMS8FEEFBBBC/ ̽fdacedW lϜs?h.l3l3m4k1h/ѼîoDuFxEvExHxDxJ̽4CBEAGCDI39ABEEBFD@?`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMF< @DEEEED8 sw4 FEEFCADF0 ǶhcabceX rϜs?h.l3l3m4k1h/ѼƳoGrFyFyGyGwBxJǶ4CBE@DBFA; ȷ8 CCEFDEHB: `9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMõ6C?EEEEE@=EBEEFBBDH: mY[ϽfcdccgU {Ϝs?h.l3l3m4k1h/Ѽ›qBrDwHvEwIwDtFϽ4CBEBC?C? M#'Q.2= FACFEFC< ns`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMwz3GCFEEEE> CV-2> FEEDCDFEU-3ͺfddccdU ιϜs?h.l3l3m4k1h/ѼʣvCqAwKvGwLxFrBͺ4CBECA=E=V/4bBF: G@CEEED; kEK`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMgj4D@CEEEE> P#*_8=;FEEECDEGO!'ѾfddcceUzϜs?h.l3l3m4k1h/ѼǣwBr@xKyHxLyGp@Ѿ4CBECC>F7 b;@nOR:F?DEEED= jDK`9=;FEEFF@?CrSX< EEEEDDH.H!CEEEEAE= gJMuX[6 CABEEEE> `6;jDH9 FEEEDDDDN!'ƳfddcceU lϜs?h.l3l3m4k1h/Ѽ˼s \/6mGL9 FEEEDDDCM &̹eddcc dU nϜs?h.l3l3m4k1h/ѼĴr9wAyJzDvHxGxH̹4CBEBB<F; X27sSW9 G=CEEED= lFL`9=;FEEFF@?DrSX< EEEEDDH-H!CEEEEAE= gJMy\_9 C=CEEEE> ]18d>C: FEEEEDDDM &”j"dccceW ]ќr N!(ο\49= FEEFCCCFM%ʼs0ac efd]Eͷw?h-l3l3m4k1i-оzn;xHxHyHxJsFQʼ4CBF@@@E=KȻ_7<9 >CEEEED; lHN`9=;FEEEE?B6 rRX< EEEEFDB6 Y^J!CEEEEAE= gJMru-MCAEEEE??P%*@EEEEAADD`39ƛw9_c dfe cn-λ|Ig-l3l3m4l2h,ɲݲfl8xHxHyHvIuHX4CBFABCBC3F?BCEEEED< os`9=;FEEEGAH5 {~pQW< EEEEFDA= g=CI!CEEEEAE= gJM.GCAEEEEB? >DEEEEBAC8Z_H^dbcba`ߜ{Pf+l3l3m4m3e'U⥀To {\`sRX< EEEEEC@AH"J"CEEEEAE= gJM@@ E?EEEEE<sNUos5 FEEEGAB@0 Y\deda"c^nd+l3l3m4n4h+q:֝wItAyIyIwGyKsBw4CBFAABBAAM,1pr: G@AEEEEBB`9=;FEEEA?FIM(-yX]< EEEED?@F=ECEEEEAE= gJMZ385EDEEEEF=N"*Z/6> FEEEEEC>. m^ced`"f[ vʶg,k1l3m4m4o0f+n?tBwG{KwGxHuDͰ4CBF@ABBBE5ijU48= H@CEEEEBO"'`9=;FEEEA?DK6nLR< EEEEF>>G: ~kl@CEEEEAE< eHKz[^2FBEEEEFH7? IEEEEEDC4 S04Ÿd_daceZ{DǗj5j*p4l7l3r.j,pH¨k:vEwGzJwGwEwDí4CBEAEEDDD8 jNR; = FCEEABHDdEH`9=;FEEDCDCF< knb5=@EEEEEA?C5 Y27uz@ EEEEE@D; lPS8 B CDEEEEH6 C*-^DH? HEEEEGFI3oqh_eedc ^i&aj+m2j7o5p.p1c-fUq@xGwGxHxHwCuE4CBEBEEEEEC6ötLQ3DBEGF@AG= `9=;FEEEDECG@R#*óK"DEEEECCC>>: dFKB EEEEE@D9 psW18:EEEEEECA.{~8IFEEEEFIACw<^fhddcYƴɶj6m4j7k2p3p4o/`(oԏoAvEwGwGxHxHtCd4CBEBEEEEEH9]>Cò1 CEFEFFABE?ǹ`9=;FEEEFGDDF=jo6DEEEEDBCBD6 S69H")CFEEEDCC65 @EEEEEDE? <S+1@CDEEEDEJ- uTXq[ddgeg"VP^j4l8l2p3l3p0r1g2`~msUZ2 FFCCDGFA@Bô`9=;FEEFFCDHED8V4:̺B?DEEEEEHFECA?DaCEEEEG2yzt/]b ege!gW |ůa0n0p/n:l7m:p:n4n/j.l7T{ιŲıİŰİŲdzdzdzdzdzdzǴǴǵǵǵǶǶǶǶǶƴŰxp>w@xExJvGyGvDY4CBEAFDBEF@<E>7fk. AFFDF?CB@7 qIO`9=;FEEEAHGCADC2 oQUyZ_@>CEEECDFGEA?CA N*/ȶ9 ACDECFBK7 nPS\b9 BDFCEBCCF=F,0ķfHK9 CGC@BBCEG4e@E}T ba!geg!ck!ha!p,o6n7l8n9o9o9p:o7l3j/g-f+g+g+h,h,h-g/g/g/g/g/g/i1i1j2j2j2k3k3k3k3k3k3k5j5j4p=A `9=;FEED=DG>=ICE8 ];>ru: C>CEBDDFF8: A?AC?R%+D@ E@AD@DAG7 `6<5 EDACFEEEG5 7{}ȺK&+3 EEEEFAACD6 K!'وe`dfcf!g#[쥍k`,n-r4q2n3q7q9p9p9p9q:q:q;q;q;rb;@H!&<DEAF8 <ps?; I?@E@BDD4 V/6I,05IBDEEEEEG; 4 _@CǾqLQ3 5 DFEEEEDFN4 @#Q}V feg ed al0߰b)d+q3q4o6o8p9p9p9q:q:q:q:q:r;r;rF;1 O.2|~źȺrv[6=8 ;KIEABGBAB?2kq`9=;FEED@BMa7/ M,/8 BEEEEEEIJG2 3 T-1y~ȸɽ\:=9 ; E FDEEEEEGJ8 G"&ą\_deh"e e"_|ÎrGd-o3p:o9p9p9p9q:q:q:q:q:r;r;rAGD8ux4 EJG>@F?9 6 CJ&T*0[6=]c_e]7>Q(/O"*B6 >GJECCCCAA@;-gk`9=;FEEE?G< z}0 AECDIE>;EO#*S,2jHN_efCGS*0G#8 : BBFCDDFCF@3 uv4 DADCGF> <CM&S)/\8>ejrQWO(.R#+I ; CFD@ADAD@B5 fJM[@B2 AFEEEEEGEC@; 8?K&Q&-Y18|[``feDIS*2O#+C8 5@GHFCEEEEEE3N46쪁MYgef!d e#ed.潡ur > > < 99 >@AEDDBAFBAB92 sx`9=;FEEDDH8 xy󒀁A = @A@CDBA= < =? = : : >CA@@EHDEE= ; gkos@ DA?>?CDC@ < > = < 9 =>BB?<>HFEBB7^/4ciD> CEEEB=@@A@?;; = <? ? =< ; >AF@;<EFEEED@<kORҺuWfgd&c&fh]g黮^vCn8j-j*k(l1l3l3l3l3l3l6l6l6l6l6l6m7m7m7m7m7n7o6p8n7q;;BI8 R.4=FIGECEBGDDA@BCBCB@BGGB@@CA 1 E!']9=<FEFFBA2 w{?< KB?BCDBCEBCC@BCBBCCEAFA 6loD;HGAAEDCBBACBEA?BBCDEBHD : O.3ǵh?<?@B@CGCBBBAEACBBDEHFA: 7V(0WXfd$d'cc"d c$ͷƶs`____acccccdggggfkmmof}KtAuDuDvEvEwGwGs>\2RF@GDCK= ܗ~C"8 ?HGABGEHDCGIGEDE@ABHJC 7 9{beY9<7 A@@AFF6 x}\;A1>D@B??BDGHEEGC>@@=A<3 ?`?E57 CAAB?BBCFEEFF@AB@=;5 :sSX~`@D; 8 A CEHIECFGGIGEBIFDB@CB?=A ?5P/4վe_cc#f b%gei.ӷ{JtAuDuDvEvFvEs>n>*B = 9 @B ; >+ľO&+1 4 ;B=?B@ACCCCA@=>: : 1IzX]S05.9 8 7 8 @A-osיִX/6:4 : BDJF@BACBGIE@8 4 <kQV佯dCH?2 : ?EIMCBABCDFF@: 2 3 bCHùൣoQVJ#27 ? ? E?>ABDCCC@BBAF@ ; 8 0F"e@EUcf"e c"e k[Yﯙ{o?uCuEuDvEvExDi7uT57eAE^DG^BEe?DeAE_CF`@CW7<¸|^a\38@7 3 08 << > = 8 4697 G#'fKN{_c^5:gBFfAEfAEf@EgBGc@FV8=⿭zSXZ26>8 ; 78 < ; 8 : 769 7 X16\aѩkoU(.9 : ; :< : ; < 8 46 ;7W.4^dֲuX[W6:85 7 46: < : ; <8 8 5; : DX.4qIOŹs6^efgg'f)d\mmFvBvCuDuDvEwFo<|L֥iloRVhEIV/3Z05[38X05]8;mLO}[_x{ɻ|egmPSeAER-2X37U03Y59dFInWZ}~Ԗ{`chILV26U/5U04W26jEJsTW|fh㬞osxX\mKOa;?X/4^9r>wHuGt@wBsAl6l}I]ef#j&e"h$e%^"`˼ʶpHrBuAtAtGvFx@y@j;eٕi)Zd"c!d"g%g#i"b`;n?q;u?uAwFsFwCv?o:|Uƍc#bg'd$h(f#j j)cZͼi;o9xAt?sAvFuFvCsClE«շ]cf&f&f%g$ij#a(YUh9q;v@tAvFwIuEuBt@h=ͳ`ah'f$c!f!g$e$f#ar:˷àYd0s>tDrBxDrAvDt@sr:kAɶj,[h(e%h)i'f+d,j%lf`&`鳙{l>pq:m;yTͼΪ]Xdi)f(i$f'g*i'i q#j_b)[հ{kAg3n6t;s:r;t@r@tAuBtAq9g5d̹Ʈc"^e%f+h+h)i(l(k*i-h+g)\`Kͺɹ~Xi7g-q5v=q;r>r>s?s@r@v@u>o:n;ªyC^g&i(h(g,f.j0j)g)i+m1g.bbe(zIêĵXt@g.i1p3r1t5r:r=u@p;q=q?r@r;k6}Ti*`k#i$f(f)h(j,j-i-j/h/h/h+g(f"e#j5zHjzο˶̵˲ζӼϻʴlPvEk6i1j2m4n5q9stqoq:s;r8j.i)xDeνѾwIa$]f#i(l-m1l7j7l.m-m0m2m1l4l4l3l3m4m4m5m5n5n5n5p5n6q:ru@s=k5mq9FA?^7=Ze"h$j&`q4ʿ԰vl5q>uDt@l7fmq8E@> ]7<ٽ[eh%f$_j²l9p7vDuEn:_mq8E@> ]7<ĺ[fg&f^ ɡ}Om9vEvEm3rmq8E@> ]7<ͽ]dg%d!_ȼעZo9vDvEl6mq8E@> ]7<֔m1_e"c^Ż֣Qp:uGwAm7mq8E@> ]7<۰k\f!gZҞxKt>wDt@wJmq8E@> ]6;˹[ef"`l•m=vEvFn;mq8E@= ^7=۞~I^f"cc$ð龥m4wDuFqBmq8E@= ]7<ȇotqQVW.4N#(O!'O!'P$*a;@y^c魝Қ鳦z~wX]V.3O#)O!'O"(P$*^6;rSXǷZ e f!e g"i(e%g"h#i$i'i'j(j)j)k*j-j.k/k0m2m2m4m5i0r>vJs?wGp;mq8E@< a:@ĸ`6<8= < <ACB?= ? : H"e@F2;7 1oPU褖7 : <9 1sKR2; <.kHO࣎Z17> =< 9>BC@< @ 8 : _6<ۧR[ e#d$f g!ec!d$e$e%e&f'f'g)g*h+h-h-i.j.j-l-k/j0g,s=Ǹk5wHvAvImq8C@@ dCH߄ko4: AA; :;:; @BAEA2M"'rPU: DD: }^b謜@CBC?tOU< CB; xX]覑K %3 > A@>; 99 <9< >AB? 4 Y.3ъ]ce!c````abbbddd!d"e#f#f#g$g%f'h.k4l3i/u@wHuCwFp@ȸmq8DB@X38sQU9CA= FoNTeint}aesTXF8 ?CBB@?sPU> GF7 }^b謝CFEC=kFN@FD; xZ_ls5; CCC;FmFK}`cormq~bid>DB;CDE< 8ò[d df"Sb```aaccdefghiikmXl3l3i/u@ën8xKtB`mq8DAA@?D< @ڟ>; DEB= I$rPU= FE8 }^b謝BEEC=mGN@ED; xZ_uV\6 DBC< AΊuy<< EDD3 |بV\e[e͖n8j0i/u@Λp;wHxFwGmq8DCDED9 W06辯D#> FCC<dhrPU= FE8 }^b謝BEEC=mGN@ED; xZ_ot5 ECE9 jFML$): DDE4͒l)_dYȾǚq;j0i/u@⣀VtCxHp?mq8DDEE@K#蹭DDFDB8 rPU= FE8 }^b謝BEEC=mGN@ED; xZ_跫6 EFC<W26I#AEEC8ˉ_ccaƚq;j0i/u@趝}q>xIp=̻mq8DDEE:蟊8 FFA:dhrPU= FE8 }^b謝BEEC=mGN@ED; xZ_S-3? EED=9DEF7kEL«^e_r6ƚq;j0i/u@翨q;yIrA|mq8CCF> a9?J#>BDAR$*rPU= FE8 }^b謝BEEC=mGN@ED; xZ_蹬8 FEF7 zkJQ? EEB8 ؿ^d\Jƚq;j0i/u@ŷp>xEtBjmq8DDE9 fk8 CFD> rPU= FE8 }^b謝BEEC=mGN@ED; xZ_w[_8 FED=辱:EEC5 ظ]c\Zƚq;j0i/u@̔nAwEuAbmq8CCBA輱6 DDF7 rPU= FE8 }^b謝BEEC=mGN@ED; xZ_Y/5< EE> `:@L$BEBA^>Bش~_d[gƚq;j0i/u@ʝsCuGuDXmq8EA=Q$)踯CADF9 |rPU= FE8 }^b謝BEEC=mGN@ED; xZ_G?DF; xU[d?C? EDES'.ع_d[]ƚq;j0i/u@ʞt@xHuE[mq8EB< ^4:L$?DE: hmrPU= FE8 ~_c謝BEEC=mGN@ED; xZ_轴E?DF< chiCH> EDDQ%+^d[Tƚp:j0i/u@ǜr;yGtBdmq8DA= X,2輱J">CE: jprPU= FE8 |]a謝BEEC= mGN@ED; xZ_ƽH>DE< |ZaiDI> EDDP$*^d`~CĹr:j0i/t≮p=yIsDimq8DA@H 跫@@EE:tyrPU= FE: nIN誚BEEC: oHN@ED; xZ_H"ACF= jEKT).AEB@]28ʺ]cal)ЛtBi/l2i,罤p=yIq@èmq8D@B9 軭6 CEF8 rPU= FC> ]38赩@EEB7 rLS? ED; xZ_c?E< DEBI!Ⱦ= DFD6 xV[Ĵùg!ba^٫df)m5f&欐nr@yIq>Ĵmq8DBC9 in{]b< CED? rPU= FBCAǾ:EF@: sSWlJO? ED;wY^nr7 EEF8 jp=EEE2 ̷ùѠ{=_eYǷe&l5n-i4ڜvHuExHs@mq8DDEC?D@FC@P$*rPU= EED;z< EEC>@S)0BED8~be:CEE>G"'AEEECGɾIJйسr\f^|G֕tDh0p4j+vDĴn DEG4 Ⱦǿǹ˻۾ǸY ee`c*o2n8l3j2wɾۯcs>wIr?~mq8DDDEA8~话6EDD?ErPU= FDEE:`>C=CEEFDA< |^d:EDE9E@EDD6 rTW;CBE> U,2ɾƼö˿ξْ̾l)_f]uٺd%m2o8o6j0i/n5q:r;r AECA4 rPU= F@F: F: \8A@vz蚇; ABC= W-4麬7 ADEF7 ^=AǾĺU059 FED? <;ǺµٹǹٵX fdc ػh/i*n6p9p9p9p9q:q;q;q;q;r=s?s?t@t@t?tAtBvEwEtCZmq8CABO+/L%F D8?gjø~G!: ECD@3 zY_rPU= EAIe>C?C< ;ioȟC= DCF9 qTX<>B9X17ȽװmHN< B@BB0询;= FEG? <sSXɾëdCH== EFE>AϿǼĶϽþ罼̸͋`df#_`˯jn:k3k.j.k2l3l4l5l5l5m7n8n8o8o7q=uDuDvEwFn;νnq8A?; gjȿI#: DD: 9 =B; 6 6 @GBC< 1 }]brPU> FCAy|7 ?A;8 ; A75 >BFE9 K#ùB:B= <9?< : ; A@FB3 fjQ"(9 @CA>7 4 8A? 76 : ?FE? < bAEϿȹüʸٲzZ e%d^ȼùseghiijmmmpx`sAuDvFsAR}fi:> >8wX\ьouA 9 >BD@CED@@= 9 L#*iIM4 <? 7ž垊E6 <?CCCEB?9 4 `;B\4;; 9 >ABBDCA=2 BjpٕK&9 8@ABDDACBA=7? M&,ȵضЯӕj)`e"ch&ݷ|pE<: 8 9 < @C iKPjoV/3]7<_65; @BR(-qwżҭyZ^R+0B>;;9 > @DU*0chпǸ¿ȾЯʾ[ef&]}Fǹn?tBvFn7{ȱˬٶȪȸݫۻڲj[f"g#\[µn=sAvEr<{M˾ŵ}|񾿿̿ǿԟ{C]f&h$^VȻk7s>uGt@n<ʸ~}ɾΖn0_g&i"\xC׻i5s?vFtAl9ʼĴx}ǿýʿƾn-`g&h%af#÷΢]i/tCvEs;k8˿̺¯zu}}ȹ·ɿƾt:\f'h*f$aYؾo;m3t=uCp>q@ͼĸzww~~ιî\]e$h(i(eda̿Ծq@i/r:sAsAk4tF̻òy~͸ߺټd#`h(j+i*a"a!|EȾ²in8j,q9s>r>p;l5v̻òy~~ͺ¸ľȪ^ca h)k-i.e&d$d&o6]wò¯m{Io9h0j1p8rp7l0n3zKðȻ²zxz}~˸ǻuq5a d$g+i+j.l2l4l3m4n6n5n5n4o6m3k.i*p=i̿¼zwu|}˹·xQw=r:r8n4l3m4m2o3q>AAAGIHHPPLPSQUZUZXZX^Y_c_babbbchhhjiiiljhqjopjqqprrqxztzyxx}y~zzyyyyy{yyyy~~zzztyypxxorqimoiipwwʱ˿Ǹsty̽ŽŷcdjINN:<<>>>EFEJPPQSSRXZSZZ[[[Ybb_cbdafbfibgjhkjhkkiprmqrqsrprrrwzr{{y|{z~z|}}y}}rv{jqrklszʻï͹}}|üʷܾxzysxxżŸnptPRT:>?787@DDHMLMRQRSVSY[W][[[_\ddaccdddfkklmlmkklnskqtmtsvrvtu}s||s||x{|}}|ux|loqrsyԿŨw{{llljjikkj\\_vvx~~~___~}}uuuʸǾɽŸ̿ıоǼŷ[bbFCH8:;;=>DKKQYY[`__cdehihllnvvwwxxz{zzzllleeecccvuuvvvuuuQQQdddwwwwwwwwweeeddd~~~```jjjOOOgggnnn\\\pppVVViiiYYYooozzz~~~[[[eeelllppphhhwwwyyy|||UUUppptttRRRUUUpppUUULLLfffGGGddduuua`a~~~|||ѿȶ||xwrxzpwxpqxppxppxpqxqqyooqRRR554QQQZZ`acccllmpppvvxyztppniivvvllliiiGGGfffwwwvvviiissrcccTTT|||tttrrrWWWfffRRRqqqwww~~~\\\rrrVVVEEExxxhhhLLLHHH}}}~~~uuuxxxuuu{{{~~~OOOGGGsssrrrfeekjjٿ̶~w{{rxwowxpqypvvppwppxppxppyppwoop222DDFXZZdbbhmlmrurtyu~źɺúǺº¹·¹ĴYSSooooooUUUnnniiikkkfff^^^iiiWWXjji}}}kkkhhhkkkpppsssqqqvvv|||ooo```JJJOOO```sssKKKnnnnnndddjjj[[[\\\```\\\===HHH{{{poo887FGGikkQTSadcտǶ|}~swzowxppvppupooppqppyppwppuppqooojmmSTT133QRV[ccimlmuwvz|y{z}ù¸¸½ʾǹûɸĻ¿ǸüºķŸij÷µNKKabbmmm+++...```uuuyyyVVVEEEBBAttvqqqmmmssswwwzzz```zzz{{{lll\\\nnnWWWfff___qqqccc{{{~~~iiiwwwppp[]]WXXZ]\MNNHLLWXYdfjqw{Ĵ{w{}rwwppvpooppoppoppsppxppqppoppppppjppnrq\VV4,,DLL[\\ahghrqsz{y~v~ĽƻƿƾͶǺ˿̻ȿ˿̼̾Ż¼ȽȻǸĵoonGGGuuubcc999PPPooossszzz111__^QQQJJJRRRIIIooo|||iiiDDDfffzzzeeeGGG{{{kkkqqq}}jjiXWWOONjiiPWWX[ZlosȺvzqvyopxpovppuppqppuppqpprppopppppppppsssgll@?[[[e__/..STS^ddmmnouuw~}ƽҼōZZZҚɽ÷innGMLBAAdffJ22?;;ZZ^bkkkutqxzz~~úȿ˪UUU躻̿ǷsvyJKJFEEonnƭ0((IHHY^agiintru{~{ķδllk}}}Ӧʿ»Ĺx{~KKMGGGwvvµ]PP+((MTT_cglnpprvt}|··ҿÅXYXɜʻù~~RSSEGFƵŨF33;44VYYahijsssw|w|~ɢ\WWಲȼĸ|}}WWXLKKǷɇ.--GFFZ__biijrrt||y}ſʱieeϛȽŷvzzTWWNMMой^\\+))MML`aaijjqsss|z}н}||fee箲ȽŷpttPRRPTTϾɹI887+*TVXbhhhqqsxyzy{}»շzrvzy̙d_^ĿΞɼķnrqMMMXWWϽռ3,,A;;Z[^hgglppqy{}~ԩwnoQFF9-,3"!;@D?++WGF{poʪ^\[Ϳ︷ƻķpoqKKM_^]μʲtmm' EKJ_`dhlmquuuyyzzssF21:? M%%N&(S)-X,+X**X((T##I$$N46xpr̾ghgڧ˿ǻ¸ottLKM\\[οܾYLL3##QUT^dghpqqyy{~۴VKK2>M''O((Q((X-.`03i:9p??rAAq@@f88X*)K'*\NR˄{xxƚɻøqvuNNN\]]οѵA::799U\\eggoppqyyz௲IDD8D%%M))P((P))X//a11n>={KKZZeeeeccTTk9:S+,LFEʜbaa{zz٣ȼĸqrrQRQaaaï+))>@@\]]gnnpwxxyzzڹFBB0D I$$M))V))Y//a11m=={KKYYggwwbb|JJV00KEEиa]\ә6%%?AAÖϿȽŷkooNQQdggώvnn2JOO^ddioopwxy{XMN0;E!!M%%Q''X..a22i::vFFSSaauuəѡ۫ə||}LLS//YNOjjjܾpqq333,,,TTTΟƾƷdmlUTTgffֳ]XX1((QWVddgpqrr{zx}yy.9E L##R))V))_//h99lBB{JJSSbbppÓק踸踸ԤvvvJJP//phjʆz{{罽iii111...888ttt˾ƽŶ_gfTTTjmm̭·BBC588UZZeimnwxx|⪨=((0=H I&&U''[..^00h88rAAzJJSS``eettʚޮܬook==M0/վɡda````666333666RQQ˻÷bhgKPPlllĪýȨ-..DBB]__enmswwxTLN%<A!!H&&P((V**^//e44i99qAA{KKTT]]eewwե緷Ϝ\\R..PFE̹YWX]]]:::>>>;;;@??feeȻùdfkJJJlooҺ¾В2$#IOSaaelnrwwx~ण0.@ G!!Q))X**[00_//g66i99p@@tDD}MMVVeellxxبĬpAAD,,nijbbbCCC???EEE@@@CCCdddɺ¹ikkIPPllmóyxy2/.NRSaijnuvw~~i^]% ;G!!O''S''\++a11_//f66i99p@@rBB{KKTT__ggkk{{Р嵵Ң[[R''ZMMɌrrrLLLFFFJJJNNNJJJ\\\ȼĸkjpPPRqqpZ[Z555X[[jonquvvٲ0#"*@I""Q((X**[11a//_66f88i99p@@rBB|LLPPUU``ffkk~~Р嵵踸}}k==F00ΤohhԎ[[[NNNLLLRRRVVVWWWYYYʿǾƷeeeRRRnnmʼCDD??@`_amrrv{xڄ{z# 5FP((S((X**[11a//_66f88i99n>>rBBxHH|LLVV^^``jjuuޮ’PPJ""g__̸d\\ŕmmmaaaZZZ]]]VVVkkk槬̾ƾƶbbbXXXkkk̿ɯ~}}0))IHIabhmsuv|~wPJI=G P''Y((W))[11a//a66g89h88h89rBCwGG}MMTTXX^^ffjjyyϟరبjjZ,.F=>̽hbc̾ƽ·cdcZZZrrrϭzy}QPQ6NRSdgikvtuz}|͹,##0CG##O((X))W--[11`//g67h85h88i99p@=p@AyIIOOTTXX]]ddnn||֦꺺緷||j9;C(*ѻyz{˿Ȼĸ³^ddXWW|{{ڲv{{uyy}KKK5.-QVWfmnswzv~~Ջ :G M&&U((X))V11[00`/0f62i90h87h88l<9o?@tDDzJJOOSSYYcckkss߯͝ݭ{FEL keeőYYYɺ¹aegYYXxxx鶶z{{u{{u~~~;;;799[ZZkpou}~}c__9F%%O((X((Y.)^00_00`00a10b20g77h88j::p@@uEExHHJJOOSS\\ddhhww˛۫ÔLLT##WJJɤMMNȽɸĴbijX^^lllDDDᶶxx~v}}}~~ww~~}}877@AA]ddossx}|~JAA#> E%%O((W((Y0/`00`00`00`00`00g77h88j:7qAsCCwGGxHHzHHLLSS[[bbffwwoom<=o??wGGxHHyHH}JJRRUU^^hhyyjjm<>>:::555:::SSS˟~wxxw}xxxxxxxxw~tuu>//LIKhiirvu{YYY$H$$V,-Y1,X0/_00`00`00`00`00`00`00a11h89h88g77m==qAAp@@v@@xBBwJJ|GGLLVV``ggmmww^^k::P&&e??ӷuut˾ƹº»øsx|WXZYYXxx{ߤѿǽŵPXXpptZZZ222(((000333222111)))---<<>ͽηz|{w{{~姫ɶbbcIIJǹɤʾǴyxxwxxxxxxxxxwgee222SXXirqt{|eee#H''V22Y00X00_00`00`00`00`00`00`00a11h86h88g78h8:o?:p@?p@@p@@sCCxHH}MMOOWWaaiihhXXi77R''SDDҿǒư真ȹaaa\\\ŘȾ~wxxxxxxxxxxxwzccc888Y[[jqqzz|nml!C''W22Y00X00_00Z00`00`00`00`00`00a10h83h88h88g77n>9p@?p@@p@@sCCxHH}GGNNQQ__bbiiRRb..P%%LGG˝ȷwz{]]cدпǶ~wxxxxzxxxyxzxw^]]>>=\^dqyyz}{}  B&&X33Y11X00^0/Y0*`00`00`00`00`00a10h81h87h89h88h88o?8p@@p@@r@@x??wDD~NNPPXXccdd|KK_--P%%ZOOѠɷnrweklĠпǶ~wxxxy}wxw}z~{w[[[BBB]eesyy|ӆ A!!]88^33X//W00X00`00`00`00`00`00a10f60h80h87h88h88m=8nAAp@@o@@t??xEE~HHOOYYaa]]yCC`++O++bXXˠȷiopy}}޳пǶ~wxxxxwxxxwxx|wVVVCCCbeezyyΛ! :X33a55Z00W00\00`00`00`00`00`00`00`00h80h85h89h88g78h==mAAp@@r??vEE~GGOOYYaa^^wEE_++P++g`a˥ļȶjkkСпǵ~wxxxxxxxxxxy|wWVVHHHgjjyyx̳.7Q,,_77^22]00a00`00`00`00`00`00`00a10h82h8:h88h88h88h88i<:p@Ao??tDDPPQQXX[[UUo;;T((H**yvvʭ̾ƹ{z{~χɹ{~}oooϠпǷ|wxxxxxxxxxxxwW[ZGIOfmnyz(&&+P//`22[00_00`00`00`00`00`00`00a11g77h87h88h88h88h88i98p@:p@Ao??tEEIIOOXXWWMMl88T))F**ɪȼĹ襤ɷtvuدμ{wxxxxxxxxxxxwW[[GPPgnny=99&P//Z11X00_00`00`00`00`00`00`00a10h81h82h89h88h88h88i98p@:p@Ao@@t@@FFOOXXWW{KKh66V((:00ɫȽųppp詭ɿŸmll溺{~пŲ~xxxxxxxxxxxxxwW[[NPPnnmySPP# J**W11X00_00`0/^0.`00`00`00`00a10h80h83h89h88h88h88i98p@:p@Ao??tDDHHOOXXXX|HHb..R$$?66ʳҿǿǾƵ}}hhg઩ɾ¸cghƚ~Ͽdz|wxxxxxxxxxxxw\[[PORnmqyjfe E))X22X00_00_0/\0,a01`00`00`00a10h84h88h88h88h88h88i98p@""W11X00_00`00a01`00`00`00`00`01h85h88h88h88h88h88h89p@Ap@@o??tFFHHOOQQSSr<<]))P))[MM͵ҿǹ||vvvhhg֣ɷcllpouŜz{zw~}ϾƵ|wxxxxxxxxxxxxY^^OXWowv}ҡ"<U..]55`11`00a00`00`00`00_/0e51h85h88h88h88h88h88m=9p@@p@@o??tEEHHOOPP~IIl;;[**P''e\\Ѷȼ~zy|}ruueeeӦпǴ^]^˵utwsruϾƵ|wxxxxxxxxxxxx|[``WXXovw˵"0N//_77a11^00[00a00`00_/0f60h81h89h88h88h88h88h88qA9p@@o@@s??wEE~HHOOPP~EEh44T''L&&uooкȺwx}|tssgffˤѿɹ^_]翿zlnmjpp}}ϾƵ|wxxxxxxxxxxxx|]``ZXXovvĿ3/.*L--^88a11`00_00`00`00`00a10g71h88h88h88h88h88n>8p@9p@@o@@t??xEE~HHOOPPvEEc00S&&I%%}|ʴȹ~x}}yyysssmmmäѿȹSY\ʲz{{abb]]]nos̵{xxxxxxxxxxxx|]ffXYZovvMHH! H++^88a11`00`00`00`00`00`00g77h88h88h88h88i98o?9p@@p@@o??tDDyHHxHHOOHHt==a++S**?32вȿƺ~~yy~xyxppqmmmձǻó|yz{ԾfjjONMEGFSSSdff~Ͼï{}zxyzxxxxxxx|^ffQUZmuvrjj@""^66a33`00`00`00`00`00b20g75h88h88g78h88m=8o??p@@p@@o??tDDyDDyFFOOHHm>>Y++N((O>=пοпζõ}~yx~xyxjjlnnrɣǸ{uvys{{~~}||{zz{{{zyyqqqqqsfhf[\cY[][[]\\_mmoξƱ{vxwy|wxxxxxx|`ffUZYqvuؓ : [44a88`00a00`00`00_/0d40h83h88h88i9:l<9j:7o??p@@p@@o??tDDxJJ~HHOO}IIn::Z))K%%YKKѿȺ·ɾxxy}vyxkjjpprأ¸wv{rtvpttpttotsquuνƴ{wx|xwxxxxxxxzdff\Y]wv{ϥ ,P//`77_//]00a00`00`00c30g78h88g77k;?o?;p@?p@@p@@o??tDDxHH~LLPPwEEj44X%%@%%``_по̽Ȼ·ɼ¸x}ty~tuyfjjuttʾľǷĽƽƽǽʿνŴ{wx{xxxxxxxwzbee[^bvwzĻ7..'L((`88`44[00]00a00_/0h80h87h88i98o?8qA?p@Bp@@p@@p@@r??wDDwII~KK}KKw??`00V((:++w{zноѾͺķɺ¶wz}yz{ruufgjxxx뭭ƾƾƾƽӽĴyxwxxxxxxy}x|cee[bavw|QJI F%%Z22`77`00^00`00_/0g70h87h88h87m=:qA@p@@p@@p@@p@@s??yDDxIIyHHxGGq??^--U((F44пппϾ˺ŷʷxxxxxvuuhhg榫ɷz}yxxxxxxxyx{cee[aavw~xxx >!!W11`77`00`00`00_/0g70h87i98o?:o?@p@@p@@p@@p@@p@@s??yDDxIIxHHxHHn88^((R&&R==ппɺ·ɸyvxytyyuutfff٨μzxxxxw~{xxxx{cee[aavwwٖ5P00_66`00`00`00_/0f60h87i99p@@p@@p@@p@@p@@p@@p@@sCCyIIxHHxHHqAAh77V''K##aPPпϿɴ¸ɸy~vx~ryxsssdddӻͼIJzxxxxw}zxxxx}dee[aavwwѲ3'(*M--X00]00^00`00`00`00g77i99p@@p@@p@@p@@p@@p@@q@@uCCyIIxHHxHHqAAe55U''F$$pedѿʿͿοͿѿȵĸɸw~uyxpyynssbaaյͼIJ|xxxxxwxxxxwfddZaawwwLFG%G''Y00Z//\00a00`00`00g78i99qAAp@@p@@p@@p@@p@@r@@yAAvGGxHHyFFrAA_//O''G32ʿοɻ·ʸwyouwpxynssccc󺺼̼IJyxxxxxxxxxx{bii[__rvv}oqp!B!!V11a33`//`00`00`00g74h88m==qAAp@@p@@p@@p@@q@@q??sDDyJJuBBm<<[,,M%%P<;пͿʿͿѿϿ˿Ⱥ·ʹ~xzouxppyostiiiˣӾƱxxxxxxxxxxxzgmm^]]nuu~۔"6R22a99`33`//`00`00g70h88i99qAAp@@p@@p@@p@@p@@n??tDDyFFqAAi33X''F%%OMMоǿ˿˿˿ϿϿտκöʸyuy~puyqqulkniiiťɻú»ú¿ͷ|{˸xxxxxxxxxxzillY]]nuvҿ@.--L++a99`55`//`00`00g76h88j::qAAp@@p@@p@@p@@r@@t??sDDyDDs;;c11X''E&&ejiͿǾǼҿʼľʻøzvy~puypqvkklggfʼĹǴlkmlmm̺±zxxxxxxxxxxziqqWYYnttXWV*K**a99`99`33`//`00g72h88j::qAAp@@p@@qAAp@@sAAu??tDDuEEk::`00Q''N22ϿϿȽǻϿҿɿȴļʹywyyqvyppvjjillkƻҩ̺±xxxxxxxxxxzjrrXYYmmm}}!B!!`88d::d55_//`00g72h88k;:qABrBBp@@vFFqBBxFFt@@o??q@@k9:Z/*K%%O@@οɹȼȽȽȼȽȿȿʿʿѿοǵ˹zxypxypvvihhmmmɿǽŷ֥Ϳı~xxxxxxxxxxzpttXZZemm~ׯ/8S11e==f>>`22`//e56i98o?:sCDxHHrBBp@@p@@p?=p??q<o?@p@@p@@p@?p?7p>>o==j88b33Q((E((}{|Ѿξ̽ȼȽȹȻȼȾȼǿƼ̿ȿǶ̺zx~txyuwwcbb{{{󰯯̼ĺôx~~ɠ˺±xxxxxxxxxx}zry{TVUegfy|}E))d::g??`::`55`00`88k:8qA>p@Ap@@p@@p@?p?8r<=l::i66`--K&&=54ǾǽǼ̿ɼɾȿȾȻȷɼȸȺȵȽʼͼȿȿǷǺ·~yx~xxyxwwbbb|||ﮭ̻Ż÷z}|y{{󫪱ʹxxxzxzx~xx{xzx{xxz}XX^dciyз)!!9^99kCCg::a99`11f88j::qABp@@o??p@@p@@o>886^;;rBBj@@h88h88g77k<lAAzIIlAAg::j88m<>i88d99`33Z00W''O&&D##SGFȿȹȸøƸŸ¸eii_IIQQYYTTQQLLHHGG}JJo@@m;;^00Q/.cVUпйȱȷqvvJII٨ʹxyqvxpoypptpppppppppppqppvppoppppppqqqZ[[[\[{}~iii#(6:@ B I HI&&H""P''P((S'+X+/b98SFF\WWihhoppoosptypxxpwxpxxwxxwzzw|O>>E''\44\44_55Y11U..N''L%%>&&O??׾͸ǷȾȻȸȸj^^nBBTTTTII~HHxFFxBBwDDwDDxCCw@@wFFq@@h99K%%UDCпʸȷ~mnnYYY᯴¶yvvyopypptppopppppopppppppppppppppqqqaabSZZv||wxx (79@B H H G N''K((O((P((O''T++X./c99]LL]WWghhhpokorqpyppwpwxpxxrzzx{󶷷_^^H44C..G+,G++B++B..K99TUVɾȸȾȹȺȸɸǹ±cZZ[55JJGGxGGvAAu>>p>>o>>o??p@@n99o>>p88p::p<>f<>l66l77k88g22h77k77g99i55i55f99f22g88l66f33i99i66c66R,,SBBмɱʼŹ˼UUUpppWWWyyyĮ𽾿пȼų~x{}txwoxxpqxppxppxppxppwppvppvppxopwU]\bacQPP8:C B F H%%H J!!K**H((O((P((P((P((P((O((U()Y(/X/0]43gDDHJJZZY]bgghjioopprottsyxxx|}žȽȷȸƸƸƸU66d55k::j::i88i88i88h66h88g88h88g77l77o88i66o88o77i66q88l99i99_11H**z{Ӻʱʻĺ~͵LLLaaa[[[yyyǝʖz}οǵ|}ww{sxwowxpwxpwxpxxptxpsxpxxprxpvx]cbXWYҺ;99-8:F!!H H H''H!!J''R((J((M((P((P((P((P((O((U('Y(.X/0Y0/c55ZDDNQQ_^_aefgoojppprrsxxy{|x~ɿȽȷȸɸøǸcTTN))m==h77h33i99d33e55h33h11h99h55h44i99i88h88i88i88h99i44h00h11a00E''XWVҺŲǾ´ͱJJJRRRQQQVVV^^^ߤכzι}w|xw{xxwrxxxxxvxxoxxpxxpxxpxxqxxllkSSU~ҟ)/;A!!@ @ G H H!!H((K((P((P((P((P((P((P((P()O'(V..X00X00Y11d99]GGZVV__^fhiiopoooorrs}|~ȽȼͽǷȸɸ¸ŔL88X**h97h88h88h44h//i66b22g11i88h00h44i44c00g77h11h11j99e44`//f11a00M&&Q??ϹʿǹͩGGG奥AAAIIHSSWOOR橩~w}}ϾƳ}x{xv{xxzxxzvxztxyvxxqxzrxxryxqrsQQZrvzԑ&/<A!!> F""H##H J##N((G((N((Q((P((P((P('P(*P(+O'+T,0X00X00W//\11W>>TRRY]__eghinjooqrstwz}~žȿȼȷƸǸ¸oorJ++_66h:4i87e/0b0/h54f22h//i66n66h77i::h55h66p99h88i33q;;k55i56i9:a22T,+H54ϱ˾ź¶ɵӚPPPޚkkkfffީʯxzyһî|{wywwwwwvxy~wy}xwyw|yy{puxTY]ajj֎%4B!!A CG$$H''H##J))O((M((Q((P((P((P((P((P('P('O('Q*.W-0X00W//Z33g::[FFUV[```fhiijqlpqpsz{}þноǷĸXEDV&&d86e66i45g00f70c4/`12h44d//e//g33d66f55h55j55h55i::l99g44m85h65a..U*,L11ͭǾúµ~~~~Ѯz|{`ii\ddutuxz|orqcbakkk```檪ܯwwyȶ|{{~{||~x{~v{wwwv^adY_]ԍ$8=A!!G IHG((H((M((Q((P((P((P((P('P('P()P(+R''X//X*1X00W//Y11a55L??QQP]\`ahihjmhqpmsrt}}ĸοи̾ƶ¸ƹG*)c34k:2`0/c./d10d50c1/i77i77c00d77g77a--i11j00_//f44h77f..e11i41a1/`((U$,E00ֽʱÿȻŽźù}||Ѱxzztsqy}~~bbcMLLLKKJKKmmmɿﱱʹ°~nmuQXV՚069B G##H""HM''L((I((Q((P((P((P((P(-P()P(.O(*V('Y*)X)*X00X00W//\00B77OLKYW[`chciglllqttu~¹ɼʼżüļѽɿǼǼȷĸõlbaG""a34h31f11e55c00`/0d//c22b00h00i44i11h11o99l77e11m99m77f..e44i78b11`--T),B00ȭ{~~ժuzyMLLႂnnmпǶ|TW[{{ѳ?))6:D I&&H##HQ''O((J((Q((P((P((P((P(*P()P()O('U',Y,/X).X00X00X00Y00O..JDDWXW`acahiijnmutqyzx~º½ĽǼͿɸǺ¸¸ZGJO&)\10g/0c00b22c//h33d33^//e55h11a//c//i11e22f22h00k88j88g66l77l::g22a00T-,O<<ֵ~}ޫ~Ȼî[[Z~~ȿƸϿǶ]__enmP::2?C I!!HH&&I((J((O((P((P((P((P((P((R**U--N&&U--Y+1X(0X00X00X00W//_33G>>TPPZ```chchlmlppvuvy~ĽϿɸƸC67X--f44h88a11`00`00a11_00e55i99g66a11h88f44^//f00h00`11a11i11i11d11`00`00M&&TCB٨ɉȵkklɾ|~}[[[^^^nnnvvvzzzɻ¸uuxX]`XVV1A ? C H I''H((I!!P((P((P('P(-P(*P('P(*P(-O((V((S((W)/X00X00X00X00Y00R//OKKXYY_bbchhhkkmuuv~ollb^^ieerlkysrz{ȿȸƸ||K&&^00a00`00`00h77f55_//`00f11b00`00g11g88g44g//o77j88a00b33j66d00^/0_00_0/D''WWVԝ岲ϽŸoooǪ˾ighNNMXXXZZZVVViiiùWWWֈ3@!!@ @E&&P))K''H##P((P((P((P((P((P((P''P(&P),V+-Y+*X0/X00X00X00X00Y00R//IEEOWYZccdhjhllmtuv~~qsr<43= D Y54xII]]ZZaMMh[ZʿȸƸd\\N&&a11`00b00`00f00d//e00k77b33_//b22a//^00c//g44k77h66g11k99p::e55a0/c30X.(H++{}|жṻqqtttuϽŸoooШȸ\[cffgoonzzzwwwuuuooo~~~~~~[Y]mps˹6&&7A DI&&L))Q((L))P((Q((O((P((P((P((S+*P'(V+.Y.1Y..X00X00X01X00X00[00S//GCCSTYZ__bfifjomqvv~~Ĵ6//4AL##^66}PP``bbRR^99XPOͿɷƸOFES.._00`00h00a00^00`//f33f77a11c33j99h33`//g11c22[,,^..g00j55h66d22h3/i71O((G:9ԨٸϽŷkkk̹uvxqqpkkkkkk~~~}}}yyyooorrrzzz~~~~~~{{{|||wwwwwwvvvzzz~~~z~{zzzyyz{{|~bgh[_bSQQ/@!!H!!H((G%%K''Q('N((L''T++R**P('Q))S,0S()['/U'1S'-W//X0/X0,X01W00\00T00>;;WTSZYY`dcbhjmppw{~Ķnbc17@L##e66PP``aaXXd99E21uw{ȼƷ°D33Z//b00_00c00`00e11d44_--_,,^00d44d55c44f11i99g55]++a33g44b--^++^00c01\,-C''URQγ׵ϽŸkkkȥ̹¸ssspoozzzsssssswwwyyy~~~zzzvvvpppiiiccceee```bbbbbbhhhkkkqqqpppuuuxxxzzzwwwyyyzzzzzzxxxvuu{{{yyyyyyzyyzyyzzzzzzvvvxxxwwvqrrtwwbfeTTVٕ(=G&&I%%HL'(P(-O((M''S..Q++P((O((O'*P'&V++S+1N'1W/0X00X0.X00X00Y00S00988WOOXZZ\beeehjmlvuxůR?A+8?N##e44yII^^aaSSl<=3F%%I''H O''P(*P((P((P))P))P((V((O('R'*X,0W+0V,0X00X0/X0+X01X00Y00R00F22WPPWXXZ[\aceemmowvɜ5))(9G T++c77p@@[[\\JJj;=F&+NA@ɿȸƶwssI&&\11a00`00`00`//_**_00b//h66j33a00`..e00`11_,,^,,e00j77j99h11f33i88a44L''SDDЭ泸}ϽŸpppʿǹ|{{uuu~~~xxxwwwppphhhdcc_ccZbb^``fffggglllkkkkkkfffeee___YYY[[[YYYTTTKKKYYZ߈1@##I))H''O((P((P((P((P((P((P(.X/0W'.W**X11X+0X(+X)/X*/X0)X01X00X00Y00J0/JJJXXX[ZZ`ddemmnwv̏.!!(9I!!U++c44p??ZZTTyHHl;;P"#G66ʺǸe\\J''\11a00`00`00`00`//`00`00a00a00`00g88i77e00]//d00d00a11`**b00i33j:6Z./E(+xuuλĵϽƸrrrȹ}~}}~{{{rrrkkkkkkjjjiiiiiinnnooouuuwvvhiiOOUzz|F882F O''P((G((J('R),Q),P('P((V./P(-P(+P(-O''V..X00X00X00X00X00X0/X//I))E??YRRV[[[ddehlosvxȂ():J""T**c34l<8|LJQQyHHl55M$$9.-uw{ʽǸUKLQ('\10b11[++^..a00h22f55_00`++_--`00f77h66e00c00n66k44a//`**a00a00^10L&&F>>бϾƴrrr˾ƹºº}y~y|}~}}|||yyyxwwtyyW[Zaaf⎈.?P''P((I((L''T++S++O''O'*P((P(&Q)+R+.Q()W-/X00X.0X0.X00X01Y/*Q(&H'(P22TSSR\[\`ddegonnxtxz"*@ P((Q*)^32m<<{KKRRvFFd33I""7&&ilm˺ǹF;tDDyIIp<>i::V..I32}ͪϿǹyyzwww孯λĸwx}zxu}}V[]VW^smm7O''P)(P'(Q)/P(+P((S+0W/0W/0X./X00R*0R)*X0.X0+X00X11X/*W('G**CDDTTTX]]]``gffppwgih,A I((S*+Y,-X''X((X((Y((T&&E7&&MPP˹piiG''Y00]01`00^/.`00`00Y))Z((`,,d00h66g88a00`**`//a00`00_//V..C**jfe״ϿǸxxxxxx孭μijyz~yxzpsrRTTcggQMM;J('Q)-X/1T,0S),X00P(0N'*U(,Y/1X00X+0X00X02V.+V-+X))P''D((CDDTTTX[]]_`effopwlsr"'=J&&S(*W(,Y('V((V))Y((M$$F7&&MQQ̸pghD$$[11_0.Z/*V(&[++`00a00c00b00^..]--_--`00`11e33g11c11Z**F%%PPPֹĥϿǹvuuޭνŴyvwxxxyaeeSTTsqqٴ>++;R//Y21Y.1Y(.Y11U.,M&%U.-Y11X00X11X00Y11U-.U*(Y)'O''?""CFFSVVXY\]^`_gfopxw{y' 6F N)(R('X((S))L%%P$$GF7&&OUXǷohiJ))Y-+V1&Y-)\+,[++_//a11k55g33]--W''^&&`//a11j;;i66`.-M((N<:ԿʪϿǸpvvݭɽĴy~wxxxzt}}W]]W\\w|~♚7%%B#"S-1S(-T((X10W-/T%)W-,X11X10X,+X00X00X01X2/X*(U''D''DGGXY\W\_]`_`ffiosƆ/## 7B!!I%%M))T))N%%H GI E1%$VWZǸpiiI((X-+Y0(_0/a01a11`00a11e55b33`00^..^,,`00a11e54c14Q%'E10}̭ϿǸrsu׮ȷ~ywxxxzluuQUU]`d凅))[]\αȽsxxب;Ŵ{[`cOVVfgg`aa9%%M''O)(T'(X--X1.X00X10X00X11X--X)'X((P''E--b^_`fj``d`^f`fhgoow{zɽ˜K;; .5887;9 :--@FE˹¯B""R'(Y,(X-(W&'X((_**`00b00b11`,,X''W((N&&C&&X[[̲ɾƵvwwاɽõy{{jjnoounooRWW_dd__c5##E#"N&*V--Z2*Y10X..X00X0.X02X2-X*'N''M00likhmp_gi`bhbghgooqyy͵JJJ*# /68!!E448::444]aaʹijE&&S+*Y-'Y.)[*+Y))]--b11i11e00[**S((H$$E""cQQ̮ʾŵqttথŽôacf__awwvOTVZ_cfee,AT00U.3U,-Y((X0+X-'X1.X12Z..I((G==vyyryxhkk_hgfhhhoorzyѰliiLJJH77G55OAAOPPTQQ>>>IMMȹƴïO==P-,Y2,]1/c33Z**W''\,,Y..W++V''N%%K$$fTUɯʿʵvvv礦ͽƴtssY[[mpo᧧QPTZX\}|zz9#$@""Q*,L'(T((Y*)X(-X,/Z+.V,,D((VSSxklleffghhhooqzy޳uxwssrnsshjjU[Z_ee¸øýɽfbbE&&W,,[+,],,Z))Y((V''I!!K%%E##C..vfj¦Ȼͫruu󤧧νŶ_cf\\\Ӽ[baUW\rz{ܒG44@#"B##K('R(*T(0W(+O$%E! E,,vttmppgnnhhhhooqsxЬȹøƿɌ--WVUswwllmʿȺǸƲxz{ӼW[ZcbbވRTTZ`bӜbXYD..>$$>##8!!SGGrzzprsjooipppqx{ɾȸŸſյ]UVC((A$$C%%M77c\]wwv}}}ɹǶ˩zyzϣܶonmLKKfihOSUlor͠}}|rlkuvv{~qwzosspoppqyz{žƿȿȽƾƶŸŸɿᰲȱރ|vvvʽŸ£xxxޥ٠W\\dccߏTUUZ\[}̾ĸt||ryxptsqxyy{ƺǷĿյmoouuu̼ž»xxx餩׏feenrrNSVedjzyz}qyyqxyzyȽȽĸùķ|{zjjjxxwx|}ʼĵ~~zzzԒ^__LVUioo~y~pyyqwyxzij㹽hgknnmyy~ȶƯ罾poqּghgXYYjpp{}}zpxxqwwxz{{ɖllmnnntttmloȷvvuק]]b{{z曛abg\]_hnnprrpyyu||zyx{{qxxoxxszzx}}||w}|з駦cffott︽dfkQXYX___ffimrptxpsxpoqoqqowwnvvrzz|媪ïònnn߄GGG训}}~v{{gnn\^_XW_]^accbdffgllgonjnnorqs{z|ȵ}}}ф}̈́ͫ㹹=<<Ʊ|}~~ooq\b`RVVOTTWZZ^befihhnpoqrs|{|}}̺ñvuuxwx{z~y~~ԩjkoވaee𸸷ڷ쟞z{}ehhRZZNQVVVY^afjinlsqrx|}}}|~}оŵxwwyyy䝢qutuuuonnψ覦Ԣ嘝pyy\acORSUTU`bajmmotts{{u}}||~v~ʹoookkkǽkjmZYYŷsrsʮ⸸ݹ⤨ٕsvu_ffTYYX``bjjillmruqvyqyxrzyqyyrxz{{ѿƶkjjWWWvvvuuuiiiǚ~~~eeeY^^ɽ㛡}ӋҒȾŷ~zzyzʸmmsYYYddd~stsҚuuu{{{xxxyhhmևx|{ᙛŏø¹»ɷu||\[[]]]llrssvrzzijjsssuuu|׃靝ɶ̹‡cbbeeegggfffaaa`eewwwyyy㴴ݒȺ²ʢhgghhhnnnqqqjjj{zz|||wzz|||㦬ȭ馩Ȼóɷgfeqqqpppcccyxx{{{uuu҄}|||{~PUV薖Ƚžƾƾȸorr_ccabbkqqw||fff󰰸wwz|~~}~cdiUVUݐ̺²|bccђrruuutrquڂYYY؄ɷ```fffªuutiiiPOTҦzKKK黹ȱaaaWWWiiijjopppʗzzziii^^^緽puu~~}}u}}نbaaڝ}~klm]]]^^^pppu{{}xxxmqqqqqxxxyyykmsprqࢦσrrrٔŹ½¶y}}bbbaaa_^^]``\]]ihhyyyzzz}}}}}}䪪ilm쐐붸t}{һ˸Ⱦhgghkkmoolkklll|{~|{~~~ˍфᠥxwxعɽŸĿȺihimssikkihhxőٯЅghhʾοǿǿǿʹlqq`eedggqqq{{{~wxyߠ{~~}}|ե˦ޥjjjaaa̼±~zzyppuˌtttЖʴǩX__z{{ȋö˺±wyzffe}}}ɠptsuttjiitxwڻÍћnnnceihllsrrvvu꣣˺±z^__\\\uttzyccbyyyűwwwXWWڮʮˊ˺±dedYYY]]]qpowy{zzqsykonŊoppuuurrrڻҿ餤lll˹°opoeee^^^]\\\_^`acennxzz͘΀˾ſǼĸbggssstttihh}}|x}uvvәɿƸͼijymlmmmm^^^rrr||~֢Ѣͼijstsdiimpoz{{~xxxҖ}ݷͼijoonݴ}Дͼijhhipppƌpvv~߾Ǘξ쩫ͼijjkl[[[^^^oppjlkeiiaba۫יͼijwxvdddUUU\\\ihhrvusuwoqrqqqzyyӠvvvmmm_a`ڙͻķiiiiiiaaa```gii|}}Օ㨩̺¸u}}kqqzzzkkkxwwvvv}}}Й人˺¹Ⱦƴ||~iii^^]ggg̚ȶȷ~wxw׉ίϾ´ُνƳ褢z~μĵvw{ټͿǺ¸ፔrrrsssxyxϼͿǿǿǹ|qrrnnmyxxʍppo}}}ι­( @ U_UU?UU_UU?UU_*U_UU?UU_UU_UU?UU_UU?UU_UU?UU_UU_UU_UU_UU_U_U_U_UU?UUUUUUU_UUUU?UU_U_UU_UUU_U_UUU?UUUUUU?UU_UU_UU_UUU__U_U_U_*U_UUUUUU_UU_UU_UU_UUU_UU_*_U_UU?UUUU?UUUU_U_U_U_U_UU_UUUUU_UUUUUUUU?UU?UU_UU?UU_UU_*U?UU?UU_UU?UU_U?UU?UU_UUUUU_??UU?UU_UUUU??_UUUUUUUUUU?UUUU?_UUU_?U??U?UUUUUUUUUUU?UUUU_?UU_UUU?_UU_UUUUUUU_UʦUU_?UU_?UU_UU_??U?UUUUUUUUUU?Uʦ_U_U_?UU_?U_UUUU?U_?U_UUUUUUUU_*__U__U?UU_U_U_UU_UU_U_UU_UU_U_UU_UU_U_UU_UU_UU__U__U??U_?UU?U?___UUU?UU__UUU_U?UUUU_?U????U??UU_U?U_?UUUUU??_U_U_UU_U?U_U__U_?UUU_U__U???U?__U_?U?UUU_UUU_U_U_UU??_U_?UU?UUUUUUUU_UU?U_??UU_U??UUU?UU_UU_UUU_?U?UUUU_?U_U_U_UU_U_UUUUU_UU?U__UUU_UU_U_?UU?U?U__U_U_U??UUUUUUUU????_UUU???U?U????U__U?????U?U_ʦʦ?ߘ{<:y&q? *% ProfDoc Error Browser V1.0
+ Felmeddelande:
ErrorClass: ErrorNumber:
ErrorText:
Comment:
Kund:
Name: SiteID:
User:
LanName: ComputerName:
Os:
Software:
Company: Name:
Application: Version:
Context:
UnitID: UnitName:
PartyIndex: FacadServer:
Ticket:
+ Party:
AllowEdit: AllowNew:
EditRule: JournalTypeID:
Patient:
ID: CodeNumber:
Name:
CareLiable:
ID: DataID:
Name:
+ TAB: Focused:
Module:
Name: ClassName:
Parameters:
+ Layer:
Layer Facade:
Version: Application:
Layer Manager:
Version: ServerName:
Application:
Layer DataAccess:
Version: ServerName:
Application:
ConnectionString:
ProfDoc Error Browser V1.0
- <#Felmeddelande>
<#ErrorClass> <#ErrorNumber>
<#ErrorText>
<#Comment>
<#Customer>
<#Name> <#SiteID>
<#User>
<#LanName> <#ComputerName>
<#Os>
<#Software>
<#Company> <#CompanyName>
<#Application> <#Version>
<#Context>
<#UnitID> <#UnitName>
<#PartyIndex> <#FacadServer>
<#Ticket>
+ <#Party>
<#AllowEdit> <#AllowNew>
<#EditRule> <#JournalTypeID>
<#Patient>
<#PatientID> <#CodeNumber>
<#PatientName>
<#CareLiable>
<#CareLiableID> <#DataID>
<#CareLiableName>
+ <#TabFocused>
<#Module>
<#ModuleName> <#ClassName>
<#Parameters>
- <#Layer>
<#LayerFacade>
<#FacadeVersion> <#FacadeApplication>
<#LayerManager>
<#ManagerVersion> <#ManagerServerName>
<#ManagerApplication>
<#LayerDataAccess>
<#DataAccessVersion> <#DataAccessServerName>
<#DataAccessApplication>
<#ConnectionString>
1PmoResourceSysInitSystem Not in database PNG  IHDR܆ gAMA7tEXtSoftwareAdobe ImageReadyqe<FIDATx]U>;d ID%(@(aWEa}k9\y" 930< 0szFAWwӡx9۶_Ϛ F&````````d F&````````d F&````````d F&````````d F&````````d F&````````d F& 8?-rص#l?~#̤`/[6lں,ڲLKobSzxj[JCK+C1Ɠ@Nrő "m%B^V&dg@VF ʚħ>OxK/[\lbeSQW4xpx_ 2"mkk6!1\ =FNΙ?;?R LbqaO:O(wd:vI=M#696xCUAtS + {I@6mTٳouK@S Pt4r[!I2N .'l$B<\M^!ٙЬIiüz~ʑ2GrSX*4#@\ /YpZuO՛vټG08 8F޷e~G8].ؤѻof֮^D{Wѣ7X?פf```d F&~x<ܒ'~W\Qk[|)sWH*StP57X 0-Zc@У@ɯQw{H>8j \~r6@cB2Z Sй]W?/x<ƶ[5f```d F&~b)]|*@ x^HQZi۸C*6hEJ@vg`I@E]CDsx!6}Mo݋(eY;x>|Fx*=!6~/Pr+ x%BH؉]|h~Bg7m*Bk#Fo0R#L^"dh@3'ӦzJK9duXfk7CqK%`Nk&O8q, 6G@s~IFAIJOnQx_3m滊+LM' o Z کÞ7}8 9뮻nw謱)#LԁGc0cRApr~'E]2eo~8TV6/QDe8A Q Zj`ݩks5*F!quW`'9 }%h A$Z?R ;IO92˦sJ#7mYA;>䕱,ٺys,eb F&`d((6Eǩfj_JͩUfPX: p1Ul dB  -iA$ߑJ"l9Խ{?J6Wp~xB8B Ls 0t t崙mҸ @)d$A &iaq"L]"nBB[Ac 8(Nղ=}+R# L002?M&4D'xliD6mܡ۱I_/xZЈGݰPxc vIH s$mK69dpJ)G/[wJVM@ 7a!2F-nߦd&SQMrIa$~t}NW,iZ}鱮qY湹Q]!s?#5@!W rjIhj/B~~}WsɳdEln/(jV<.\Q@8!- rŸ?&2v$Y ۴j\  t\8&>tx]89Ǻaز}h ɠFB1yV*3M0$qJ$ tMUU!772Ruo^ozbS}쯑$tÏ<=0PxND+RK``d&a 4$Kvy~ĢU.O}ӞjQA\2FUQdaȹTꮰTlR$zo -#;B'dqC"jT㑾t4jYDrH4Υ樛â"<q א,~&FHbUC&\.g@uxdD4C_{CcqҜ9G;v|pMyF&"iTؕ!-eyK4;\Ihxы~82k@˥P #AhDSA}Jfu.%B,hڨ>de+f|^,R+.eU%SD:$ܾ s׬hjX&Oװp>GB%&XSEB(ѓJ5\vnϪǚ+PU-yZShߦrW#EdV%0u1 %%eɹq-z]|Sg?_iq'?D3Pq";P?/ª^`%2fPmP`V`QpNfxC{7Ϸ WWkJ2MitUHo L̬,[y \>/wg-Hܗ-РK]  BN5tjixѱBqz/hG|Je (Q$H*|.8n M}՟M~o twY=wrEE[Lîb L002_B&Hp]J~.mō_kg\:e/x9+*x2j"*8 Yi|DP aWEULr6A&GrӴV-laNިkc5ۢ {p *dy% <򻯿ek}ۖ{u›/mUU!AЛ6ij+éFMcMIkZ'5*pP5Ÿd2ɵhLZ_$Ć#D?17/OrVvguui|K7;TI[C &dBpBAS~y ^#`pBc4( .?}="ڷϙz߾}c35$`{{0002qN&&vٓ6]LU`@2F.ah %0E鏁Az:]Xa[~}hݺ5(sya{z D?WluR ύ}(eq0kYjGT!CZdLTKYW bxg^!''}by2ExqU, ]jIӖ b)Zf,SHгk>W>/jڴi 5`{}0002@& -K]: 9nQeO>TVVhH 5"%E݂C,M S1CV 'fa@^yٵ3$Ӑ#V8캠V+Xq_:GR;rȅТEsy׮軐G~war\* x2Hag4XZ)eь>#qg)`…?'6k&7S43d*PXџE>B(LVD` ]=ȉn!p_tee@"T y~ 7}qquÆ TH!DF&``dO&h HlCY-zӗ,hLH8 uP0ډJ|AXuX|.wu֢ ՄDImZk5kqHB.kX2|aiwؼE Wmg xRVS.^],+E.iŊT+$(!x x VEkQ4yu÷Vnmy6N: 65d7s}0002ıe&9ԂO]f|=,Q3}⾮E +rssgu:A^b ./F0002ıC&LP%vWTjUEPIDדE[jMkF`f {=T-סi@G\Du( lZ%j["j]}38 )=w-Zs+^ܽpe,]`FaA7<9\h6%XI A=/w?v穛7OF Z(ز# P쓦B~BB$,$cG+D:T@W)eh p^~R@~5V݌nMm=gwd0?x`{ҕ*:46qc]uyA\.r L4&Z@Ik5[K?I$X[/:cKw]}&!%~?ֺIQL䤉'.U,nf4n'x+vj. jr0dp+Chj.VXgٵyb^/8Nw7E# &BU t!E2c#m((.~wM)EW? :H3EdEmsr^߲q4F(Q9A""QĀ I7՚\𙵫q̙3 ZG"6-M-DD7 V A؊#շ?xKѝ@֌0 o)Oz\ǞjndXj>3ATdBt!%pw^0c[@U˖ P>%```1 H$Uq {/ *EA"ZLm!)pZ /$rnO]w J"5jE&ti&+]cq17&ϛsrF.գL?!@p@(m` P/>DŞU_w>gWK6`mdZ6io!tY@Cՠd ݼ._ 9#Ta%VYSk g5 tm,‚Tc6<n6$ kCoZ%3FȲ+]!?CCbx{$DڰS;b m9E~(ɟ.*̇4MǀLOnbL00000279';JCz_XlӢ즙qD;e\  :C z0-: Kəcgy-FT>1s͡б=gl?-]1fΑ- s& Z !3/4Ak%NUW^,SD&M5ZkwڦJ,,ޘˮiS'[qӁ;nF ZbVS,T Ă[ɣS">eCoڸqL2JcM#:ۓ?ۓK\"8.C1uPuOuOLI _q;,6(w*ɖfۼۼW UETQo}|K r"]k$AP AEDd]:о;T5L&S06y* 6N="#lq~ep#s!礃k@&0Xt0(ԩue\">}Gm#)͡[_12d&d\saVqu0 ҲFj-yWL>5o|Gӹ^uV>lPDcؗL->:' uҪdtV=N?ŪE |sE;10 YHK-#ȼB۷oyo(iݺmVּ}p_r!7l%w J~~ǺS07HPU' [,SDJSŪXfr,?vV$ڔEeQq JũW. %@7(8|e+-+E$".Ϙ9C?>8B %^&~K+H jl?焖ڼjw!vH'"#4Qt5{ڱ`ffF={wuL;p|~li4=z#]v׬YMۧKڵkj꥗}χ9s6&M Æ~$`"9aA~W5eKx۶muv(wƣIݔUb6E\5X~rv?@Ue 0epô0RaG$0O3 S!<Y8s_ 9cN?;v 'jE[O2bOM"µƿ;m[aD&sCȵ@ %"?$ cƼ~`YOEVy:\xQ]}%2lj5ah۶{',=o/~y bJtq CK _1P7 q `!!3(ĝ nޢ m>}{}5a }<0E:LdpCihXa\Qfљz//3%B",:\dq Pd>?lJHw/:r:`M :XQƅ*FѦH;qZnh^4',:?xT>M¹&d10tnVwl?D*~⽷_6mIv2 S "D\o[<}޻O(Ny'LM[^SNOh S֭YlC3L;B ;M5hWBAʍD/ \$(@}txe^ ŠGp5ÉV_qވ69`ȑ#nԱV;F p:,T=4jcXi&;$fJM[Hس>=x {@I W/tE0NMe*p8ަ 05zM/Z5oּOD9wK̓Zn:vbGa.@L|b !GF T֛"Sf(dz~J,)-L?69$qQ2 H/{^w8y9 x=zn,]Lc*D&[O E*iilsI> l+Ȣ&洿 I:| Id:x?m94{A|r /}fZWڐ?L`,MAtO/7-EɄd9PP!L._^<ʠ€-`#JIJ x+HbgAmڴCBіt"YG)x|>qe5>5k=wa0t6ipSh`JE%W&Wpݷ>4⒡eemڴӯ&ϴ97nxu5D\'?ԶX4 k&;rnnM)JfD-fJW$nO#?=WVVD6syhtE5Ώt3(ZVJHVߏj5 gtjpԤɑ`wuS$>jEEZf_o?_spD0޳؞h<:oTSM?5^}ݕt?^2e+ $@8 iKHwu7^JNfnuTn/^zYBqǍ{B u~Μ`-_y+/olMR5 2QX )Ñ\a׌Y R7CT tlx~?9F| L1ʕccaӆ_~NRǞ,2wO}%@H5~iBS݂ACݨ吒I\P۴"j (kkD7â<}1_RѼM",EβQ/]RZۖ 9L!pIp`jqĪrٺ\>Iwff6Z)uԫ{hz>ʔkPI2g=KO{A3lJ&z 3>7Z{*6mYzMrŊu~'tq!HB d Sj!dM( W.1[!U#[DZcQAMΉI$[p?o"/^,G(W; Pẝ>|>(C 3#jp8v ׸`Җ)J; N$׊ϝ~X5U 22ۮ+~'(K'RcOR~~ޒU[o T Aw$ t^\V^2T )Xu#7ΛȒl״-)ί8->?i[+D9IEi=h@mJoq1X[!2w]ѽ ޝ8s#  IHy i1JT(I%w^~yS/@m̈́=E$v落aox=Žn!rDsvkMF!MxuK7o,UUUD́H vFւH+4E2!ZV =eK<HR)d^'[d< Q KF'(g>Lڝ*ZLhf[o|Hm`;ȥȀM5M5t\]i96.~zGr|TrMX=g>˯os=WocJ&Gz޶zQ.6gs:LbLVWT/YT h( GcIrsI?u|^hI hN xv@f}$q!9'aҕw]h!8H] ρX!:H؛+5ׅGZkNFK-t<>dȲϧ] X!g7 ]q1!DyG܁xoPz |^$$dgB\ ＫjC%N[`<~Տ.` mZ_G <ۧH Ϲ<45l麭Vlٽs¥rՀ dj!]m2h&G72Hze݃:ZLD݃;fvh9z͠,&U⤝`䥺؉, GªOn٪uf hᎱVv)IH`>,h%dQH[]M1+qh Va8E\Qlɢ,vZXQ 1XdSH?4n@v9AbHˆ1Cs̻`RdF5mZADIO3}m҄\|I{ ᗈDr %B%XaLՠ>p"$y$0ek[YB0Ph_Fxau+%dC9DN@iߠ{IU,*C/ چW^uutb $W!(..xۈZQM%E:|+%cC נiktB[KtW(t6 b;H6ݴc Z=m5O.ٸ+Ŋ:fܼ<vVfzߎ#g(@ y@304&"ۦ}dc6xܞ62frp7jB$"wcO-M%0B@ i%y(:i{ KCIr> n$;D 3XPDٰ"{9Co/m;YHkL|]8LDx!&)Iklgl! 7&YKj$QX؂-pr,r=mC"?CWr-c3M0 m>fz@FB DR5YD{agk`ؠ7ddeggjgTq,髕>D<ũ<@tG^'sKD "Wsؿf<܈}kH{y5-AHA=&+JĎ˂EK 8>Bxx|GI1 O[w9dӚ'Ph5֒ TܿvG%\2i#%81HIvzMb{ܴ0l&ys þװi;LH`|JRˣn$Cq5i4'Xssa%̜0ԩsII'32"ڎ%vR$sWibL;JPCM&d./7VA2YME 5O&SK?9!Xp;6= V)$l؏s4+#̣ s6>! (#7H?VeU x" IB08qAtΡPMP&ڶDZ %I6DڼAud¤wTH C~Xw) rݵ5p^LKW\\V/SV &g {oBɒ'ԃ>9\]$p5O8'!RGEohaS|ߝ`2",tܓ 'eˆt;pǃO^FԤKKchq 2 ` EgX^" GQԿEh  Mh.X ۉ'U =&y<ֽ5j]| uDǷ hp0m*TAhx9 5;vG_`w/`@kѣAh_3BDc!hԨTWW>-'H>Y#EU4zo>.Av1 ;6oH q6 d! K&uzx~+ c1 ;HƐ` +/3g{ 9|ÇQRp$ZSs!0 sy,z 'wi \z"W!PRIEFF%(LU-N9} ƾ̄ݻwÚUwހFh;vE l]"ŋW [^{=֬Ͽ9eS i6O/儐|4QFkn<1!l=zuCNS#Ǜ^ 'ӎSZ,PLWɑqcnxaϟ ( CzP]dx271pD!c8|GCzi,Z"6C XLF *B1P?p "DFA #1px ɴYܘƨj윜7*+)]ptNvbL,֮{;B#_!W_•}ƩWO'k۱W,_naք>qKH6)|6f!aֈ.HbJNT`L}?*ߟ{st 1̚4i2?|ucΝE<_~xteY򲛃WS)hUx 6yjpB~}̤)㿝?zj [ !VӶuҥK!h#A"D8UCҁw:0Lg^D^ >bz$hA@׃*!IaJ 'qpι,[1i?ھuMvwKݹl*ؽk/ckMSC.]<:ٻkw˳fO۰|E:x)Ɲ>mwUJTR柎s]S m7~ .0W_& [ ɏDɢ!u]vfbD Gl_j럛&_=Tb$ t(F6jd=s[=xB1Hxm J+]ڸu~ԄfqSstcdO*I1S>,E!§# x V2g{A".C+ifggDyG8ÑJ‹훑iM7үUS/֤ЈuMfɁCƆ $t?T.sv_$,ZH-HHҩ,t$å=gJXF֦ V LuqIC<0lؐms"D"a '4I<Ԙ>zvC> Kh̢E0-ZXM!DNpkjE΀v-`Y= sɗG)S 6|rN N}YG3ɼ4I橕 7\ M|d&rȽ'uBՌ SO}% kX-!o*@X?`P9J\Z݂5dPa*+/& ]?pS(F~ڷog IfG!4R5f=eNs[KU 6;1?Zu۴iٺuÜ BꈘzW ~{ni$ Bv#Šu"!mG,50Pn(*mX')t8_ֳDp|Fh]dWISkrʑ0h(H3T ߍfm8C_Agܝ PWB ?/K䓏э&Lc@]i%Y܏<9so@EYa^(I c'vz&4σ55 (A]NZQY>H)!W4蜚ém6FV-m ';h$A%{E ()$Ѓf%4B]@3.itcItbPb8rlC铚4(&[ne}:s6zD NůN 2D1n3RsFI]NN٫wOs[~:۷28nz?Cs~my5~;oաdeexQ .+# eRlVyj򑡎a:0xKwYl?8wUmA~3У%\1iGS>Ld1sa(-no"{Dx{z"e*D&P—.enUZ=KCZ  #$d׳>Jnn^QQn58 ѧO_X`jL6mJJJŋr6mkWц24K:L(4Á8jJI~zG>~e`1N:Ɖ:P}dB4Pv2>l x7"Y'*jFF^k& PiuϾ}عyfz=5hOOFܣB/<}.hJGSz4@g~:H"Bhv'㳳r:\EZ^?>r[Pu(7 8nK/W\e:Z:Gt[7Ș溜}{ܙԺ} '=)Ie(Юc};oi읃"*-xہHbx,G;Gsb -C-.:eGȈ$\hZtYz# esi„O/~ǟ6" } vW.z`,o=2eQYte1c7D$8Z"o,y]zwAp"dm:Y 1B7;3 :vn8htAZn#eKVzrq jj ޜ6r8@Y21 s- .YdB%L`+_?6zqEڷ6m*F~o&Z &, \n8`}]v׬Y+͙7_z%2RqplHvG7228ˆC NI'R:vfU8WEk8US屏=i$\}_swp㞧c.`{4+L۷QS2L08!0Ů'5Q~J*!C /DDhfM&&!xAĊp},HA6C/Z|(+ Z?[ڍ}g{ExP"+8LYtʼ<^Z3F! a2VMԈfiвA6thD˔a~yɞ '+\{7#r-'DWHBM6zSYԝـ!OIP:DGn]Y^V:p4T0?}qsZ'hM ESffshxjTM]?7D$c Ω GF w&d TQb2ӥ{[?scx 9wNPwYNӵ|5}p̏hĸp*9xH];vpD+'NU14ij0Ȃ#Bd.8E$8^GJd F7mXTX̓o\qKBԒETuE@Zv|d%'L$u9gxRekL}xAR阄XZ7W qmT'фpjmEbv1a\d>; :f]qKX`Vtťp!@$ui/ƥ9VP3~ϝ_zq!̞=ʘ`FCD::W g,c㏏xVԑ@y9{l`jtOЕHEcJ5$9;l͛7/cwQV*Z(X B$V'6?;aF Pq7:PlmVkOmUnܲF}syD MH|^½Insg}O;WZQCQ6AI5cÀyE~t!܉ #ͧaCOt HK\'>q. q:;oѦθųl A's+ /r~!N@fEl8Mc"?,_/x᜜p*@8P\c;niӯ;EMS 6~ښZn6lt||1`w[Ꚍh(`vV׬/d944wysH{#xߎ,ws~%Þy_(1ɹyfg۩c/}_uٳW-[+fN5ǖ]+ز}-ԤaS:DBljyf-[[\^shŮ aqY%I G@"010q̐=1/> b#')sfK/&!Xk7ϜIΜyslCn4Lb:ϼ.DA&:b/P%l[gܽf|&:&j$Zzgc'zw J kf lQb*m1`(49絷NˎLЉcEdscS1,KX,zŒ'D'2oq+}l6Jm x4{b ~^y%y^M'ZTM'Lb wtsٳmu>i%ppEHЄ +buk&1@DВSL,P"DYhh0WLl'-@DPʡ_oxd@4E"ښUgIx4x'T01Ԋ*;C>)L}Уwb#} mg ' _, ,xСw[LYH~6|EmɎݿH%`!n0Aa\d'~6-` '<1r䩗92ra2}ђg.^ѮΝ;n V7!'% cJo355ѱcvإ/XלoG.89&RI`GHDvq,y))$?$Ȏ-}(nK\n<--Y٦ה˯7&CۗL>Sho۲~2Wc%hE.gsl_,8J#`X(>,rN5Q8/޹ v'+Syu Naf :gKץ ;==YDzŊIaD~X6,F=cs4SD #q.|`b77y Xp?Vc E'^sͤcV7QF@(sxM>i"&.1"kI)y:Rq[;a+ L4;c`'訄sbN{[st38]5:cG!B9Mb{.{(K.G)6w#}^F C)G^I Č_|H/e ; ;ͽ(%977G&ϗv⊳m4Q+ޘ;ƏOVM*Ja4y nցyyy-V78Xq(;/D5p@x'61FRUUjArl}s@eN.!?A݉0S:>*V͉Cݎ{*;2_reK.5Ma;efkш"ZV*M@0Sit۶]@DϚ\lي=8 iS)DS~~vވ,[n&64]k= Xߟ>mڜ9my] N&e SHA+Vøqv:kw`4soO`@e>8Jbb&Ka.PUY,_lth@Bm!M09pk]7"E#JFt%,m}SCrkwl0$w~#'dmADFݠY(?ZuIh"?ϺG.5 #þ K/=zHϋ/33ڗ@תn6%uPz-Bq \'LE!yUښ2ue7kJ,ǰYaQp֌N)X3/)/t7BԂy'2Sf؜X?1q~EvDG.òhr3gެ?պCkZXTt4*YS` P4JJ {ՄhLDX\5IS r se$6 ME ޳7I* ׮+7Z gXpw8;&5>Y7P6PGy [Y"ۣ -4 :!޶m uu޽{Q)8";Td0R7nB~ +ęGk4?AB .aDD⟞$ҀaĚd`DދV)USiqLM0 7yw&Ehzu*]4k\:Mд~G] 6l2fʲÇ^0Iqvm3, ir+\=Kma[Kh`B1YZyxcm}dpRjЭS>|{ Nkyc=uII&$CGQ~ 튬>~xV2ˮ)J>ʼnֳզj| PFt~DrS/`0|&e&{6/6kE}S5:`ذSٲFrTRAT%:t(O?{n\RT1L14N͵L$6ep21Ku- ÔyϞ=mƅy/<0ǺGjj3sI}K'|XHV7T,3_Cr?ˣhE ֬]DRTōqOFusy8Z{ӏyz9-~ymcnZڏftZZ}é& TMQ]R>v`,ڹlYb2M`ZѦ5h lhimz,Yҹi 9l6OQɀm;Vņ)e#X[6(}eKQ^v}uM @c|*q`!x_lNH &iMAFG1k̫:цx΂uZqB f U0hRHQh C:`@>]lys6ϟL %Noq\X>LnISK@F`8z[YAmeOxVc%x8K Fmcvb P1Z7"^^GcЫ`lq"Ъ!ZzC${۩:i^Aqٟv.# >po:fuAZ{@ ŋ_D|D?=]"FePB@]8+`kúuE߶n@Mu}0JΑhey]V#2(`-dJTU^eASz: JNLjYI~m~T9^`;(kHRW]LRi X.4C1;xRg]m)*󲘒Hģh/ϡ&Gk&=Æ O8+:uTκ8`e eԵE͎0. &=`7.8IfT StěB"[R/Ԫ*3~<2f"ҋ6T@5''[ڶΝ;g63̓ `@T#L+Xm &`OP`Jy]h"9ҦAHoֆb1.(4ׯ_wvzEdw?C2`̱M:^]SSc05!Az*-\5td;.Y@x0tr"@0x4^⤃}[޹h8q+&|gcfE$% R4 @^zt[Օn(DY:ApYϛ {vѱ\Νĉ/v 6*3SYjC6{" ȠѾw#ˊ%yJ+p ¡ i;vLG ӫP=~Y_:m25zȭ=[wleڝ8Q,WyXw x}|@r O Jm=k E^?e!'VSi]5Uo+Wb1D[QeZ)}a[hHqelB+S ;0# [ݞ&(9&SbrK:t%MyHvt7@q5%ttqrgut0$ۡU_ӦO>,5Br#:bΠ̪W}򐨾zQjkપ*:w5i4#_)cǍ2b DEAJ7+_xŦ.&,5âɗ ^]WN HX ]8`Y6`'Z蘛 N kS [lYVU"d} nj (``o diM%h  ZVVF^=V7SQ6 *VdE>"NT9UYMڀbe:iM:XkNG֒ L=0Q3FCD +$8+t:ǹx{NSzM485I@v9cG eŋ{BoP:Щ[F;8@k'Zarf F:( " &R]SL[%ZUTV"!bÇ OQB( s$ZA`$*ciT4f0g0OZH35MG0!<#\o.x"IN@`oY(1ZVQ/qo)8 ŋ(Gwz.xŶf".^G>]o +#ÇFH͜!ۛoΧ?,/"`BJIw5bj 'wޘm"­DfVIR{kFi4͑Tᯪ:TAFfqӺt rH$0*8"eMEC֪89aG)V80 ڣϋ8)4k:+6Qf½6HLJmkkw`O$  A14.(5L&]cpܦ-Xc?|p(Xzo4MaK8GͽťpyW@jn^ꫯPcQUqw6Vdq7͚E ~z~6L[M^D.⡬b׭zyy9%D54嗔U.DhվAm M!#_xQnQ&<) (zoS2Eg4qfMmLYXء(2dO/MOo3wp4vI F>Mۧhbh FdQ__ !?><4H/#= 9D8)p`%. [х81MŹ~xΛ2a׎}g?$}5t<8njr>&F%E4Q'&/QvYY eW ﷉Kr <-;;bÎ|JUQh]ZYݺU5-lXе [>XZe:TnݺM9h3 s~vg۾}֬Zq9nW[l%?U;|%(]8ߥ1> "Z!h6gJ/=v<Ciŋw=32mF~bh(lʨa) Y^8ܒ$,Y*f3ŭ6:,x#; ;v0w>e1x)Prynj&-tU+`0m)VmL1B٩F&0LHW{٧%O6"^% 9Z]%{d-r$mӦ͘K4O 2x]cDNxxO跿⩧@pU#ܡN<ؾ~iH{jjedz! C/"d]o@7ozq&Ҡ>`s_?ߣ\z>#4xKqMl ]P__gwz񴦧xAvЯN?}dʕs=ߡd~ɽic ֋GFukg~˥-6sOmGyEchkF%%0Ո8_ϭ"g`08h%hHyHtn)@]Ti7( &Ӷ)wp7f6D'_ΏbFKd"aV[,lݶߗ233X[ AsayԘ$xEj -q}oJ[fdnW%Hcx N@jUn߳ǬzZ8rm߄= Zta->}ҐV[AAh% u*d$Y'ʂY-T\LkqSkF/cdXxŖhdAI8;fgBV"g>%'P%h w̸ s 镂I: ?^cmwNSoҽ4*!3& ,Z I#fv>Xd3[[zYgEE+#cǞ#1T1cPΤޟ !>flXQ[/Dz=%?1{KBF!gC4[2EO̪ȫPXjkj;0enʗN|Uv8^`Y w:Z(ȁRVvNaїkwɄ[J󯏫'Nd#!|Ė, dM*3„ 9׬3OϾQ~G;'@;7-dln8J%!GEI5O.$Ne ?~W>2 vdk;)V)#d-9TX:+f#04%.|qQړgXdh MD68B74\{P7%",? :MC1ʔׄ$eѱa!wTVo-[kD`)3o>٭~}, -pjq8h0lX B/ gY@NTڗ..A‰|8|H~~~4W{ g cߓ;wT>{r.pߦ;gK @&f>n#x)B-lhY%@$ߋS $@ x^ U솛g^t%jMM zO 1O5ЊG~ Q  >vH5 I֬ ?ÉAF7=[]y> 0 ί_j֢w֬Yq p%7.&tyBlP%0|ZxʠR];WIȁHLogW3!шshX,^Ḧհ@ /Tl>SX yDf ØsVM-*ZT᜜T|)sMK!{n)9]xڜsYCC 5K-z,j"à7MdP#88Zuad^!<3I썓>Ǣk삪ynI8#'Cn6M|# 'Q㭳yHk0Ǎm*ZT9b)19'(CR*%S%C1!å)~}Í?t!ЃfC2!b &<\[qڰXFfҤtZ+f}z%ܶm[[=0*ݠ^C(.e_EtTjuP`;pj(Jo&D<.-t`HJbXHpLddd$,AWˁ0<@$~4zz&HD`DhԨQq5}4IUz}A$1[L"7A9$>NNR2( O<<Ǭ\5;v׿SVDErܼ|sԈaCB=&<4D1t9hç]l84!vk< zCj8tQk7.xƒfjC !Dlr73N ^ Bm:Pq}XJc2hb'( EGLd/@=N)DyƈŶ &e"=EƯ9|>kDU14G6] +y7%%Qު@%%C`QYYeLZ#Um+/+d4`Ѳ-A]Hx21j:z%VaFuSᱻo.BRRr 7C/Vǜ1Ba0TS8RF͈!R:XZF[Ӯj?g\搋/~\$:c+@ s{rRa/$?"[EpJ9DxE"i*(X*NS PFZ ]{8ݯ>{-M[/cmۦ=ģ8g@iqu`;dkdHzsgL7ʜՆKG/pBZ\ ;jdo3n;'Esw5yX' !z(iċ]wgGA3US-gw]AA=]H`fq5FSwX7DC' ]”Iy4cdȍz#C>}DbwH!F+U+7gP"BA3l_cg4X1w;]KAZjCP Y$P.G}Up 0MY9lg{ng[/:b*eYլV6gVoUe"UѶg5W[rgo1?gZ֛?J:+mVnamYI`-#ѡ{h)1%,~{@sȴ5{de+F\Y O/|=yպ_Z`b ъK2Q<8V(Ÿǂ0+4=`1/t苉)(X,h:us8F~y X8z K FMC<]6Xh$5v@;8F?c"i" 8y7$QZ{7wm Lv . y:"N/~<(蕚:`G[Cx` ^Ti`~GXhKߘ~/iWzW3WHn åS+Uc+G]$-tyi!xX^G.~èv;|s=狅aZhI}TIP1*~lTa+om3@: 9hynO?AIrLsqٶ:);&UB8ﱣOt=;vZP$ `{~M:mo|%2w<|k ,`ar!{O0zAk.xAc=XzJy4 e4 \!_K8/3 ;wK'N@'w+LaaZQQ5F1Hמt5m\6D״XH\NOs[51l$򿘟NL%J>گtʠB>YԎ H#F4㘑  F&h,F| nPQ4OSZJ<|RD6="@ry!N1C!`x G Ou?r$l5 ?2uESߺj?-$@N7O24DXi key .7h:糣=5@[EUg>3 bbp]:eq+ q-EqpXp*M膠LrV!@H8 (=#w>A#?Zlģ%``(77hFVT矟7-LĮcG "vKKj-}޲3A=zaÍ',sǞ3.3-Y ֬^2M`%sc2z 1b!!*#! {W=Oov'olc"ܥK4Hn| O?,ڞLp$8%(/+u]>~| %?[;+a1\AKv4Ϊ|{sNTzkں勫JKJPJ|Y (͘Q8QOf n|_L=Z:3\-\cJ{yyy}ݸ*&Z?iBM'kNfu P/dq(~莿3 `D"FkUUUm$J28ouOQ xz喓5(tK7x}Oܹk$jRZn[թ`dwgYs{ЊZ3a,~-UW]5QT>cƌ;~V]]s˦o>C[PAȴ e P~cBxʀЎ_ڼwoqvnjPVr>+Fb\gxQlMLʙ8zAys10?_;_[򿚚jlPif`X4@k?P#зC۟~辥ӦNҗXUSqlr{hamLt 0x&4uJK݇K󃚃x&E,0 [튝|(+?i[٪yL+bD n=,(ڊ}lӯ;tKCieo{>0ưsh[,niRgĜ._I[R n&9CzVV-yGb|9:ڼΛ04/p$U'6%jǟU1yHr$8ŸL> Œ3`-=DoL6MZ>9 s3ǜeN*uÆ Hq3j8" 1NL8V ş< u%ԫwcj 0y-.6Jh&,hG{1yJ5TRqbG$d)\ƞPKo.^yePb*D= E9.TOTvvV..֌J4 6 h GZH1!˟wqh*ՎqdcEHn.33O:uhTUUVTLRЏ TU搵0&ݗ"iU9+jEA9Aae,;HF<=x Ѱi+Q.XkYss'~BW)H8W^,ZIɷz $-g`ЀG0ϋPYQ.u3܏z1йsGr7דD}EP8@; n>"#"E`Gb`N;-Od\Oi0ь7Q#n?_Ի8A5A(2P!$e9=NrpGoIT~ QF{| %8t-& $lx}56#9v9xZy8s yx g]UToiE&RW$^4$Cf66TGxs-Qߒ}H:HsoaT[4Lޑd"W'>E55 C/Y}ˤ+*\ ) yP_ߢ!)E J\Bemn"쫿>px3WB !Y< QQn ~U_2.:Ui+Kn]&@w,WM  P~`uAhFV4 ջI3:sOطą腟|,-X[uX1 Xȳ@>0cK|e~|XSh4O_v\jj pjUD/NuF gxZp oGF.3uv$aTLI:ő^^ͳL, `4qœp. )YM6B!s EpAeXX?mYcP6oҩ~S[ɩ C[/_.ն_W8fd##ArP!S<>r}}} QDxPEh*y4_7O++`ЄsDcsH-$pq9~:%gBa BMHy}y-<;f6l܄d&'Ҁ8ҺGM(@>/v9Ay<'G 1uB~o# Laɓ@"++ &R%5@e}mx <@)~I.Ahuÿ"28-f CxÙM%#v"#~҇.)ᇟ䮸róA;y tCE Dzd=17ȁuu__Wy9,"x \~3ERŘYgj5uUhhmhynJJ4hS2?{g G}7v籋A) UZ5E*TQH\h@H%:7ٝݓ\(/̬3nj^tE>}8mt=V**8 Y 'O=gfE]Z:ڻG[_ذ#w~N:U?Sܨ"F2{;Z" ߙLZ4y۾cƱOr'_[OJ X Q-䡪 z:DMWx"afn YPX,k **<MquW8MkfZ8? J\JG+JrT*+5bnq`9U#um)gso>wogrKWވq&[&5\|p<[)S'-[˖'.iJ?QA!<5aCc gSSah܃%Ϝe$( )bX [ R]< .\R9}˦̹cLZ{6dmHΤ F A2Q*d{`zhr0EpⅿX<:.|>l=죏joW4@U-"{XhE-7k_ngd5Q]t @Bt- D hj4У`e,hxlw( QM(8ӔaOj7|zzԽtp=Lkc]P̿x_;L#/*ZzV\ +@ua 0k=m 4LfbX3ar\NeX,Ff-.'ShDdx4NυLτtO;32yj}o!P!ggD-Z)"0/|^nseVnhwݭ_KWkҒ`UЙ!U,2f>[hKpI AFu%2 Grt4ih$n6SNfk, 5HT-LohX-Ni'tkΜ3vQg6͹)v8XFXi S(Jnz$qXm{ֱyI=sOz9S?--ٓOyZ7U HJmR\(U{hB_qc4Mm̟}Au@Okk\_8m6OoX,{&>R *N-e[[g0ul˱!#:րVBދ W#! ^Xo?}·x32];sD%n>%jhmAܐxml]M݂o nԳ`۔;ަͽ߽+_1v>{2v}O7WB'@@wW'$t# *WN8r&8xC !&BI{3g~UK`X,L|`+to=t^~v?bw73gzLkki"J 'P]wA% *W{Ĭ#4-5<0%IӪNW5ϻQX ^Uh\ſ*"x_T D": ٞNHK+&ǔ/r#F(b`X,O Pxf9wjy]CÈy'vtFHv2 (c diρ1Жu.l8b_W{rE%e}r˳DkS'kҥo:TrSO@^GGw6 =LɅϩy$V?v=hcwιGOE M:H&*8sѐK\Aw&<iT[ہT)Y.gڨJS%*(J bX!<:?"vM81~57'hYsZ% u(dA3""tDȠ A+:h)OGWGX}֊Y_fW&Ək;ei|؇YJ 6؞"<[lܸQq=kC^xc-Xٙ΃|ĄmP 4Q$aBS8z{so^=q„l&jhh.^Lf=b?*|jȄ."Q^h=UuNß.G]hGk# 6b !2x]K;׶ݑ8s~dm:JhnkZS] P8.jxNiPahYhZƇv\+ɮ{9; o|^G#>?ԣ⵫Ce\ڴe˖o.y=ڰgM JPhf4J'Z뚂 ,nGD&(ɥ@qs0<w=>DS|gÆ4i bĶ𠣳%yϼg9q'\ _]/) .x!tUzp,8Pxb;(U"݊ m~LŁvܐuʄoeN~{XZ~橧O<N98Zl?6yXj^Ky/oBwc_JamNzz5eMr^F4=0ax56u|wO%vzmlԃ{&X`gbRxVN}ddώ^y9-(=ljk+ǡ-kࠦGATa"!,QA xgBکMU"BnQÔj`:F 6Ӧ:_~{BHIZS|kz"(tJ ˔`ōX,{&>u+`,(8l ` TDW(伄xdh~#է K݈@W8 zu6Æ nuUEx _X,׍HԱV4]V4CuȈMouZ2U:`교׌Sŵ)Oy } hA,zU¦)tZp`X܅YXsޙ'~>Pl#Ufl{GorJ.A>ՕIЋ$o bgL0L ,;ūuzE}w>t$ D!UN8;ӴGC-h)|:#?@HT n# Giq,$W0hԆaIT4k04ETD CB* v0?W?ё1bDK lTN]DL.[E>މCb`1L|Za: n6O85kGs)Z7XոW ݠḢ9z-BPg5X]9> [Ȩ' խPk}Lρ:i%^ؿ@K$#2Ɋ8"täZuLJo%|7:|>Jzvi[ )T@(_*&X ~D qݷWl{N;%ŻN>mȹ:Z[@45\i:Q y49*y&lx~_vC} U pAAշ * [> y%1B: kֿ.;36p?֖cƌɯY&5{#X, ֶ *[x 7}]]]?/wgGxV CA zQ!Dʽ}J {@$@|ޏip,y?#a >F䡠8B3!E͉ڀ"ږ J"YQJCḷ|k6qGt[ӦMHbm`˞r٪hHRp?r䨈n'V}o& !@-^ v oW] b!DA!QBlQ!.…m!ЎEF|OibE)ş! !%1bԉ*p챓xkWď;âE:4n3ӦӦNu***Ş L> >`qM.[T㎻{_1-;8yr3_oiH9:($E%(_8 ITH=)3 .(:vm(#C\iw-p(2AcR]MYyoͷљrmgDvvcEN#h:Þ{ū}ݰw,ab Ϊdm.GU7MkϾ(W޹n o 2$\0a+Xj=,_BQx4 ^${#`emCi[ GƔ C@'B2f;MiS&O_ho$Is\GGgfӦM"&9uapRm$X, 6)5~A0hmmm37NWsiZJLU}|MOV %T(P˰ pSd0&lF !p0AsPW`lj#`M5_ef&E xSAgC0b`x0Qv%)S-cvך6zw!@LK3"Q 37;7QHTe!c,|TEjD_2ލWgn K-iބ+Y, ć _S/uf}fV|k`DGuguE_\nY 9$mW[5Y~N nE\P7OJ Gtpm{B<CJء0uF!ϻ麿?̓mmy =rd֖knnObqڂ'UtW y-)H268_:nl}fK93]4,_6ga^yv1=lTWF"ɵ?؃O37nؐd2Cee7t{Ŋi,p.gpe?s X, VPРgk!0B!H0C^G]p.b`4*M -2_ bX [,nA C0`C0<08X,ab+`gX,)cX,b/F_,b&X,b1LX,b`X,0bX,0bX,י`>bww>SMAm'U9r=@@M*hho+pJ+ah+O}P, i"!hG?a aṴʃmڜ؞Wm<>yUfLG[Sq9~kY,jqhg"E*j ܹ>M{ؔ)O@ UEI}CΑ.  TX:x+h/wd&X,֧^4}q6کhu"%cµu›h?Á@m.t#&ey$uw]<ɂm0}xW,X, Nh?BMN]6g;1m* |bOXh*iBNK8-\M]'n:̼eϴ,4˺ ab}b=ڷѾS1T% }Ei^|b6h,DLJD 0A`H2,pTŇ HBvԴeʙe \zp`b&X,'GQ.D\Fݗ7 #@S$T aUq&a"X~Cz.8@ڴ3Ԗ;xl?>ab}c 'k{OU`Sq‡RxH7"eB`!!x<T K-+5Y1;ή!'O TX ,cV'`Y6+/=mK@BUzH !BAE }3t 4 -v r  Hxlة%๿g`&X,G'X{%SB:mq3[ J,&$D,D|P /4@BF CWP|NXH7 Au,UHʶߥgi}/0b>\%nB;!Xa׋JRI) P,nP@m,j4v>eUX, շeU W-kW; 5+|2D1x: 2b&lpDY(X7XTQ/ >zmtE-1m8lFP-jh@ p,X ,kKt0ZEٺwq,|)%nS3{R`Kg͂>Um]H \WG';~K}z~0A?'qHXz&Pex2hDUƣ4C!`BQvÃj|g a9D^?)C1L&X,֖wnɊ;{%L [ˏvqpPI\{Ґ ɁbS'8CW&ޏ+DPD1bMT/ yF6Ji,@!h6)h-G4hBuge?E NrO+xm;AGm| Sy=uX ,V& ܫ|k]&@%i>;أHneX\9Peڴ!F뼬 gO/X{y9vGJj2US ٓɋASb1$ k/e*26U!;T)A !/` J}9MO@bA+%XL`~ /K)*lyS:4X:U~_8[q.AO [ϗc%׍ &ZcsX, k+> ќEhh@*CaLɪ.[kWo?1q {蒇_x{؉`)ɘ4!4OLւt΂a^W'( sbİJwßʘpGԆ~q"tpkpGyJ 2ڃDʋjF^{(v yh?qcPqiD[e]bl '4B pnZc m,ߋP'&Bhߗb}iפ>u@t0PU'Rj{Z KoiAޅaՕ0El!\+"' /o)ABack]oQBWO$(03Pgwˉ/BHUKA-6n4ߵx-ĊKx O"<=U1@)WTy n9@?!@C\(By>]!="EKG;|MfG^^z+/G H [z,h oy%B{)a4/0Jkg}T'#jqE7{XxISYhBCmBLQ ά{SkH oRR .HQ 멆PjjKE.-Y N"/\;dz T.*gcYz (xMЬ]yxUpXfhϖ?V5.8?5uy(W1+k[|^lFT |홠 X 76BJ^xKihY:R+OxK*jZ `,q?(=18+ :XX(@OǺP#|^oQuyiІiHWqc2ȱ~k~dڕV6$e3|(ό0bmݪA*e>_ p,[Rv8vgKPUvM&0cr_։CA (:\c)qHXdG3A~,b@LHZu22GiÆ" SdžןpdnGBlibOho]9F)"HȔBFaFc#A@ (%T7XvnށB6vLm~"i&?΃e^{b`X[*1Ҽww[:<=qN5#Eq` A=4 !,x=\]0eT|ОB*gkZ?"w-֛(z&l0>V'0yl1d$53 fz&\1መ lnzϯDZWF-S3Ж?xh(RBHT fWnK#z!'@Wyw#KB?@ 2`QPrGb`XxjJN^p3#:Yn* n+ c׉؃\u1׸C,/g;g(Qj#mx}e[BNaQ7 zcP^( p鈞"b]KzIFkTG~tRȁN\5pJ%he9 :dIu&^%U_ZSe\_'H6spQ@c&X^>UP(ўw\߿Z .>8d$*7qOtݲKҦ8D!*:v4@$Ξ0d"55'J+`7CS56u (q0AAiz2@l?!<6G+ ~`\:#fI$# ~z%yyhOΐ&a1d'X-Pm8#S4A#ߨEj`ڀbt t.P6Hxn'&U<ʔG$PBsA¨!Xe0xPd}xKYRS|kX5;3 QRd8 t.'ญhBC2#k+q8y#d r*peDtjC.#sAQ,De<"O1ӃMۓG$YHlI頔AbCl聮lZr6ӐKg~{hk#~IS;߂bKh{[nKw$Y/b|> YY%x*J8Y~~@*u@w0=ޡɗ>|0}X8f_]^f&Om&;(> Z;0Hx'ȨMx! )hLC !PGD֜ۢ%9rhDzȫ@ >3稠v$あJ "ӃAg ɋ&c],tґ^{/? <9Rx?vcAZB(vrZYOpQTkIJej_c}Z,Ge YLpH@q xOS  4, UA@RA,5ExtE*[U2¯:# QX XGnlI8r&v^HbV׉b`Eѕj_soJ~׹ W ^au(+nb D82_el#kE81pE&ZM54;&Nx׉b`Eǎp* ~H)+AEЗVY!AJPB^#'`N`PP+_Xڐiz#+A¶M<'U o_'aE/ ۅ0*guCGPDq*(' /}#(Bx"bY7¢gX>4U7-*p eP YPS)b&XmV YX{u_%;Di-/ao( P(;x(p3p^eJM}ғ~ ojoPd,<4?4`W<+VX, k]Uy4yT Zi u\)´EGfr'CplI [C#ĴE_"H 0$,-]ر׋5b&XmYT<6/֏Y0F ^r< PY>T!4cÖ ?F+d̄?JW"oa viWsŤ pxb&XmY7!$rp$ʡ(v1:ДF0a>40Lp?`ZNPſl rD( N( y*|/ESNv!.D H(hI=^.Q|ׇb`X~%;xR<#䝨{c^ ~>7€Ou(ZkI:"\HLoc$"@t?0+Qxm؞JPk`pmY,MjE%**}Ũߍ~eR>< 7vt*N`j+43be姀 A~MwFO.O^`?߯у(LC ~]׆b`XEQof_v01Q$ʖU2t-;,{>a?eֆ<YJ@2.3'yK^k7b`X?@5c=C +a^@D8a(DKבBI/SSfnK27 :&dsN4̯WƈbY_ų;. 0bz w ?=ï=qqL^fFl7S< ,m @U(SD/!72\:yDB{Ry :^9-7ׅb`X}'0p݄L8|;}/ݛ$Lu{**ࡺ Xao1m93nțnoo4#r6\>hWb`X" sPl]ܾ^sM`jīo"TSc^ u ࠙ㆶSeڨRH 4 U!" >W@"Ѕ f"9|ö`: |ڏ|њkb1LX- h56{I;ښR5M4#/őeP(;HձT7<  +BY HqDa*pr9LW`y?{QcQ.Oׁb`XOڟ(?g4VOkx 1(PŔ 5Ou(@@p]t3Y~*?7_"@Bb_IL-ԗpLѴ9&NQTG_yb6WX ,+v ch؎1˅u*_4p=8_ ե  !-KBԞiPqjhj *g=;o!nK~drSe *=N̮ ǧ& &:X, k1rpaDiT<8oPe\ 7( p<B_p䧾0!=L % ѓJ!HSܖpኸ8A'|{m iC=9ƒ(PW$کh9Y, h5hw]qp3ŕ:=r;ϝFVv ~PkCnHC}G`# @xz(ki.z#D*#*=X 0ʃA0rE Ѫ8ןb&X,֖3^Gi 39ǁ"ܷCl!my G4-cA~T@aF\P`h  C<=8 9sk?k[X ,#ՐxTzbzϏ =?dm Z{2#< thznƒBqRʷIb&X,ǠAq)i-SLuh6zIWayuDK %j'DM+$.lvP\IT发b`X:оv NH Ў@mrMM(qJ(#;2*c&X,'KY8`CA% O"XS܂zDv'Ѩb`bg@d{-ǵE~p0b>ŢL~ ~p$:m>0%X ,kU|Q bTTT&h(&rPaҔIZ3ڻhKѨ2bmRzeX,q&bX, bX ,b&X,b1LX,b1LX,b`X,0bX,abX,abX,bX, bX ,bX}P⅁B5IENDB`PNG  IHDRmu pHYsodsRGBgAMA a cHRMz&u0`:pQ<IDATx^|Tg=>XK[ZZPx" !@e'  ͲvK?dr>~#rHF342dȓg7/^x_Ƽ43B }Oi;nD=??8?p%r|\%2Ư4sQ"d |Hs>%r]vZ3'>?L __̉ ,%2FE^4_wAy~dgGDhB zVx\.j Կz#9i7hAHRB1Oth%"b<c@%l1 8j K.fHT1"(LYe\ OO.fYBF%bvKؽZ$y %{(Qʄqx~F p4>|P!E%U \ ICs.e(pTU h}^~YXCAAgH=,#+&K8Ruhs5 U0ۉa-JF&Ri*++[i<#]^nfOe=£K>v}sid[J@~7ct%z~gF^}n[x {j':Cޮ[ׯe$8}|Cbo4uzJ~/WY 'm1=֯uǃǛX=kxM>yk{&ͽ y{;(xr K(gJ7VRuE+8&h;t=%Gs(k3}pB K"᠁"3 4Q9|s%<.bĀ\vBw@HzAIM;Kߡ^Yq-&)'36w84fӘ].9nטN8ѠN<A}Ѡ׎zՏ&y^ssaNGyEu\hdԟYb@"G%W)`+9dCl$ Xf t.>B"SH|"GdoC&=6^~y.eֽ(TKbXDA_˒ U$ $4X2[J{K`M#*L4s+mL<\==2r;9|VQUr5z=9}äMV3yf6q;<&t8acvz@F>"@dNF!u6~AbefO]<ck6 ;.߷C]/8pWvynu+䘳1}wM#Wgcgk Od;"B1 ޑr{\H:\ͩ8 ۟ !.t+.!)T`=mm {{x;:^UTCZ(_Ywխ[Ld1~ĭx6Iځii3i;iCaCxԂHĤcQOHdaks޵1y q+B >Ycdp6DHՉz1NG r0lg6܍ik#Y6&"g )9 aTDh0e||Jk3A Sv&H|~ Q1Nv.~v6 mdSE N&s LI,HmHHln_._^1C|F:FSrKmiu^ MjuHI3M59~uoFwMמZ40E0(M '2^GFńBG?8(й`3\@Dn AJ)s}< Vv.Wh`:y~㗶MiNnIڎR+i7i[i{i{(i3838x䅣Q/F0Ʃg&ۖmv<ͥhQ3Uf׭jn:'rOoj Ȫʪ ik o?VZw+-!b]u^L?4 YrrmPY;? E s+.l9̴K?ppA.йRHdp9r\nN~9 R AĒE I+vQonk&SvD".lȎ`N,??-?t kO8=X̤r&a~|V"lrׁA]$D<.)k*}k8]_Ԝx5=RWҥE!];rZoD_;]6nQٻ;krW뮆겂RqUs zG?,h{\"LTKjUOGg^N@BYPaɆosJfm7mfowÎ9iii6#m'" &5^ouuv0XB_8cx̳s S 2-N;݋{^8 r6IdeLC [~YAy[bZu^֑y+;JOެ˽)ee2zԅހ6׌ݞve|`K( ly\5Gw2(b1D){888Aܽ L}zY;uA{Қc/n1cM6,hAd #m^ޤ>x}Z;Ec&t´IS-5\mMpd]`H@驐 ׬boɨiD ]؞p33rw֕kjJa5:B ~5fn%;23߉Er!6m=[9+UOc#?Gم"$}J:ng`n[TĚ;L_;H[ї~b/!k6$A׃ӓ˃ۍ}^1s pA{Fʫ'1=}E綹*&ʫAeg®F\1KZy RHLQG|iWb9QEϽ(e]*); spRJYa,.v9,u! nMzP‘IG3nlV;qCExxxX/8܅^ba/G5w [H{I;Hnunc6yACAu i+cw6f>c;N( Yh2{mvFg#GUZ]OqMUQw+'TLa/74 jd5͒FYUY]٨.)/e]UfS]&ngt۝r _-@DGG}#76]p/t 3n#xBJ z9غ8;;8zFFw8`?rfl9ChB@D;u->ő1}#aM$p$#LҖ[e>os>Q)djӘf1U6O㑀Ђ؋]+kZnmAIQ(.*iնjo]kTRWJhQbo:%7WY}wFgWse!H>Ґ=gѹ+hmfn9M?. $3^\gCAuIt5N)fj|j}mvJcsxmuW>KO: _MNuqߌ#czv 7gXpPr9Z,B0XH"W'oG @Ho`K` fi7/pb.  نHĉX[\ˍX]6w(h@`@}>qs(`1GC x2j70Hg,yU;6Yp)yOQtjB 1OuMn@O7-bw\%*+W?KPt[X(*n]k\oTVեѦnUfU0b{}2-nrJs}i>1O(-H^q7!!q va<ߎ#|>zGhr9"46/]L!; c (Gڛ= }GmŅ<]hMQE#=ь;;#?GACd+g 1,5Kg pd#DHX#qz&HPaGG*YW9yՂ DDͲviUzfvGsKu]djR=|53QR&w&3_cQW8.KG?#\)X q_ʓyb,V`#ET`:R2Ss &6IHvG,#rTկaPR (Dlt^"pD'yTP"a0Q\lpdb4m#D \`HH_ '~GDJ|'ELO#QQ;Cq8,NHRP& T7O;w{?`W{‚RLC+zTCǼ&pSG;p - 8bt%8׬ÑR8R|S8#I#u=jtk;:-yXItsIOGW~~iiυ'VLhD}jHGp !iKb"K< W,B>Y,It "l X<6AK(  >.C'QAde˒z,D&n2rd'Wj(tDFLGF)#e'0,c~!Fh%O):W<Ԇ\#LV)a%%%Ɔ QwKOptD<:JS^;6cii]ވA~x82I/f4Yfu.8 ,hIʼέGP$&tGqPR߅FU.Hu4EdVHrE\헷\kA~f!Ԅ"a* ńq@JRl沈IӨ )M&EC#9*hk? }GC0XJ htpx5XEb0aK}ݲ!J=_Wp5.*0O#BԏtK)`" Si4)'<\`bJIS4/UjfXEWREkε.LP#*!f3h2>]wKZoaA \jsoruglUWBe[nUL-dh%,R:g?l=kH(cj494B$tMqa֩snڅ<.-#䐬nmGJ69o(`>NoDrDJAgBc3`|H@P"K>ndU3Yd2uu*ն+bW酯z_=:Y:0SU!HӨD[tda _,m]d2uM^:_18|.yqDGc-Y<9$-.4$rԸMetQx.8B`-3,rstquuuwv  徹pzo'mFyՍÖp61;/($;Ƣk~};dΪkL]kCΊþFT>x)[FBV]3#׹8R"&*.ѭ_m kx9 |OJm-TC1:/]7 _vF[7 66}[7ǃNDXԭi4 Qz!+,g0o,hiNn2A xgF}Ӄ~Bqx(e+Vtv$5m1$qo@A`#U(a3zB:io ^yxX6]WH@,PRpxN嗻YE5ﰥ26mGXi 'w5F[+*x:ڻٸzjo}:SmFn0iF1I[8 'qd--MN 8Rt{N8R*8Rۥ@ՕHrR.2bΓ2:"jwɞg^']B/\75IHoD4Q&∎s_ng/g7*^3߂ųx1#:|oyRتvnU!äEFI#/\j-"bdq}bY[ZJKS!|lGU hx ?X_#".9F 3-g$ ('qd$<9|y$1A$_q[W7d4gqGoo^##TƻJ*-ʮ[|"l lgu˻VBIVSxL€! fe0q0x#ژ 78) lQpAHgc+Vy<Dp{F\):HJĽOtB Շb;|RQG#FKiώ#ē$55f֮.^n.N>6&UWqhCC^lIX.#ୂG:?Y;&W8PBM)} )5u8R"F3G`5vi꺔\n rk8ixЬvg/}9wIk=1. Na# jJO\:W`=Qhu"6f GIwe=.{?*2f'BP{vC#A ͵̝y6jC' s%} @@ P@(h*E:@ܡMu8c$2N9Fq,'T?]l 1k$z0@: &T:)0ѡSYW9s!p bwxKY%fq9 ^opW/Ɛk:$wS)֝ [tfPu6fyL,QqIxT4Hl"/t_$_U8W.x_,WߡWJD9i2jx^oJCDaU6.N~6B_d*o@S:Gа-5l1 GF(= ^c/G=шPct5A0Oy&< Mi";^νx-ne0 R+QBv(>h"p.wu;;_ 'G6{ZYVsM+;_rJ}C،jM6 BD ɃpG߈#Ǎ(e|CR-p#nG.J(D˦օK+MBHUDB~u8ҊG- 9u*ZeJtawHV[m;Z&0e:feTl:A8Rpz}bMB 0 r9aEJÁ .x2H&$L .F ̒E}(x9?h {جMvc7ڒYvXvZ@sɛX@(u_5px~G@!#8y?HCg_KfG ZYujZ|EoTAGxnObUS0>gqIL"{Dw%~17(ʸ/4pi,(cͫGLnc˞ u GZ ]cȳ2/Q 2,_b76 fY՝DPCRfE1:PaeG@LHAn%,r@P4RJG*;,2_b~7T# xD}Q2؄DRЗq2BP$Wkz-ny%$= OϿ2yH#\|fWWWX7;:8{⚔Oa41dN'ͯDlC$bM 4ENED ΨQg %\ '4 N>LHnj9^$)ɳ`,d&w*;S~<ࡅW8 hEuCxZNͼ D&T3ŵܒ:.2ڲQ,Хj A}H6I%]in HnX+s'<'\ywDa4/r5#DRgAءj~F$4)RE P˪' Y| D _ P'O]Oȑ2 b9GG oe+*Σxpfa::qbUt#ooQ7{%*0@y;h*)[*:ty&!3-6y%]$Kʻ ((d }'Ba03Ė&d M_Yǖ`ȯQWda=CΕ T&;P==.QK E/1 =U!ʛXZQOd(0DHf72{88ibJ~>ZCY%Bt~(D?D-<!b[Kݦ oE: L Эd)ѥģxvEGNB,v֧ YRģ[T?u~3';U\aO|T g\%Pŭp]}e -p!}`^xAola6;FS6hZ+ݞ1_G/X٤ifp2y^|9KMWYds,\g_N}^V|8bWkvNI^YMp-Dߗvq)ɿT'F-.mV6k%77:DM4(#-ԋ e̴rr>90-~^yKӦM=6qCVk.V]ߗOk|%aשtq(wD-O E-C 7;ĭX0biJ܋; p@#RLL>m",Cbg }=؜8 fC~B4jW'`EXnlB3 `F9*S%am?8Sv8ZǼy,b ^jɄ>b@HyƇ{bJã^4 8tyfN闚V$%C9b%A62]%PB*九^eM--5XaMn2f=&w<"jVQ;"{hsra"WsOP18Q;FXo1 ]v2_zK"m2]9}3$`@/WsR6;$P[dd BͿ'>pͨMb BXFt4UP~B"JL'a,]`XDZgE 78)DKa,D"2hX8;9yJ}護~Ş0:zf[,һ&KCA:5`Șv $mr$}h5fKmo|aӸm.cv{9vya=6/m ґhґD 2_?Ʃˌį6I|"m}Nx_nr<&mtwf#l74E%]HwܫtPB  V&^uSP)l[M:FѥZ^Q3%p8ꡠ[ VdO5MyL[M n4з^IdDIj hTU.THQ\٠H%졜,mWX-LZh"ai,Y6y3lY3IZif{ l$P\R:`EP"Rz+҄>B7t,/pnEz/u)}pi!tJaI^"/;ᕻ_f"~Q!4WRؘ[vw@ɢQœF]y<8C)KRZ7py|IS,2X}Ut%jQd T)EsCly?' ^M6z._`16s]y(ӋZm9-(h lA@ťD4<*̙59uV\IRO#8PJ`X@xrAppvswqv򊋌04rqp#֋[#c7P/C'P?;Vuyyi]ntzOZc4m6}][N|pY|cQ?A?ҡ ҡbc !y㝳A[-c[Fo4 a,UQ)S=ҍC -[&U2;\;#.4s'#YTM-VhNŭn9~Ip_+e]J)*IάIr9Gw^x#iz1vHhaˡ@] t 'N34[^-=J._H)8lBEmXŮ2 Yj? diL˴iLq`CPpvq#!֨vx,΅6'Ra& %=T ed-6¶Yh) &+O5T ~PT]eqrم. :k f}&bE ~py"EQL"b(; u:Wx-4KDfs= r >z o0%Tm_?~l1c6g82beT넹>Y}V !YFrZe E!L8Uk7c_o.MxC/deTӘ7f`42nI|ކ!iU-| W}F,_)%l$¾N1P9QeADےggfa,-hAݿ0%@WzwpDko^I]"cKz|a1kO ^Xc;ƫyEHH,I+iRNǼLIKma:_4C'^:>xK|'z}[S"sUt^\.V45!ѱQ@ݫnx++75RwaM*&!&WH@jMr%5v [k sQ H".` fiSW:c]\WE׹jAHku5 2`L&S}R-rM&rn%,4 iY Wy.20 |Uj׬sN8krVy Xk2h }'YRCΑ->(deyg oUG¸҇,գ[]gb/|:-UgWYb&>{/[29y\{D^X-T߹N'H[M(!n2Ӿ`EBðAˌ–.;q+{EpaK76/>T?li VIM#ZGmQoF/3yUڼ^Hg :75mu&}u➀Oև}Et9̽Aiκ2 c?>y}FA ,]f3kLֱۦ" c^%7O!Q"zJB,=Y~sV-zkiֱ B 3kc"눅FAs 4սn6ΚdJthgFgPƝ $5AΎ3# :[w `K4Q[mI4'l#B`V/Lɛ|ozCҒ {$0~bd䫑G?|x5x]:syh3ပWwX.+~ˑoFF.Ϗ##??y~|2wƷn W*0O~q둑~jޤW6 @!0]ʦj:tU#~xR6xm82Kf?ԭzm B. pD-BRl&-P}}2}DB8W{m侀T,_e|~Oj =/{>eY,'zfI[W=JUbNhWp&]OF.q8$}~fϬ+-bܞ57Mʞxii9zo@4kI#V&+hdn4,BG_l.*GCC.7*:?O_h}I3g6ݦW4&MJ:!5΄,P:M|Y?lCrؕ^4T,mam՚e7N9j67uW,l3wϰ:du+OF段 {]?|mBV'E&Rz>/$؈dq!$h4,`4w75ș<ڄ8I(`-/ 8U88!jh̪Ꜵ sh6@{NTXל< yLEtF~qF~n'#bH&~a e.3bu<*gq~on39M "! USp4-p4L [:ԫ:1qiES|;9!S3RR p!ee$Ά/I^fO~xǀ 8WԾSKLb&.LY`mUZeQzrPTqL7ss2ODjunr*,NH|U?UTVY<?254l tsjGoF42{s !RlrJ:)&|p7(z]\YzZ$ئ\F;ݒ^*/ $zt(e4CYhR6ಓCX]ks5?~C|+PHy0]3U.oqNLȷVy JΠYRxO#,%Tho LjZ`И qMC9;{8ػ@MR0YrTX|YXӫn^dk@:: [-Wp"y/_4F+c&K-xMvݴ6i Z$-0Z{:̃*mUr'}z_c`u=)019@I<4Jf*71ZjpgiY{930z3SI |?0PKFv/A¥dC>D &svJ)fod,ΰɾY.c ䷉Ϸ TLU-/*yiߩ&3mǯ4vHi?4.G'&8ZxPƔ 0>@V$/;|;=o61T,/!'bXЎh % ]Q#, 24WPHmA^~N !v`OXw80ufLHZu ޝF}2?lwVoo4é덧7l&+PQPm4eI㋀D/~|;?B B#?u. =6;pLK?jHT|g c R*5=gc*~㈷gi C$x@&IR M*Zv !|2 ;ԾO0@D~571KL$"2~!S4]=4)v#7؅Q$Bi?97ZL7Ϙc0,,PeM,Bu91uI"VN 0:J _%4U#Cb3 xnsi'(ϕV5\j(da~39)!b:mMf1٬~6ĖbtHp Բ7h3^7i*C z =&WV%5q&q';{>]LPCmͰx&7ҳ[q6.9R]-##wIֹw1?0 ]yo]6Ǭ]y={- ,6 .9Wdr6=9V@~'.B]w}xhs#G׻qe7UGn7{ $AڪH~'_phGylr)Zc~~ԣ?r˴ C@T(x%G ;w]_b22jy ӤxA0Qа}9ϥg7?`7cK,YͱtlGIk7-҄ͮYv=2Rt+ v[0}t9gZ2 $(B~JCcӵ\U[PS)j4rzi$${:6~MRt44:FRf ͓W] P h ;)7٨&GJZ]Ɉ <>&ĥDtL0 n}`\%)l CdNMV!/k ӂh<0 _t ] ]$#<9,|uIZЏQr.E1JPHnr-g1.k> 3nt/6Oi,m= %r>3d $_]n~F7'V5|i &ZR&(Zh uQĦ‌߲ {v9 L#DQu+̽FͲJ\fw*0U u[kiw2 %1VY͵c&8%|!m YQZ50PHϥШ|Ć d+yNK$۝#[Th)/KUcLߌԺ<5!漆 AT_`#L0#d2YI|a ]VdX/:r'>1tyaSᖸCaDGK?wE&>J 1|.O|HQhN%gC߳Ϙ$vY62q;uObA/Gӛ\RӮPh( d[Wn[\ ,_oֳv럈_%/k4:9H#kmrnuIipCDH5RK"OA/p*]kQR8g4IaޅԐGO(9! pDecu=`5݊q0=ejG4}]/as,[v+ DǓnYySTٱ1ۉ!xqr:bHrW˿ .&Z*D^ QҤrIݠF="ue s[>3AW2#z%A5) 4琰2gQ[l*{??tߡ#`DD#s:y]JE14rvM#Xe.3SEWu2,E[d"L;i@pn91HP+ֶ:!Ug'" `!Ax\IrB/&< "n@z-3.l'mVl2QQ _~)r;HI( "p`q{q q!"Ty^׷eՐODҁwųlQ-{*m˷,֚D3b:z}~%H /*5(3#9.8Bt\ީki_FqD2EIUg54{ ZQUG ҫ;C?'=:ʏGYYu`'ۑ:*+nr.W Ūψư6;CEziL㟉 YWZefiOFys.k6..3%㎨{'=J! Pf+ՍU KOB 1y\uuuhlt#P&R 6TMENHmM6ty0N⑷#Od>c#@W-bcp&aO/a2,av|K ZfPX8d; 3|(tU>EnI^tߩ(~h[(c7>2<{EbKP noC7qU[Vǂ_eD8~ÑX;]BQ1P-(n[VKQ=Jfy}KML1Oߢ>J 8f 6-y ')cR1=%!# δ~,>^3,A_oESк%Jhc:%*A2!EIg>3e\`#Kjk)GNuüUlY$!Dܜ8j|TT*LlPYdmqy}!t;vk['wzGv/=9#bdC1n7O>j(iC i/,^׷ZLjvq</`~{l:_~SPIf'E)em|'}291~-CLBTDf,tA\+R+Y$($mJe_ڂ)Pirz~b \4On?K2*pm۝aУ6zSsZ2J \:  D0}ɍnn|[$7Mڮ*Udr?V\PD^;Qi>Ϥ]C08 &L_js"&,"3VN1g$r@*;pGĠK~l"C I3 F%d 1#ʙ!6Ygw=듳"x/TQ5؄W6F$pJO>b3+9R9|)U,Wc@A"Vk=h_Yy QWQ%29'gwW/'g=DŽw6ky mj||ȗO#W mqW0\Y98aDO?)nVAYNW[2;ʙSbG~ X@ $>v@X}~%Ű5G,2A-,tL2lTt'6(dUBVIwqPPLe(p1N%RJ%7+QY`4aY_+G]_ǜ[k50zE;'o3dCdD〭 N9;*,([8G\MfNO_f6Wgóq%c%\P*Ĵ.ʅe.G% *( Cyx>Lp* KM!? k~+#T#1 H e 4wGj3wÔ)sݝћ;_p=m^#vcHKzMN]$E6eHixva m>w\ﴞsCCɈ蓑-1oGe蔯Kach~bfɾ'he$ǟq GXئetG;:*=PF.53xR|VAHrwS <` zp=]fAK_Xh?L.sgsO(TԄ /m?K#+ }ZDβYlq5vL*/lX"2+1DA^w?Vo3HQiTq00kYȩoۇV Fnpe74ie~4e#JaQoG&xsn$#g>$y+Ab7oy nCCv%-, fg V`F#Xl 8.`\Mpdy,l}cKkѣ%Pl'oOM7 >jMP6sp>@hH4k$L2hCbCB#T\rHc`nQhm}.5cn{gsKYrdS5:jJ/>bγ " J) <=bees?M@ٰCT"/.]F07ϫ酡Ds^x,2(=<Aja}P@QiD|)Kݻ:xbkG]=ݽ(8%ԅj{sXBGڦG>Fv;tNk/D_?ٝo5}iD+0O{iX(nsiN o~]IrӪ{_F> {c ^kk;;l9&w2r%se-Dp> tLl{!!IL)vQQՙ[TS}["rUDntIA%j$gO.]i/.k&3#^ :%fEygfu-=G*k.)*Tr>8" e ~SNھ8pu 3P3 K̕EA_w*7SٽJv7>>AEAm;Me> MXD' O$55?زO7NYhd\١E?kcƂb9"gq߷pdMd8T)/@: !Ɇ\[ťlSaR㖎[ :n&oPZ\b >,r}T\QDh<_1 \h0+ϼ "ilP_?xi=rVZZ0%0` VfpqY,92s &9L7MzU1ßiAw5=2)BgE+rRuaM]yCK'LHtc Ae%B GyDA$ W(i'`Olwl'}ߦSq3i׿ԷLjBz4&[^2q3 \mǘ}/|qoФMIzF_iɦ( , OGOdi< mzS_?yڣŏ p$: 8ǖt|~-B+ ǵ/k~GhE(  paD _PPRKW=#u4YϔS<.}`{ayܹfr[/|vH~N͒s`@#V]( K0rgIk/8j0_.̏ey!@-;@AaZ’* ܿR˛wno9 ͬqD-Yg50niXFWev8m) jOE֏y~% Mc6zGb dy5R"{&rQ\Zv{H9 ŬEiy({B:`WZQ=KJPnKٗz?ghjx$<" $4YlzlՈ69z‘d4Bk~D1ۧox}{Q!m֎3r"0P{c$9qIx!aYoG:i£֓wپm'?(\k%{U.R' G,2lè5B7D'OƁsdaΗUUF>z ѹnKtr+:gpGBH>S׽=뢥s f eƶשy[WgvzF[ &" 2p*ſt6,ETK8܊wJ,n`w)z@sɽHE1=Z`1tOYj` fM"޷N(Pf D<$}qQ,p.nqpr81TI%BaUM$Dklʺڕ"j'K΀]@as]\1 sṯt_1l*=?;,<#KF&]CX@[bix>lcW8'M9+ = yfa,GE?> )wcoV9tIdZsp|FaF]d;4} د7m4 6^^x̪#w &lq m#$y=&>/=0ҁҮxҮWvo4 F>V<&pN?8 ]s;m5 cWYN6kPT&cFwJam~e{UZ'v|r!R'jfE.}b[t9D *<OͿsU_B[d$zw{$\V}KV&0C4I]jk{0yT*,UR&9 q\W}9۵&HzJWa`p{`8kTf#QX{n(B=#Y7:M5 G -)$ꡔ=sL5es :7ܤ'TT I 4G*O*Vd[ջVMf8'pxDpJ]'o͡YfS-RfXeO9UdXYC^y_=P9B+AS,b Axu?st۰7]^mMfIlsɐ)>oXchq*޷K+inF)M46}("fS`ً'"W1}i-{2O OwY]G' Yy<| 7AC^zq-63v5JBVBlY}ݖȋ+>v{qfg  q3ёRO1ֹ}ߏ#j7d@:9cܯ"B"<2T )dPx=O?e$+:T_{z~ߏ?H*+RH,]EeyōC\uuYM{Qs\Z_`rnitXϰ\Yiɨ5 8 "*Gr9R*hsM^K'9gs@jm3+N8OJEi>ݫD[BKCܽJl\}!riw4kan-Rs:R Piͅ) fW%[DK7-s1=av@wG`Aݏі-J6Kq=w|QZҤν/ncLur=Y9 ~, 8bYjPX[x kK=/P"rgT]nlf QW{%ߓi;]v+šIiX@)9Py  1#" [g!Y`.6SNgR{"m'*=T}JwJn$|,t!BK 7,!J#AbI-#|ta0 9,RK>eA[`1oBSi~y7*+WLEK^e:;n9LQoZmYPPJlXdQO >r˩- bV-[z#ob*[i]¼6^M{탾Kθ/]e'y%w?rΜ":5kVqM>VY5}XC^wÕ^TRɢd7Ĥ(JlW2//7i&cթz~qnVql6m~*beb g[ͷ3^;bJa>)PJ$[bM\gXҮ" H &h]l1qJ̥V(٢t"0 k `Up*Za,Y ,>-3 G`> LHRow5z,mQRkM_;kw q<؉Y,9%1,4xQz㈭&޳[ntiaocŬc>Eb4x l~BP6 Yr>:gW[Fe UI-Wk/¸`iJPPTa.2 ) atRF!/u /6~h]vWGÞ E&duH]e<N2%r")1{=EEulkt Ivg|vNHjHjP'g٘n6Cl1+o' Al'fW%iqwk4F ~~/hȏ_k⛑$L=4f};Z+w@A*yc/  Hhox[D]642RPK!T`i %z#J Ҋim~G0[ޛp&O0>rIMRFoz}VcKdӒJq`SPISʕ!SyC1r[g=!ok4$YhzOypM\+sk}3 E #0g/3ZO h`<T hi\LEvk[AiڔC5^X!ÂC+c(VAaqyIW9Ă> ae2%4XEkg,5g9|m=i hgiX} D[X.N^M Hr֎AGh43>]GU6q}0bM2&Q'4MF7ҧOf"6fưP<]%H D~_Ӏ ?0wiY*S^7In>k}b+Ś_\o|J7᰸դ~'jF!ꡩ<0Y)0p<"z}bٖ۬o%O7M_|4D/G?2=J7 (Ԅ(2 o'%!}_:ZAsq%j"Zxz;^p(.5}.GL̶ڍl6[q;<"gCd)֑1^gQlGK Ϯգ |͕ @S@ c%E]q)rXI}aiEw#TSA9 (a#VJ $fs-1:#uDw-vKq-F#]҇Rf. k H\%UV&S%饲貾ML|6Xl${Q<.2Ov&G_Ⱦm&0bI(^pt( HtL.Avc'GP"!S7콲8k @@zW Ÿ.p 'є1"ol}K[/;`t҃{{Aω]w!r{c?Tܛ}col~{GqO{&y'X&[gXbDJm|Q&&q5Mc:\ ʫ(T֍= 7$+\GȢXUd^]Ĝ %]k]ќRF+lITV>CW.)|l!Zn>C sي@:/et ESAENVf t#sY<,*ꩾl2*m*3+* {j!J%_[R}:Zm&B{,V) lLqᦘ"U~xSSIv;l}$Erk{/ܡ <!0ՅJ&h&=, n1QȐہ syd5ma=_ ,~&IzuU 0=. (xbIpF'X*g,3zQ(}wă9kv7lfW9fWV4:Y{P3\Pw}b /&[kLÖ+yj8~H*1]ʇكTj붙5=j#ʚYM(g0b<.hrZ.W22jNd&߀ s?p$3+Rd4 ,(=мwAh!g71}_n*.li 1 EX.G6-IՎnnW?MYc{<{}(c>MM>4TмS,=܏=VG6zp3c]QģNi`S`,EU6Vf7fʸQ(IKIŭ:2h{Kc*|rpN{`f}X1{9ǝ7:᛾#=Ǽf9S 2_Ox6!'Br@?G0^, :A {d(4`ڕY/3,4Ƥ+!at^[w@,AUdXf=L6uT@2Ÿj]|e?@#s'li%fc'\i 1S$g2? ~ΔcqTCU1}\%waƃ7qh( qշJtPLxd"J30 2f${.Sԃm MN_'45dPy_հ`F@$"ǵP>-2礛#тi[Ūv11)˕`hIp`߬KP_(h'bT p' , ubSdݢ~: 'a+;e?$8OTq Dw# k0>/p!^:o弔 7a i`?BT1H*|tk kv -]ޤ`"D&EJ#A1G텉m!fxZFJ*$F ^R9FWqzTlE=Oc-kOc&M 4P٘?P+NRC0uJq^nYFgEbDQS!3zh^&Q C섾O,[?t>aQdѤKAzDPWS$H"9HmjiKPӉcXd9( )!EILQwv;'E.bmBGK# 4Ywˡv.uA2'I?hc?H`F/銬>|&r~rا Bx EQB<J3d("s"P 0IA"ByW΀Uz Z"g60!x57}7Yu)Dd_2JXp ?:xTN$x+wq v#@uL"0~=F[D^ ;\H,1ⅭP=w0I#p/lq!\HCI"II'BUzS g4ΟoSJ8op>%}G <Rj :6Sr{{ڄ5--%B;R܎ a| #5L)#'<@%{b5Ao-9ꝱ3kGbq脝OxUt;`Zʂ|3$R>%*`.S &, MY`?*d]KϤz @Ϥ܅ƏhqN#K\}N, *;g&K,) 0!Ԁbš W?3>/} f}'03fx@&pKgP~Jf'K AI,$Lg4Q NUB?Imޅ #6֙@ΔpG7|Ʀ}c>sWA#׶3t>@K'F ZDitd~qgMm%-dᜨ-(BV7 6΀hzi.Yԃt}1_b:cV&=C|h`@*x`Ma<.ᮨy F7W!B?^)bXH[;axϳ{H\Wٚ/_]6Du-`V1KH@7:F7.xJINJirS>u?0kCAˉHxc+0yƴnu`ǦaAo˄mw# ?r!#iGPӏyV#oܺS36dMޔəg&8ikײ?ݘe SJOo=;~-<|_Vמ/joWEt#  t882Gz(qR 8r۔3>8{g {/QjXqˆACF6<>s7Xp0zAPf6yWYw:nCfZ(,HII؜ZZY},>gKް7'v?72lxMwm8qU3ʚ݉4ZM"#wd7&+~$efVyИW撞J`EGtN_/uAD.ڷѳH*xP[wXLv-O_c6#`ԛy+ ɪ]}닆kF+ZpK##%Q̽y$?5~׌){K`Ȓ%'5'(%INIIݔؐT̪ceo9폞'81#opa8r%wNM}l 76}Bdzk#h" +jlOYYſ@vv9LKUJz쐕q+^88t D#&V +λը8>ӏf1DV{UƜ.i7>3 4ʊQhcb2|%Q82VA5`IŒLJEwƒ^e"(D  pQ!L݁)bIВ,<`@DZTA \k18u'c+(Qeɸ ߺ3U'}hF.32#ajj Gf/uB, ᏎܗQzE͗VgϞ7{_^cIXlh0 _t"|#a eMf/gbTy#{ _S4__ܰfvYA?BZ*E:#L,'%GVіpBr&4,χlHg(Vu=\ Gж*EIqdG%AKg\<,u$%LNEgzGDŒD%mPm"K4oOh>X$%GR_}(A19X{Gu<'k3ݫOLq.{ۺ~>R^M{};aF~fJK=ٙ"K˕yXK=6 \Y}TjBr z37a|3Xdjf`jiQao'8.ٟGJ;iiWY[~ɪ?bCqǘďw:}\VT7T-֧g3ޥ{\R?Gx,r"Ȫ K6mѶ>@Ԣы5IJmH'\VrL |k){q{" &R!]1nu_gjM/yn|d{둳$*޽dť#`I>^|!?ŒOo-iF?R?=(FY%,ϧpOCݍ/keI87{rlJ +F[S{aw=U1&艱“5j }דn}2򆧜}aU#xF- #$/zT$choVC~SJD'kVmPjo&`f= J1/;jK*2;h]JU@qӒaaX9&Մ]#};m]*|ondh"¢l&ݎׯ"1s;qD;JxYKrp<7Α2ֵp{Lߢ]oЄ3'eP+^ҠH0\o#x0P㣬4!.FXЄ<{~{|d~n|\IIVyYk1Jp!7>nacG?-Gn{ޱqEA pΪtpmiGK:N+S\w8#zVE  +|RV`]I61.FH}AP9*dQanKs=gwʅq;CCMF6@mFP=}ZvUt`[aA=Ft\B޶6ɩ GlD1bK 7 :;72wݚذNw&ƍ55UM3n<|7?|/eހpnZ?U82kX}?Ai[ۧ/kƢT$Vm 0$d{튶u3Z%5)^$(0b\i)[ES藾ݰROMzc\쎡?n{!L[pNٌc{V$Y`bXZSLGP)*(V“Էֵ/@yjJ rM:afCchIho#a.q rb;?>S.uU`te.ig|c 8V}t$jPrϵ4q@m' yvlAC?BRTHcZ+[}`<({8<{ m|P9ఛy#rJ@Ujua+_:Z]NUT{O:F aAKL(:I%ר8"}0 ,y:wVuvQ~h z=.4ti|y):Juƺz׀v\lo))>J>[!vd3׆ػEE].FNZ5s`RywꉠQ:ôM򧉷> >#Ћ:=pDXN+Y~ҼEwXx̴Z!Ո6$/X7aHlKe-Ɏ;$ƌ7gۇ+pE,>vD%TY|'t[A Ϟw`jҞ F7X3+ItV#qeXQBq'm ߯/cpUaT҅b2ɵu棏>lY9a7??/J'@Dsrsy̙ y ^X,F?>~8aHwy2p}dR¼-gffd|,qEl)FSKPmh||ZE ₂fYf^ i,I?p7S9/ӏjn먙{3XLI8rd2|/)NVmRSX,6%J,VWDH`ټaqĤs +?dлGYu ?ʫ{"߯ԏ|`۪d7D [)67NII%aFJXy޲qmZvp݊t3>DƤJ* 49`",>KJžq^ l%Ӗ*dSx%7#öWBʺFY^ujkE[YaGw'7_l_X iX IKA7~mn{/7%8"%)ӓL78uIƒah ){7oH1<o_Ia=7ۓ;bcۥ_w.y׶J?ZU}::&∥Y(SI6>5WYuحP;9gN#f;P#0e*/ Zzv@ k(b\@77@ۯ2z2Xf# kL vxdnV҂$#t!;BM3)p<%x'U| p3\-P>Tq Rv34J61P!F<bMt7GE}q(afUOEt2m+> `1LG---@ v@`i~$).6p-v\n `%o𦉉| Z11Q6/20:V/^XZv[3!/:t\|qCߡq?2(wQ\YUT$6$7OהN%BXyU@Sp}δV~X Fb@ 3$ sCTT;!!!??({i~/#Ȓ7 afΜ}&. $Yf"a@wN ІNz@ȀJy-" ;@ " |8xALhطyI: ہ PDx誕(`In GVQt=^IP@ ׹s`=+!!Ƞ9C"BrP:@ jP(()8PpP@X4)'sQ '8ʵw32"% 2n_T5`֎ݍeE$+m.=Y|6<ɉu Hvi_wU=sK8Ѡ-2$|,;'3e, m#+UOW0~޼nmH7@ X< 17p23i'eF ۧoN f,(x3RowOcwd!UkC{AkW^mVו̢-@vht8ڨZ|cYtCBNLQVVAvg8 @ V#(ǏR@x5 $S3@ 5@ϐ(<9tFE(A'&h@8ae@DJՇ>Hh2MPp*D8P>M4jƊaC*=Xx(wQos o(_Mp 5pKVRȈ0ZOD`CeTTTdQT.:)|p|~`| 8z!a8 {Bgu6v492փ0#Y¡|zCMb G:DC}6bKu]N$[cF=:(9i!}B:|:ʶLz0hR:_,_C3M5ȣ$T$*rˁN^Ly'Ͽq|m^ͶS߅1|$JKMa@bId X,(&bW{ueZԸcN)co61ÉWrԸFYK7wx8NY߿t8%=b I~p<:-e0ۨ=tU52(JY(Z`(C!̽P TĠ*yeDl6(/..fX32jDM%0Yڀ.+ .m3E^WxcT$,>.5={aXGZ{ď|AUͥ02vW0>ep-K75gVTY˄Ș4f`1n?͞!Qd! zY@[y z{P$Gb5گAInl8>E}'-i YK*k,6?GzT(y,!h212! ^R&v9ҹyێOٷ<'ۧm33b]}KѩS ؈`kd}DQ]FgWX />>WQMh lE1 3I±]W!ɈDLˌujbY(S 3!'Q94 AJ0WOKyw #H C&<¶P WA"-1,>r wڍ:j0шI_'bDL`@F`dCRD`OqKR * |,0J-|#W(?o-0 `l1QbtCKP hFItS_9+ؔS =jr[MN+`#c=[vMm#iVj>Ӣ틽g , \+ s}ሥs;z#Z"i8pĭ{kLYGt,3)Ʃih;f-7xC^kaGSJ &;aL c|(, SvRwQ&xw cG9v>2"?`ڢGk0zə7zyYjRw piv-}fHd'ˣCbLKFy&4i}h 3!o&|@yA;E'dtP,B _Yp:p ;r{X+E<,@{eT",` 'yGD`T(8xwq3'5vhXyMC,^-@'W:f͚d%e'OH"V|X'Uݐ%2ldјR654C']΀}#}HoWE>6d%;-F%ax$.*̀j B1c@3=}m ,R1ELF'.-!&v͍ۖ-MMRlӁN]3odvED)S)7>L[hF^hpgnSXOq~m8A7>I717LYxԅN[|̥-?xك@IrXG` qdX W2BClY5¹~kKn4&, :R^vm<ܺiu_ٰӖ<857^;`=#f~\A/[nCTHX3Y9|jx(cvA}JGy-8 cdhi3a!3(1ʤ qET]F30!i`Kb!K9H@IP'!iHS} oB*/'e‡h!oNBB? P%=°P3Ma2o!TG"k@3*PO^yS7 pFxPDV4hKJJB""9B'58(t4Y7aڇnAg4/И0'&ġj*WXpm5zGZJ:Vt:i>s>RLRb<,1G>mʂ)j&<[:DEBDzȨI/ҵXH GHGqQ7g 쒴E6 ^($4 54 GD}Mr\o6MbV}DdR\|RBbFFsrsO!<tPϵO:y*Dݳ _tÌ!$p膂#vF(l D^^:t㜺qn&㽽'xy7LŒ(Kq4İp}8|#ri2zδzy5h2Ȫqw&t(>g@R'+|O+ Y}eNMmP/M,Hufcl̈}8^g MzL>! E`[#E"ښy?9P((@c,T R/U,5 H` IpU8Dy!;@QU2JM m"Ȣ(@DS4Kkj P&5uXUǕu_10YQFHAC*g`% P5( #cf F@g@|@p5;8BsKra 1"pb2#:_ &''7hpAj왈6@xaw:RuK<~PƋ `Fq(=opdžE9H6~7ZEaeiXTI1 ¦/8qfd?ٷ-,8BGFt# J(m1 cfxzdŒ`z4e@ \%D PaճϘְdPz5yjox/;g/rrK>OS9uumgW96m "zŹb^ac@oDRtשHB ܳ7#<3*Xfc&P8H! L"|h%='AxD`GDL [^"Bh+h5T,k܇)ó$UAr$ ƒ\8L?#SD ZbfϞ RoPDJ9/Jk?P<|0JJw`RV>d ,|ҍ,oTЁOU|U/k\DEh"$hIhkI  H}+ Uk=R>}zecj#ˏ4<z"hw]V[SYp4liރx3q],k|ҡ w^7qA?.UP(&׌qKAWw8-@ $83cAi^Ppo,EAW_<L~,z_kׯe~ ѯ~V.Z{ϻwJ\l+J>lnXSTVRuhϪ1S6&dSUd@B>Ќ"U%A9K ..x//^LJxa&8w1 dW1cTXo% ;rǩC:q/3y/mJG2/' UT%x%x W9I#ŏzO\q4]8I3d2Qs@ogdKr]^M%|;C_iF7iqcˋxJQSC W>L3q8+_-  tS-hNQ:7GF _tQ6d.~5}z=ZKOvmdJs񙢣җ.a?Dm89{ 7?qK[ 膒C-#ʒO7׍a {%"Iq#{@}(+!S~VQYDeI?{f ~bCKi\bmEG$*dxUU\BDηXiŒUgU"!ZgdXdX6nVHr#EU;ie_HLIK߽ z rf/>ʂ)i "9( ǹh&sJ|#Lb"PlG#ηS mf}/E71{[2W8gA(_q( .N<*/m@|4F#[y7>iAx) =1 FC'' j+ddGOte;?;5^lѽ=e=%VA_L K1<$V+q^rcoPiSpIm=}3 +4Eʃ [`"*bï"?9W-rݘOI}J|7q8uK\O8ֵwd+ct"hػͭU$V] Ÿ{=A78ڱ]lxd#Wwgd+=M֛I#jo#egu tX2<( -[]hj&αLɱ:A~>^Ll= F&2*^&H/%{9N(nD]Le[6%47M`OP`vws֊ Zq_ x仧5(G̟{0xiYaEY[XR#IIK,C n[rj*3k LPBBvm}8_m[1 JJLf;^dxapȮXohkY %RR]hq᎝~~φPHUqXY+p&2>ў_NnpT8x=/g.ڹsQ܈f׷:c[b1`ǭYƖkڵH*SmlHww=݋#ۘ**z]a͛H= I8@)Hu0*pܘ%v A Eչj+.KڰIOA w}4V6e`_Ap) Gp͈kFÏW%M%OLI M|y ;72ii7OYt+׍aL-c=89{dC,bjHZs/OW6U+`%Cif^ UV.Qo}*RK~7w?'t~O8R]FeWW66Tv:X;a\>r곻XpL[u͵MUʮ--&LXM]NU[7=jvtӣӯKеOលG +@1}FU[ +D4&o2rĔI׎ibmohC7?|뀩OLw]ƱY5muU疪uw\d!2QDtln?h$}̜Vg9|})C^p]Mӹyoޒ+!"D㩢{qDE.'ʟ@vٹY׬Лkl.ĤM#4`%^ JgԬ 756]n]ܰ5{?֧eZ'>$عb0-405={t/bc9M꧕cot\~í}_4qː dHX4mEB@Pox}r{A@xKK[1Y"S.H8·Ү@IAԕen<7Y]h; AƂ_cGL.K"8`[|MqNq{C;IYainv.mε6e|p٠^Oy!0nY7ԢՆ10{تt# ZvqšVvzFgGRnd,^7q᳌]H۟;3y狀0p8}Ðkzhֽh5{㚡~#׎pQTeaگbA>Zoٚ㍗[?kz?\H(%,_05d$²seykB,jo&2R*-*t$VVk6_#؍WiWݷ=]k$-CQJj<6 P :VmGŚq1Y}&݃CFԱ/>rPQI~eMieMqUmI > ume +>,mDiE[GDi |垁znnMeQs`z&'glFhZbI=cŕg*J kK0SH& 7[4.Qx0A9#5+0 ;OVmR~  =4\{$XݞxbnTE9Z0Q<BS|\3(bWƖlln3) bѫ2"ysPeeF-@y4b7#ڡ?k,v{Icf}]\Y)5~xq4b/Y /(n 9Wk7?_ʇcIL86lqÉActI²|?Aq[ߟGFH# ߖ3gΰKPq%8ʆ;f1ؤ#kQaDͨs('iR!uH,C!If KK>u"@\6pG/Z/I` |B\<hsiomNI6U'?7i01bX©)ÏO&"Ltn>xZKv8$JBOl2bS T#Y!"1ЈOG@&ly;?y.y@CɁ7o{;sLIm3gOB3/,L1) 4^(i_{ly/;OHVn^;oeԈ_Q[\_[ 4TZ[Xs^ۈQ*fbmfNJc3b-L}v3O#bރ#JP"w5KD jM V۾JѐԂ"36\CxX0ib0-ȷ8Tp cENjB4G9 "G5qV>ӏ ¾KN)Ž LkJd3x L!q*@8vO;^SU3 Ktd K#+!$A#G@E>_g 7t0tD{fCNW@n|D(#"L^*З/?0˗hJ.8c0GG `[7X&}'ṗnWk~XXVUXQF\e9y֗7חԖ4RZB$Ⲻ򺼪†ҖsUp2)8m__|1XK tt:$ِ)HhA@_PqW/?1~ȃ@hF^&K.A9 8P" >@q*2$%rLxh)0 d8%!|C!`:a`A` "I?>18)<@1 *I9M`saC .]j #0&h`Fts do#Fԇa &WA `Ђ#'8 rZahk#=p"bVpve쩘x?aF~)ƎpaFI1.w͈hA4TV}:gst8 +ݵw!]M5u5eZV켲LJQYP!:.!1!\O8ή];'A @ ft:6!ˉkS $kU$; ׃#î GL f 5Ԍ3Ї9 JDc LXE6v(B!s0XAsdyn~` 繊S   GR #t|S hGM9ċ|#τ"Va%= 1M`U8d%:#0DQ%Pq̚BGMD1+~ R^n \ xc˗7X£mIÚNx_8e\ fM}q Plo>p򽷳ΨRf5k(Rk jsJNf>mv^z~ڢxxLUB89o;9T LVT;t9$U @H;.^I0BT$UGhfG͚ 4C\ZQ(+@jyQU\!, N<ؗ9! CB1 /M5@ I"P>Ј.5",\ \U-q3ȂC*?"( ~5 C #R}p(tÏɛǖ1$#( B  FOh%?ru؋(J4vה{''@,ӈih6'K.,> g]^ҋRdeumݸv͖ voݺwN͛__aݪ+.uDQ-cTh$l[[QdN.{qvd1z?]h8'"{pD֪s &HH:'_#x-aD *BQ LL#ABp2g+5|@-'[b\\ / !xPNv8ZM"qn|K3"#nSIB?K= WI 0M ZVj~v8$ۨ qJj dv2KbtrqD&jVW2-"ƲFw۶mrFh` #bwUW$h MR Ӏdk&kz,~KR+4QNCD&ƙ.CʘAdY)")ČqI&3 oQU ̉-pك#2eGK(z U:D"((lPDA(D@Uf%pCH$ ^5 \ aSԲƫ‚ղdKJh"Uщjy#0>q^H! U#2zoAL9k-y8,NFY68Udg%SBRCpfx(aܽJoJHW>՛;!hm^,DY~cK1f`E+&tMZ4~c$:vS͘`6cqfCŔd&x`*H7)s[ dWNjծg[E& | R2C%;-@-Pu " J4P̔JKٿp%3xbBjAbYQ'؛.!Y d$Ԕy#-GㄓqII% (YT+N< 0Qϊ;L %BP`yHb;FF @,.JM̀V~8@ܔ5i?~|zb@Dц#wl^2"L0d+ Y΂a 1vsn- k>k6Ż]>bo͞=3Re (Ex/f]E($ݑꫮRɽU.٭Č\I %03C!@LԒG =|M#Ξ9%&$D;23N  Py<0/|PXYΞ9!lZ2lyg.xKXQᐓ(li9끒E8 –G[* %܈E[}稬%ߑCJH"+ЇwQ8D PvX8O,XiQ窳f>xde/Ψ@Z&0̞41{⬾ H[{6vØbRA$Pòez\q@R\ ɁaѾpނ#W!*A1LC]-eaV=8ih) wI0PR+[` H"˝@N@C 8NBl5eDEQv%0|a\ 3r 睥* ;rRED$*͠14IVʇ`7U*`y a | W]@&1 L";(6JuC8xVjĄ OG*+sٌ65r9q RK̓'{5x@$'~A @qM.z}q+ڵĉEEg\[Kb2̝0 H1 ʢʲ|.57Yف(2E }v$gX #%[lle F dPa ^-+/Wgs's}*+ JaCJԔؓHW Y9|&<_ &#"bd$"SPO 0 E0Z}:6Jf1ڡu9E5+~TY0z@DK.+ϯ+--+(ַVeMd'jho*\ҨIbbs tXSV]V!;VΐkKGjC6ikTljJnqLĿVRϐrP,XMuB/vpqF d  "2U;O2J.,yy>.C`g"`dPK&ZW $*diYDZ$a% 䌐KU[ =Xl+@֞".QᐓtF5'(j(˦c3 ;H}0KrO\)4 O%5DQy6SW\_Fֺ֚*basMϟD_-Ys7AM0Jokm`dLP!OLr %j4tUÑ 6I[j*dz ҂ ,6j!9HS-eu,$-+uEQ#|Axh\LAΟo$쳽|(Ю89X;pTK?H(\rsјr;08j%T?p- ;'Jo$EjԠG+|)TM})U&R$v;j.Z->瑞=3?o"@OU==Cɡ:{z'=8҃#==ߵzpigOt_H@O|ڃ݇=5zpGzzkwʌΞ遞=Ѓ#ߵ{jJH@O|ڃ?==}=Ѓ#=8==]{+AxIENDB`
1. Avstngning enligt SmL p grund av smitta
2. Diagnos/-er eller symtom till grund fr den nedsatta frmgan/aktivitetsbegrnsningen Diagnoskod enl ICD 10
(huvuddiagnos)
3. Anamnes (aktuell sjukdom)
4. Status, objektiva underskningsfynd
 Uppgifterna baserade p
Personlig kontakt
Telefonkontakt
Journaluppgifter -
Annat -
5. Hur begrnsar sjukdomen patientens frmga/aktivitet?
6. Freskrift - behandling eller tgrd som r ndvndig fr att frmgan ska kunna terstllas
Flja given ordination
Fortsatt poliklinisk kontakt
Undvika viss belastning
Beska arbetsplatsen
Vntar p tgrd inom sjukvrden
Vntar p annan tgrd
vrigt
7. r arbetslivsinriktad rehabilitering aktuell? Ja Nej Kan inte bedmas fr nrvarande
Behov av kontakt med fretagshlsovrd
8. Medicinsk bedmning av hur sjukdomen/symtomen pverkar patientens frmga att utfra sina vanliga arbetsuppgifter (ange vilka) om patienten r arbetsls; att ska/kunna utfra arbete som r normalt frekommande p arbetsmarknaden om patienten r frldraledig med frldrapenning; att vrda sitt barn
Arbetsfrmgan bedms nedsatt: 25% - 50% - 75% - 100% -
- Kan deltid vara olmplig av psykosociala skl? Ja Nej
- Kan anpassade arbetsuppgifter mjliggra sysselsttning p deltid/heltid? Ja Nej
- Kan deltid vara skadlig fr sjukdomens frlopp? Ja Nej
- Kan deltid i nuvarande sysselsttning vara mjlig med hnsyn till symtom? Ja Nej
- Kan deltid frbttra prognosen fr tergng i arbete? Ja Nej
- Kan deltidsarbete p annat stt vara skadligt? Ja Nej
9. Prognos - bedms patienten kunna f tillbaka sin frmga till arbete/aktivitet? Ja, helt Ja, delvis Nej
10. Kan resor till och frn arbetet med annat frdstt n det patienten normalt anvnder gra det mjligt att terg i arbete? Ja Nej
11. nskar kontakt med Frskringskassan Ja Nej
12. nskar avstmningsmte Ja Nej
13. vriga upplysningar
1. Avstngning enligt SmL p grund av smitta (fortstt till punkt 8)
2. Diagnos/diagnoser fr sjukdom/symtom som orsakar nedsatt arbetsfrmga Diagnoskod enl ICD 10
(huvuddiagnos)
3. Anamnes fr aktuell sjukdom
4. Status och objektiva underskningsfynd p organniv (funktionsnedsttning)
 Jag baserar uppgifterna p
min underskning av patienten
min telefonkontakt med patienten
journaluppgifter
annat (ange vad i punkt 13)
5. Hur begrnsar sjukdomen patientens frmga/aktivitet p individniv? (aktivitetsbegrnsning)
6. Freskrift - behandling eller tgrd som r ndvndig fr att frmgan ska kunna terstllas
Given ordination
Fortsatt poliklinisk kontakt
Undvika viss belastning
Beska arbetsplatsen
Vntar p tgrd inom sjukvrden
Vntar p annan tgrd
vrigt
7. r arbetslivsinriktad rehabilitering aktuell? Ja Nej Gr inte att bedma
Patienten behver f kontakt med fretagshlsovrd
8. Jag bedmer patientens arbetsfrmga i frhllande till nuvarande arbetsuppgifter arbetslshet frldraledighet med frldrapenning
Jag bedmer att patientens arbetsfrmga r nedsatt med 1/4 - nedsatt med hlften - nedsatt med 3/4 - helt nedsatt -
9. Jag bedmer att patientens arbetsfrmga r nedsatt lngre tid n den som de frskringsmedicinska riktlinjerna anger, drfr att:
10. Prognos - kommer patienten att f tillbaka sin frmga i nuvarande arbete? (Gller inte arbetslsa) Ja, helt Ja, delvis Nej Gr inte att bedma (motivera i punkt 13)
11. Kan resor till och frn arbetet med annat frdstt n det patienten normalt anvnder gra det mjligt att terg i arbete? Ja Nej
12. Jag vill ha kontakt med Frskringskassan Ja Nej
13. vriga upplysningar
1 Avstngning enligt SmL p grund av smitta
2 Diagnos/diagnoser fr sjukdom/symtom som orsakar nedsatt arbetsfrmga Diagnoskod enl ICD 10
(huvuddiagnos)
3 Aktuellt sjukdomsfrlopp
4 Funktionsnedsttning - observationer, underskningsfynd och utredningsresultat Intyget baseras p
underskning
telefonkontakt
journaluppgifter
annat
5 Aktivitetsbegrnsning relaterat till diagnos (flt 2) och funktionsnedsttning (flt 4)
6 a Rekommenationer
kontakt med Arbetsfrmedlingen
kontakt med fretagshlsovrden
vrigt (ange vad)
6 b Planerad eller pgende behandling eller tgrd
inom sjukvrden (ange vilken)
annan tgrd (ange vilken)
7 r arbetslivsinriktad rehabilitering aktuell? Ja Nej Gr inte att bedma
8 a Patientens arbetsfrmga bedms i frhllande till nuvarande arbetsuppgifter arbetslshet frldraledighet med frldrapenning
8 b Jag bedmer att patientens arbetsfrmga r nedsatt med 1/4 - nedsatt med hlften - nedsatt med 3/4 - helt nedsatt -
9 Patientens arbetsfrmga bedms nedsatt lngre tid n den som det frskringsmedicinska beslutsstdet anger, drfr att:
10 Prognos - kommer patienten att f tillbaka sin arbetsfrmga i nuvarande arbete? (Gller inte arbetslsa) Ja, helt Ja, delvis Nej Gr inte att bedma
11 Kan resor till och frn arbetet med annat frdstt n normalt gra det mjligt fr patienten att terg i arbete? Ja Nej
12 Kontakt nskas med Frskringskassan Ja
13 vriga upplysningar och frtydliganden
1. Avstngning enligt SmL p grund av smitta
2. Diagnos/-er eller symtom till grund fr den nedsatta frmgan/aktivitetsbegrnsningen Diagnoskod enl ICD 10
(huvuddiagnos)
3. Anamnes (aktuell sjukdom)
4. Status, objektiva underskningsfynd
Uppgifterna baserade p
Personlig kontakt
Telefonkontakt
Journaluppgifter -
Annat -
5. Hur begrnsar sjukdomen patientens frmga/aktivitet?
6. Freskrift - behandling eller tgrd som r ndvndig fr att frmgan ska kunna terstllas
Flja given ordination
Fortsatt poliklinisk kontakt
Undvika viss belastning
Beska arbetsplatsen
Vntar p tgrd inom sjukvrden
Vntar p annan tgrd
vrigt
7. r arbetslivsinriktad rehabilitering aktuell? Ja Nej Kan inte bedmas fr nrvarande
Behov av kontakt med fretagshlsovrd
8. Medicinsk bedmning av hur sjukdomen/symtomen pverkar patientens frmga att utfra sina vanliga arbetsuppgifter (ange vilka) om patienten r arbetsls; att ska/kunna utfra arbete som r normalt frekommande p arbetsmarknaden om patienten r frldraledig med frldrapenning; att vrda sitt barn
Arbetsfrmgan bedms nedsatt: 25% - 50% - 75% - 100% -
- Kan deltid vara olmplig av psykosociala skl? Ja Nej
- Kan anpassade arbetsuppgifter mjliggra sysselsttning p deltid/heltid? Ja Nej
- Kan deltid vara skadlig fr sjukdomens frlopp? Ja Nej
- Kan deltid i nuvarande sysselsttning vara mjlig med hnsyn till symtom? Ja Nej
- Kan deltid frbttra prognosen fr tergng i arbete? Ja Nej
- Kan deltidsarbete p annat stt vara skadligt? Ja Nej
9. Prognos - bedms patienten kunna f tillbaka sin frmga till arbete/aktivitet? Ja, helt Ja, delvis Nej
10. Kan resor till och frn arbetet med annat frdstt n det patienten normalt anvnder gra det mjligt att terg i arbete? Ja Nej
11. nskar kontakt med Frskringskassan Ja Nej
12. nskar avstmningsmte Ja Nej
13. vriga upplysningar
1. Avstngning enligt SmL p grund av smitta
2. Diagnos/diagnoser fr sjukdom/symtom som orsakar nedsatt arbetsfrmga Diagnoskod enl ICD 10
(huvuddiagnos)
3. Anamnes fr aktuell sjukdom
4. Status och objektiva underskningsfynd p organniv (funktionsnedsttning)
Jag baserar uppgifterna p
min underskning av patienten
min telefonkontakt med patienten
journaluppgifter
annat (ange vad i punkt 13)
5. Hur begrnsar sjukdomen patientens frmga/aktivitet p individniv? (aktivitetsbegrnsning)
6. Freskrift - behandling eller tgrd som r ndvndig fr att frmgan ska kunna terstllas
Given ordination
Fortsatt poliklinisk kontakt
Undvika viss belastning
Beska arbetsplatsen
Vntar p tgrd inom sjukvrden
Vntar p annan tgrd
vrigt
7. r arbetslivsinriktad rehabilitering aktuell? Ja Nej Gr inte att bedma
Behov av kontakt med fretagshlsovrd
8. Jag bedmer patientens arbetsfrmga i frhllande till nuvarande arbetsuppgifter arbetslshet frldraledighet med frldrapenning
Jag bedmer att patientens arbetsfrmga r nedsatt med 1/4 - nedsatt med hlften - nedsatt med 3/4 - helt nedsatt -
9. Jag bedmer att patientens arbetsfrmga r nedsatt lngre tid n den som de frskringsmedicinska riktlinjerna anger, drfr att:
10. Prognos - kommer patienten att f tillbaka sin frmga i nuvarande arbete? (Gller inte arbetslsa) Ja, helt Ja, delvis Nej Gr inte att bedma (motivera i punkt 13)
11. Kan resor till och frn arbetet med annat frdstt n det patienten normalt anvnder gra det mjligt att terg i arbete? Ja Nej
12. Jag vill ha kontakt med Frskringskassan Ja Nej
13. vriga upplysningar
1 Avstngning enligt SmL p grund av smitta
2 Diagnos/diagnoser fr sjukdom/symtom som orsakar nedsatt arbetsfrmga Diagnoskod enl ICD 10
(huvuddiagnos)
3 Aktuellt sjukdomsfrlopp
4 Funktionsnedsttning - observationer, underskningsfynd och utredningsresultat Intyget baseras p
underskning
telefonkontakt
journaluppgifter
annat
5 Aktivitetsbegrnsning relaterat till diagnos (flt 2) och funktionsnedsttning (flt 4)
6 a Rekommenationer
kontakt med Arbetsfrmedlingen
kontakt med fretagshlsovrden
vrigt (ange vad)
6 b Planerad eller pgende behandling eller tgrd
inom sjukvrden (ange vilken)
annan tgrd (ange vilken)
7 r arbetslivsinriktad rehabilitering aktuell? Ja Nej Gr inte att bedma
8 a Patientens arbetsfrmga bedms i frhllande till nuvarande arbetsuppgifter arbetslshet frldraledighet med frldrapenning
8 b Jag bedmer att patientens arbetsfrmga r nedsatt med 1/4 - nedsatt med hlften - nedsatt med 3/4 - helt nedsatt -
9 Patientens arbetsfrmga bedms nedsatt lngre tid n den som det frskringsmedicinska beslutsstdet anger, drfr att:
10 Prognos - kommer patienten att f tillbaka sin arbetsfrmga i nuvarande arbete? (Gller inte arbetslsa) Ja, helt Ja, delvis Nej Gr inte att bedma
11 Kan resor till och frn arbetet med annat frdstt n normalt gra det mjligt fr patienten att terg i arbete? Ja Nej
12 Kontakt nskas med Frskringskassan Ja
13 vriga upplysningar och frtydliganden
sdString NF6C5B6EE_21DF_4522_8450_1A7D3B9E26EB sdString Split sdInteger 1 sdInteger 2 sdInteger 372 sdInteger 2 sdString act03NoSplit sdString act03SplitH sdString act03SplitV sdString act03ToggleSplit sdString act03NavigatorOnOff sdString act03Refresh sdString N8AB33753_E162_4835_B329_CF6306C62770 sdString Journal sdInteger 1 sdInteger 2 sdInteger 523 sdInteger 2 sdString act03GetPatient sdString act03ClosePatient sdString NE03B0621_A1D4_4450_A95B_2071C6D9BA9F sdString Edit sdInteger 1 sdInteger 2 sdInteger 290 sdInteger 2 sdString act02EditCut sdString act02EditPaste sdString act02EditCopy sdInteger 16456 sdInteger 16465 sdInteger 123 sdInteger 16455 sdString N33CB0284_8C8E_452B_BC4D_073C924CAF1B sdString Datum sdInteger 1 sdInteger 2 sdInteger 11 sdInteger 2 sdString act13DateChange sdString act13SelectCareSupply sdString PMO Standard sdInteger 1 sdString NF6C5B6EE_21DF_4522_8450_1A7D3B9E26EB sdString Split sdInteger 1 sdInteger 2 sdInteger 372 sdInteger 2 sdString act03NoSplit sdString act03SplitH sdString act03SplitV sdString act03ToggleSplit sdString act03NavigatorOnOff sdString act03Refresh sdString N8AB33753_E162_4835_B329_CF6306C62770 sdString Journal sdInteger 1 sdInteger 2 sdInteger 523 sdInteger 2 sdString act03GetPatient sdString act03ClosePatient sdString NE03B0621_A1D4_4450_A95B_2071C6D9BA9F sdString Edit sdInteger 1 sdInteger 2 sdInteger 290 sdInteger 2 sdString act02EditCut sdString act02EditPaste sdString act02EditCopy sdInteger 16456 sdInteger 16465 sdInteger 123 sdInteger 16455 sdString N33CB0284_8C8E_452B_BC4D_073C924CAF1B sdString Datum sdInteger 1 sdInteger 2 sdInteger 11 sdInteger 2 sdString act13DateChange sdString act13SelectCareSupply sdString Journal III Standard sdInteger 1 0 0.cita veida 1 1.stacionara pacientam 2 2.konsultacija 3 3.tieaas pieejamibas specialista konsultacija1 1.akutu saslimaanu vai traumu 2 2.pirmoreiz mu~a diagnosticetu hronisku slimibu 3 3.ieprieka diag-nosticetas hroniskas slimibas paasinajumu 4 4.profilaktisko apskati, vakcinaciju, patrona~u 5 5.dinamis-ku noveroaanu hronisku slimibu gadijuma 6 6.citiem iemesliem 7 7.tikai paligkabinetu pakalpojumu01 Balta 02 Baltijas Mrketinga Kompnija 03 Baltijas Transporta Apdroainaana 04 Baltikums 05 Balva 06 ERGO Life Insurance SE Latvijas filile 07 Pareks Apdroainaana 08 R+gas Slimokase 09 Salamandra Baltic 10 Seesam Life Latvia 11 AAS Gjensedige Baltic 12 IF P&C Insurance AS Latvijas filile 13 BTA Insurance Company SE 14 COMPENSA Vienna Insurance Group- !OVS dati 01004 (9.17 Eur) - Ginekologa, dzemd+bu specilista ginekolo#isk apskate valsts organizts v~a skr+ningprogrammas ietvaros 01018 (3.54 Eur) - rsta konsultcija pirms vakcincijas. Nenorda kop ar manipulciju 01061, 60443 un 60444 01019 (1.97 Eur) - rsta pal+ga vai vecmtes konsultcija pirms vakcincijas 01022 (19.57 Eur) - Piemaksa par pacienta konsultciju reto slim+bu gad+jum vai rstu kons+lija gad+juma terapijas taktikas pieFemaanai pacientam ar reto slim+bu 01029 (15.23 Eur) - Vecmtes veikta pirmreizja vai atkrtota grktnieces vai ned<nieces apskate (atbilstoai Ministru kabineta 2006. gada 25. jklija noteikumiem Nr. 611 "Dzemd+bu pal+dz+bas nodroainaanas krt+ba") 01061 (10.13 Eur) - Brnu profilaktisks apskates, ko veic #imenes rsts 01062 (21.99 Eur) - "imenes rsta veikta pirmreizja vai atkrtota grktnieces apskate 01063 (9.50 Eur) - "imenes rsta ginekolo#isk apskate valsts organizts v~a skr+ningprogrammas ietvaros 01064 (9.81 Eur) - Brnu profilaktisks apskates, ko veic #imenes rsts brna mjs 01065 (16.82 Eur) - Oftalmologa veikta profilaktisk apskate 01066 (3.99 Eur) - Piemaksa par #imenes rsta veiktu profilaktisko apskati, izmekljot pacientu ar saslimaanu (apmaks tikai brniem) 01067 (8.68 Eur) - Piemaksa pneimonologam par darbu ar tuberkulozes pacientu vai kontaktpersonu (norda pneimonologs, kura nesaFem fiksto ikmneaa maksjumu; vienu reizi par apmekljumu) 01068 (8.20 Eur) - Piemaksa #imenes rstam par katru patvruma mekltja vai rzemnieka, kura izce<o no Ukrainas militro konfliktu d<, apmekljumu 01070 (26.82 Eur) - Ginekologa, dzemd+bu specilista veikta pirmreizja vai atkrtota grktnieces apskate (atbilstoai Ministru kabineta 2006. gada 25. jklija noteikumiem Nr. 611 "Dzemd+bu pal+dz+bas nodroainaanas krt+ba") 01078 (2.09 Eur) - Iztriepes paFemaana seksuli transmis+vo slim+bu diagnostikai 01083 (3.69 Eur) - Materila paFemaana bakteriolo#iskiem uzsjumiem seksuli transmis+vo slim+bu diagnostikai 01085 (8.78 Eur) - "imenes rsta veikta sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu zem 1% 01086 (8.78 Eur) - "imenes rsta veikta sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu no 1 l+dz 2% 01087 (8.78 Eur) - "imenes rsta veikta sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu no 3 l+dz 4% 01088 (8.78 Eur) - "imenes rsta veikta sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu no 5 l+dz 9% 01089 (8.78 Eur) - "imenes rsta veikta sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu lielks par 10% 01090 (0.00 Eur) - "imenes rsta veikta atkrtota sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu zem 1% 01091 (0.00 Eur) - "imenes rsta veikta atkrtota sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu no 1 l+dz 2% 01092 (0.00 Eur) - "imenes rsta veikta atkrtota sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu no 3 l+dz 4% 01093 (0.00 Eur) - "imenes rsta veikta atkrtota sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu no 5 l+dz 9% 01094 (0.00 Eur) - "imenes rsta veikta atkrtota sirds un asinsvadu slim+bu riska izvrtaana ar iegktu riska vrtjumu lielks par 10% 01095 (2.78 Eur) - Dzemdes kakla materila paFemaana a7idruma citolo#ijai vai HPV noteikaanai 01096 (0.00 Eur) - rsta, rsta pal+ga vai vecmtes konsultcija pirms gripas vakcincijas, ja pacientam konsultcija veikta ar+ Covid-19 vakcinaanas gad+jum 01097 (9.79 Eur) - Piemaksa #imenes rstam par dokumentcijas un noskt+juma sagatavoaanu un personas pieteikaanu uz Covid-19 vakcincijas veikaanu dienas stacionr personm, kurm vakcincija tiek veikta, ievrojot +paau piesardz+bu 01098 (9.79 Eur) - Piemaksa #imenes rstam par dokumentcijas un noskt+juma sagatavoaanu, k ar+ personas pieteikaanu uz Covid-19 vakcincijas kons+liju vai rsta specilista sldzienu, ka vakcincija ir atliekama 01099 (58.85 Eur) - rstu kons+lijs (3 specilisti) pacientam, kuram ir nepiecieaams izvrtt Covid-19 vakcinciju. Vienam pacientam vienu reizi norda kons+lija vad+tjs. Kons+lija rezultts - vakcincija nav kontrindicta 01100 (58.85 Eur) - rstu kons+lijs (3 specilisti) pacientam, kuram ir nepiecieaams izvrtt Covid-19 vakcinciju. Vienam pacientam vienu reizi norda kons+lija vad+tjs. Kons+lija rezultts - vakcincija ir kontrindicta 01101 (58.85 Eur) - rstu kons+lijs (3 specilisti) pacientam, kuram ir nepiecieaams izvrtt Covid-19 vakcinciju. Vienam pacientam vienu reizi norda kons+lija vad+tjs. Kons+lija rezultts - vakcincija ir atliekama 02034 (13.83 Eur) - Intravenoz z<u Methylprednisolone ievade plaukstas vns roku pirkstu intrafalangilo loc+tavu bojjuma gad+jum ar ~Fauga nospieaanu uz 30minktm 02035 (132.15 Eur) - Z<u Cyclophosphamide pulsa terapija brniem vecum l+dz 5gadiem; diennakts kurss 02036 (134.60 Eur) - Z<u Cyclophosphamide pulsa terapija brniem vecum no 5 l+dz 10gadiem; diennakts kurss 02037 (136.76 Eur) - Z<u Cyclophosphamide pulsa terapija brniem vecum virs 10gadiem; diennakts kurss 02038 (178.80 Eur) - Z<u Methylprednisolone pulsa terapija brniem vecum l+dz 5gadiem; 3dienu kurss pa 2stundm 02039 (184.52 Eur) - Z<u Methylprednisolone pulsa terapija brniem vecum no 5 l+dz 10gadiem; 3dienu kurss pa 2stundm 02040 (190.21 Eur) - Z<u Methylprednisolone pulsa terapija brniem vecum virs 10gadiem; 3dienu kurss pa 2stundm 02041 (179.37 Eur) - Kombint z<u Methylprednisolone un Cyclophosphamide pulsa terapija brniem vecum l+dz 5gadiem; 3dienu kurss pa 2stundm 02042 (186.85 Eur) - Kombint z<u Methylprednisolone un Cyclophosphamide pulsa terapija brniem vecum no 5 l+dz 10gadiem; 3dienu kurss pa 2stundm 02043 (196.10 Eur) - Kombint z<u Methylprednisolone un Cyclophosphamide pulsa terapija brniem vecum virs 10gadiem; 3dienu kurss pa 2stundm 02077 (2.60 Eur) - Piemaksa par gaismas jut+gu medikamentu ievad+aanas a<irces un savienotjvadu lietoaanu 02078 (19.82 Eur) - Z<u ievad+aana vn infkzijas, parenterls baroaanas nodroainjumam 02079 (27.55 Eur) - Zematslgkaula vnas (v.subclavia) vai jkga vnas (v.jugularis) punkcija, katetra ievad+aana medikamentu, infkzijas, parenterls baroaanas nodroainjumam ar rentgena kontrastjamo katetru 02080 (9.89 Eur) - Piemaksa par vienreizjs lietoaanas kontrastjamo katetru 02082 (7.31 Eur) - Piemaksa par parenterlo baroaanu un infkzijas a7+dumiem (diennakt+) 02083 (96.01 Eur) - Pastv+ga pozit+va izelpas spiediena (Continuous pozitive airway pressure - CPAP) sistmas "Infant flow" sagatavoaana, uzlikaana un lietoaana pirmaj stund (iek<autas visas sistmas lietoaanas izmaksas) 02084 (73.90 Eur) - Pastv+ga pozit+va izelpas spiediena (Continuous pozitive airway pressure - CPAP) sistmas "Bubble" sagatavoaana, uzlikaana un lietoaana pirmaj stund (iek<autas visas sistmas lietoaanas izmaksas) 02085 (2.35 Eur) - CPAP "Bubble" un "Infant flow" sistma - par katru nkamo stundu, skot no otrs stundas 02086 (238.15 Eur) - Augstfrekvences mksl+g plauau ventilcija brniem ar vienreizlietojamo elpinaanas kontkru pirmaj stund 02087 (3.13 Eur) - Augstfrekvences mksl+g plauau ventilcija brniem par katru nkamo stundu, skot no otrs stundas 02088 (5.04 Eur) - Skbek<a padeve caur deguna kanilm ("ksm") vai masku par pirmo stundu 02089 (2.74 Eur) - Skbek<a padeve caur deguna kanilm ("ksm") vai masku par katru nkamo stundu, skot no otrs stundas 02090 (148.15 Eur) - Asins apmaiFas opercija caur nabas vn (v.umbilicalis) ievad+tu katetru 02091 (270.08 Eur) - Asins apmaiFas opercija jaundzimuaajam ar vienreizjs lietoaanas asins apmaiFas sistmu 02094 (651.85 Eur) - Piemaksa par monoklonls antivielas Palivizumabum 50mg lietoaanu 02095 (1235.29 Eur) - Piemaksa par monoklonls antivielas Palivizumabum 100mg lietoaanu 02099 (170.18 Eur) - Manula peritonel dial+ze jaundzimuaajiem un z+daiFiem ar svaru l+dz 6 kg 02101 (15.30 Eur) - Lumblpunkcija 02103 (20.61 Eur) - Diagnostisk lumblpunkcija 02105 (23.46 Eur) - Laterl ventriku<a punkcija caur lielo avotiFu ultrasonoskopijas kontrol 02107 (40.12 Eur) - Pleiras dobuma punkcija 02120 (12.27 Eur) - Brna sagatavoaana un pievienoaana monitoriem un pirms reizes mr+jumu noteikaana un monitora prbaude 02125 (217.37 Eur) - Poligrfija stacionr 02126 (296.61 Eur) - Polisomnogrfija 02127 (269.40 Eur) - Multiplais miega latentuma tests. Norda tikai kop ar manipulciju 02126 02130 (8.28 Eur) - Brna sagatavoaana fototerapijai 02131 (118.55 Eur) - Fototerapija 12stundu kursam 02132 (10.08 Eur) - Piemaksa manipulcijai 02131 par fototerapijas katru nkamo stundu, skot no 13.stundas 02139 (21.46 Eur) - Spie7a kaula artrijas (a.radialis) vai ciskas artrijas (a.femoralis) punkcija arterilo asins gzu kontrolei 02140 (8.32 Eur) - Augajo elpoaanas ce<u atbr+voaana un takt+la stimulcija 02141 (9.45 Eur) - Elpinaana ar pozit+vu spiedienu ieelp (maisu - masku) 02142 (9.69 Eur) - Vienlaikus ar elpinaanu ekstratorakl sirds mas~a 02147 (10.64 Eur) - Elpce<u atbr+voaana, intubjot un skalojot elpce<us 02148 (40.20 Eur) - Mksl+g plauau ventilcija (MPV) l+dz 2stundm 02149 (34.27 Eur) - Mksl+g plauau ventilcija (MPV) par katru nkamo stundu, skot no treas stundas 02150 (15.53 Eur) - Infkzijas katetra ievad+aana nabas vn vai nabas artrij 02151 (63.36 Eur) - No perifrs uz centrlo vnu vienreizlietojam Rtg - kontrastjam katetra (l+nijas) - ievad+aana parenterls baroaanas nodroainjumam jaundzimuaajiem 02152 (8.47 Eur) - Piemaksa manipulcijai 02148 par vienreizjs lietoaanas kontkras izmantoaanu pie mksl+gs plauau ventilcijas 02153 (16.95 Eur) - Piemaksa manipulcijai 02148 par vienreizjs lietoaanas elpinaanas kontkru ar apsild+aanu lietoaanu pie mksl+gs plauau ventilcijas 02154 (20.04 Eur) - Infkzijas katetra ievad+aana nabas vn un nabas artrij 02156 (465.91 Eur) - Piemaksa par Phospholipida ex pulmonibus suum (120 mg/1,5 ml endotraheopulmonr instilcija, suspensija) lietoaanu 02209 (20.90 Eur) - Brna att+st+bas novrtaana pie neonatologa 02401 (9.83 Eur) - Papildus profilaktisk medic+nisk prbaude 02405 (8.58 Eur) - Fizisks sagatavot+bas novrtaana pc EUROFIT metodes brniem un pusaud~iem vecum no 6 l+dz 18 gadiem 03004 (3.51 Eur) - Galvas, pleca, gk~as loc+tavas vai 7ermeFa riF7a apsju uzlikaana 03006 (1.52 Eur) - Loc+tavu stabilizcijas prsju uzlikaana 03015 (17.63 Eur) - "ipaa longetes, aptverot divas liels loc+tavas (pleca, elkoFa, plaukstas, ce<a, pdas) vai pagaidu prsja uzlikaana lkzuma gad+jum 03016 (25.12 Eur) - Augadelma kaula lkzuma imobilizcija pc Turnera 03017 (13.83 Eur) - "ipaa prsja uzlikaana pie spie7a kaula lkzuma tipisk viet, vienas loc+tavas imobilizcija (plaukstas, ce<a) 03018 (17.57 Eur) - "ipaa longetes uzlikaana metatarslo kaulu lkzuma gad+jum 03019 (22.36 Eur) - Pdas un pdas loc+tavas imobilizcija ar #ipaa longetm pie apakastilba kaulu distls 1/3 lkzuma vai citas patolo#ijas pdas loc+tavas rajon 03028 (17.23 Eur) - Cirkulra #ipaa prsja uzlikaana vienai loc+tavai (tutors) 03029 (26.11 Eur) - Divas #ipaa longetes vai cirkulrs #ipaa prsjs, aptverot divas liels loc+tavas. RiF7veida kakla #ipaa prsjs ar plecu saiti un galvas balstu 03030 (31.99 Eur) - Cirkulrs #ipaa prsjs trim loc+tavm (gonita tipa prsjs) 03035 (6.43 Eur) - Cirkulra #ipaa prsja (tutora) noFemaana vienai loc+tavai 03036 (8.62 Eur) - Cirkulra #ipaa prsja noFemaana divm loc+tavm 03038 (82.70 Eur) - Cirkulra #ipaa prsja uzlikaana abm gk~as loc+tavm 03040 (28.38 Eur) - "ipaa gultas vai nakts trauka 7ermenim izveidoaana 03041 (1.75 Eur) - "ipaa prsja noFemaana 03081 (1.10 Eur) - Vakc+nas ievad+aana d, zemd un muskul+ 03082 (0.44 Eur) - Vakc+nas ievad+aana perorli 03084 (57.15 Eur) - Adrenal+na (epinefr+na) (epinephrinum) 300 g vai 150 g injekcija ar pildspalvveida pilna<irci 03097 (13.15 Eur) - Covid-19 primrs un balstvakcincijas nodroainaana #imenes rstu praks pacientiem ar hroniskm saslimaanm, senioriem no 65 gadu vecuma, grktniecm un imknsuprestm personm saskaF ar Imunizcijas valsts padomes rekomendcijm 03118 (13.15 Eur) - Vakcincija pret Covid-19 brniem l+dz 11 gadu vecumam (ieskaitot) 03138 (93.80 Eur) - Piemaksa par BCG (Bacillus Calmette-Guerin) (BCG vakc+nu intraveziklai ievad+aanai) lietoaanu 03148 (81.14 Eur) - Piemaksa par Anti-D (rh) immunoglobulin (1250 IU) lietoaanu 03173 (14.60 Eur) - Piemaksa par Anti-D (rh) immunoglobulin (250 IU) lietoaanu 03180 (12.38 Eur) - Loc+tavas punkcija 03183 (20.09 Eur) - Pleiras dobuma punkcija, izmantojot vienreizjs lietoaanas komplektu 03184 (15.26 Eur) - Vdera dobuma punkcija 03185 (17.58 Eur) - Sirds somiFas punkcija 03186 (12.91 Eur) - Kaulu smadzeFu punkcija 03187 (12.38 Eur) - Piena dziedzeru, vienas vairogdziedzera puses, siekalu dziedzeru vai sklinieku punkcija 03188 (17.58 Eur) - Aknu, liesas, aizkuF#a dziedzera punkcija 03189 (10.04 Eur) - Ur+npka<a vai hidrocles punkcija 03203 (20.22 Eur) - Augajo elpoaanas ce<u atvraana ar konikotomijas pal+dz+bu, ieskaitot endotrahelo intubciju 03205 (15.38 Eur) - Dz+v+bas pamatfunkciju uzturaanas standarts -mksl+g elpinaana mute-mut vai ar masku un ekstratorakla sirds mas~a virs 20minktm 03206 (101.87 Eur) - Izvrstais dz+v+bas pamatfunkciju uzturaanas standarts (asistolijas, bezpulsa elektrisks aktivittes, ventriku<u fibrilcijas vai bezpulsa ventriku<u tahikardijas) 03207 (47.77 Eur) - Transkutn kardiostimulcija, lietojot multifunkcionlu elektrodu 03208 (117.20 Eur) - Neatliekama kardiostimulcija ar transvenozo katetru 03209 (34.11 Eur) - Aparta mksl+g plauau ventilcija (MPV) lietoaana l+dz vienai stundai. Manipulciju norda vienu reizi dien 03210 (27.16 Eur) - Aparta mksl+g plauau ventilcija (MPV) lietoaana par katru nkamo stundu l+dz etrm stundm (turpmks MPV izmaksas l+dz pirms diennakts beigm iek<autas kopj gultasdienas vrt+b). Manipulciju norda vienu reizi dien 03211 (28.47 Eur) - Piemaksa par mksl+go plauau ventilciju (MPV) par katru nkamo diennakti par vienreizlietojamiem materiliem un aparatkras lietoaanu, skot no otrs diennakts 03212 (0.00 Eur) - Maska/nazls kaniles ar skbekli l+dz 6 l/min 03213 (0.00 Eur) - Maska ar skbekli l+dz 15 l/min 03214 (0.00 Eur) - Plauau ventilatora izmantoaana ar neinvaz+vu pozit+va spiediena piegdi (NeInvaz+va Ventilcija) 03215 (0.00 Eur) - Plauau ventilatora izmantoaana ar neinvaz+vu augstu gaisa plksmu (Augstas plksmas nazls kaniles) 03216 (0.00 Eur) - Plauau ventilatora izmantoaana par katrm 4 stundm (Invaz+va ventilcija) 03217 (0.00 Eur) - Plauau ventilatora izmantoaana skot ar nkamo diennakti (invaz+va ventilcija) 03221 (84.79 Eur) - Tiea asins prlieaana 03224 (16.70 Eur) - Piemaksa par traheostomas kaniles lietoaanu 03225 (30.09 Eur) - Piemaksa par traheostomas armts kaniles lietoaanu 03227 (0.00 Eur) - I l+meFa intens+v terapija 03228 (0.00 Eur) - II l+meFa intens+v terapija 03229 (0.00 Eur) - III l+meFa intens+v terapija 03238 (9.31 Eur) - Vakcincija pret prti7u bakm vienam pacientam, ja konsultciju pirms vakcincijas nodroaina rsts 03240 (1.50 Eur) - Gripas vakc+nas ievad+aana muskul+ gad+jum, ja viz+tes laik tiek veikta ar+ Covid-19 vakcincija, taj skait vakcincijas fakta ievad+aana vienotaj vesel+bas nozares elektronisks informcijas sistmas portl 04006 (27.67 Eur) - Pacienta sedcija un analgzija pie sp+gm manipulcijm ar lietoaanai gatavu gzu mais+jumu 50% N2O/50% O2 04100 (4.67 Eur) - Retrobulbra anestzija vienai acij 04101 (8.40 Eur) - Virsmas anestzija r+kles, balsenes, bronhu rajonam, dzi<kiem deguna rajoniem, bungdiFai, bungu dobumam vai ur+nvadam un ur+npkslim 04103 (9.39 Eur) - Infiltrcijas anestzija ar vietjo anestzijas l+dzekli, vada anestzija kjas vai rokas pirkstam 04106 (14.37 Eur) - Spinlo nervu vada anestzija 04107 (14.14 Eur) - Nerva vai nervu ganglija vada anestzija galvaskausa pamatn vai retrobulbra anestzija galvaskausa pamatn 04108 (11.67 Eur) - Muguras smadzeFu nerva, muguras smadzeFu gangliona un simptiska Ramus communicans anestzija vien pus 04114 (5.34 Eur) - Piemaksa par z<u ropivaka+na (Ropivacaini hydrochloridum) vienas ampulas (75 mg/10 ml) lietoaanu 04115 (20.73 Eur) - Pacienta sedcija anesteziologa uzraudz+b da~du manipulciju laik, par 30minktm. Var nord+t kop ar manipulciju 04103 04116 (60.50 Eur) - Nervu pinumu anestzija, pirm stunda. Manipulciju lieto pacientam, kura atrodas operciju zl 04117 (30.52 Eur) - Nervu pinumu anestzija par katru nkamo stundu, skot no otrs stundas. Manipulciju lieto pacientam, kura atrodas operciju zl 04118 (41.23 Eur) - Intravenoz re#ionl anestzija (B+ra bloks) 04119 (87.92 Eur) - Epidurl anestzija 7irur#iskm opercijm, k ar+ stacionr veikta medic+nisk aborta gad+jum par pirmajm divm stundm 04120 (58.27 Eur) - Prolongtas spinls analgzijas sistmas uzlikaana un saFemaana pirmaj diennakt+ 04121 (38.09 Eur) - Prolongtas epidurls analgzijas sistmas uzlikaana. Nenord+t kop ar manipulcijm 04119, 04135 04122 (44.48 Eur) - Kaudl anestzija 04123 (24.80 Eur) - Prolongt epidurl analgzija ar zlm bupivaka+nu (Bupivacaine) par pirmo diennakti 04124 (12.44 Eur) - Prolongt epidurl analgzija ar zlm bupivaka+nu (Bupivacaine) par katrm nkamajm 12 stundm, izFemot dzemd+bu pal+dz+bas gad+jumos 04125 (4.83 Eur) - Piemaksa re#ionlaj anestzij par z<u bupivaka+na (Bupivacaine) lietoaanu pirmajs divs stunds, izFemot dzemd+bu pal+dz+bas gad+jumos 04126 (3.33 Eur) - Piemaksa par z<u levobupivaka+na (Levobupivacaini hydrochloridum) vienas ampulas (50 mg/10 ml) lietoaanu 04127 (41.73 Eur) - Visprj anestzija ar masku par pirmo stundu 04128 (27.74 Eur) - Piemaksa par katru nkamo stundu pie visprjs anestzijas ar masku, skot no otrs stundas 04129 (11.91 Eur) - Prolongta spinla analgzija par katru nkamo diennakti, skot no otrs diennakts 04130 (22.19 Eur) - Piemaksa par mehnisks infkzijas ier+ces (easy pump vai analoga) izmantoaanu l+dz vienai diennaktij 04131 (27.96 Eur) - Piemaksa par mehnisks infkzijas ier+ces (easy pump vai analoga) izmantoaanu l+dz trim diennakt+m 04132 (32.78 Eur) - Piemaksa par mehnisks infkzijas ier+ces (easy pump vai analoga) izmantoaanu l+dz astoFm diennakt+m 04133 (92.51 Eur) - Spinl anestzija pirms divas stundas 04134 (23.28 Eur) - Spinl un epidurl anestzija par katru nkamo stundu, skot no treas stundas, izFemot dzemd+bu pal+dz+bas gad+jumos 04135 (125.65 Eur) - Kombint spinli-epidurl anestzija, pirms divas stundas 04138 (11.21 Eur) - Kontrolt analgzija (PCA) vai sedcija ar perfuzoru, pirms 24 stundas. Manipulciju lieto pacientam, kuram nepiecieaama atspinaana 04139 (4.45 Eur) - Piemaksa par kontrolto analgziju (PCA) par katrm nkamajm 12 stundm. Manipulciju lieto pacientam, kuram nepiecieaama atspinaana 04140 (37.59 Eur) - *slaic+ga intravenoz anestzija l+dz 30 minktm. Nenord+t kop ar manipulcijm 04142 un 04143 04141 (20.05 Eur) - *slaic+ga intravenoz anestzija par katrm nkamajm 30 minktm. Nenord+t kop ar manipulcijm 04142 un 04143 04142 (93.12 Eur) - Visprj anestzija ar endotrahelo metodi par pirmo stundu 04143 (47.34 Eur) - Piemaksa visprjai anestzijai ar endotrahelo metodi par katru nkamo stundu, skot no otrs stundas 04144 (386.89 Eur) - Visprj anestzija ar endotrahelo metodi kardiolo#ij un asinsvadu opercijs mksl+gaj asinsrit par pirmo stundu 04145 (52.12 Eur) - Piemaksa visprjai anestzijai ar endotrahelo metodi kardio7irur#ij un asinsvadu opercijs mksl+gaj asinsrit par katru nkamo stundu, skot no otrs stundas 04146 (101.96 Eur) - Totl intravenoz anestzija (TIVA) par pirmo stundu. Nenord+t kop ar manipulcijm 04142 un 04143 04147 (45.58 Eur) - Totl intravenoz anestzija (TIVA) par katru nkamo stundu, skot no otrs stundas. Nenord+t kop ar manipulcijm 04142 un 04143 04149 (20.77 Eur) - Intravenoza narkoze zoba sancijas vai ekstrakcijas gad+jum 04150 (260.65 Eur) - Implantjamo "portu" ievietoaana ar implantjam "porta" komplekta vrt+bu 04155 (1.97 Eur) - Piemaksa par z<u halotna lietoaanu par vienu stundu 04156 (15.44 Eur) - Piemaksa par z<u izoflurna (Isoflurane) lietoaanu pirmaj stund 04157 (16.79 Eur) - Piemaksa par z<u sevoflurna (Sevoflurane) lietoaanu pirmaj stund 04158 (10.31 Eur) - Piemaksa par z<u izoflurna (Isoflurane) vai Sevoflurna (Sevoflurane) lietoaanu par katru nkamo stundu, skot no otrs stundas 04159 (16.76 Eur) - Piemaksa par z<u mivakkrija lietoaanu pirmaj stund 04160 (11.19 Eur) - Piemaksa par z<u mivakkrija lietoaanu par katru nkamo stundu, skot no otrs stundas 04161 (7.62 Eur) - Piemaksa par z<u cisatrakkrija (Cisatracurium) lietoaanu pirmaj stund 04162 (3.82 Eur) - Piemaksa par z<u cisatrakkrija (Cisatracurium) lietoaanu par katru nkamo stundu, skot no otrs stundas 04163 (9.89 Eur) - Piemaksa par remifentan+lu (Remifentanilum) par vienu stundu 04164 (9.89 Eur) - Piemaksa par rokuronija (Rocuronium bromide) vienu ampulu (50 mg) 04165 (5.93 Eur) - Piemaksa par laringels maskas lietoaanu 04166 (77.91 Eur) - Piemaksa par dal+ts intubcijas caurules lietoaanu 04170 (43.12 Eur) - Piemaksa par augstfrekvences strkklas ventilcijas (JET) izmantoaanu 04171 (25.28 Eur) - Centrls vnas punkcija un katetrizcija bez katetra vrt+bas 04172 (11.30 Eur) - Piemaksa par centrls vnas vienlkmena katetra lietoaanu 04173 (17.23 Eur) - Piemaksa par centrls vnas divlkmenu katetra lietoaanu 04174 (16.81 Eur) - Piemaksa par centrls vnas tr+slkmenu katetra lietoaanu 04175 (31.77 Eur) - Piemaksa par centrls vnas etrlkmenu katetra lietoaanu 04176 (49.42 Eur) - Piemaksa par centrls vnas katetra ar antibakterilu prkljumu lietoaanu 04177 (36.71 Eur) - Piemaksa par hemodial+zes dubultlkmena katetra lietoaanu 04178 (40.95 Eur) - Piemaksa par hemodial+zes tr+slkmenu centrls vnas katetra lietoaanu 04179 (38.92 Eur) - IlgtermiFa hemodial+zes katetra ievietoaana vai prlikaana bez katetra vrt+bas 04180 (112.95 Eur) - Piemaksa par hemodial+zes ilgtermiFa katetra lietoaanu 04181 (49.88 Eur) - Parenterls baroaanas ilgkatetra ievietoaana vai maiFa bez katetra vrt+bas 04182 (110.90 Eur) - Piemaksa manipulcijai 04181 par parenterls baroaanas ilgkatetra lietoaanu 04183 (237.00 Eur) - Piemaksa manipulcijai 04181 par antibakterila parenterls baroaanas ilgkatetra lietoaanu 04185 (376.62 Eur) - Plauau artrijas (A. pulmonalis) katetrizcija ar fibrooptisko SvO2/CCO VIGILANCE tipa katetru ar ievades komplekta vrt+bu 04186 (56.12 Eur) - Invaz+va asinsspiediena monitoraana (IBP mr+aana). Nenord+t kop ar manipulciju 04144 04187 (17.57 Eur) - Piemaksa par sistmas ar viena signla prveidotju lietoaanu. Nenord+t kop ar manipulciju 04144 04188 (29.15 Eur) - Piemaksa par sistmas ar divu signlu prveidotju lietoaanu. Nenord+t kop ar manipulciju 04144 04189 (40.73 Eur) - Piemaksa par sistmas ar triju signlu prveidotju lietoaanu. Nenord+t kop ar manipulciju 04144 04190 (173.30 Eur) - Plauau artrijas (A. pulmonalis) katetrizcija ar parasto (SWAN-GANZ) katetru ar sirds funkcionlo rd+tju novrtjumu 04191 (191.71 Eur) - Hemodinamikas monitoraana, izmantojot PiCCO sistmu, par pirmo diennakti ar katetra vrt+bu 04192 (19.57 Eur) - Hemodinamikas monitoraana, izmantojot PiCCO sistmu, par katru nkamo diennakti, skot no otrs, bez katetra vrt+bas 04193 (72.64 Eur) - Piemaksa par krikotireotomijas komplekta lietoaanu 04194 (48.91 Eur) - Piemaksa par kombints caurules (Combi-Tube) lietoaanu 04195 (9.99 Eur) - Piemaksa par specils anestzijas iekrtas ar monitoru un perfuzoru lietoaanu magntisks rezonanses izmekljuma procedkras laik 04196 (32.76 Eur) - Piemaksa par sensora lietoaanu anestzijas dzi<uma monitoraanai (Bispektrlais indekss) 04198 (80.03 Eur) - Piemaksa par parenterls baroaanas mais+jumu par vienu diennakti. Nenord+t kop ar manipulciju 04199 04199 (23.89 Eur) - Piemaksa par enterls baroaanas mais+jumu par vienu diennakti. Nenord+t kop ar manipulciju 04198. 04200 (87.92 Eur) - Epidurl analgzija dzemd+bu atspinaanai par pirmajm divm stundm 04202 (4.83 Eur) - Piemaksa epidurlai analgzijai dzemd+bs par z<u bupivaka+na (Bupivacaine) vienas ampulas (50 mg/10 ml) lietoaanu 04203 (23.28 Eur) - Piemaksa par epidurl katetra aprkpi dzemd+bs, taj skait papildinaana un evakucija par katru nkamo stundu, skot no treas stundas 04204 (5.34 Eur) - Piemaksaepidurlai analgzijai dzemd+bs par z<u ropivaka+na (Ropivacaini hydrochloridum) vienas ampulas (75 mg/10 ml) lietoaanu 04205 (9.06 Eur) - Piemaksa epidurlai analgzijai dzemd+bs par z<u hloroproka+na (Chloroprocaini hydrochloridum) vienas ampulas (10 mg/ml) lietoaanu 04206 (9.06 Eur) - Piemaksa par z<u hloroproka+na (Chloroprocaini hydrochloridum) vienas ampulas (10 mg/ml) lietoaanu 04210 (0.00 Eur) - Epidurl analgzija dzemd+bu atspinaanai pc pacientes vlaans 05017 (5.10 Eur) - Elektroforze (apmaks tikai brniem) 05021 (4.36 Eur) - Transkutn elektroneirostimulcija (TENS) (apmaks tikai brniem) 05023 (7.17 Eur) - Fonoforze (apmaks tikai brniem) 05024 (4.36 Eur) - Diadinamisks strvas (DDS) terapija (apmaks tikai brniem) 05025 (5.31 Eur) - Diadinamisks strvas (DDS) forze (apmaks tikai brniem) 05026 (4.36 Eur) - Sinusoidli modults strvas (SMS) terapija (apmaks tikai brniem) 05027 (5.31 Eur) - Sinusoidli modults strvas (SMS) forze (apmaks tikai brniem) 05031 (6.22 Eur) - Darsonvalizcija (apmaks tikai brniem) 05035 (4.04 Eur) - Induktotermija (apmaks tikai brniem) 05036 (3.10 Eur) - Ultra+svi<Fu terapija, centimetru vi<Fu terapija vai decimetru vi<Fu terapija (apmaks tikai brniem) 05041 (3.10 Eur) - Main+ga magntiska lauka terapija vai pastv+ga magntiska lauka terapija (apmaks tikai brniem) 05044 (7.14 Eur) - UltraskaFas terapija (apmaks tikai brniem) 05045 (4.17 Eur) - Aerosolterapija (inhalcijas) (apmaks tikai brniem) 05047 (4.36 Eur) - Ultraviolet apstaroaana (apmaks tikai brniem) 05048 (6.22 Eur) - Lzera terapija vai magnetolzera terapija (apmaks tikai brniem) 05053 (7.40 Eur) - Paraf+na-ozoker+ta terapija (apmaks tikai brniem) 05102 (7.00 Eur) - Visprj mas~a brniem l+dz viena gada vecumam (l+dz 40 minktm) 05103 (8.92 Eur) - Visprj mas~a brniem no viena l+dz triju gadu vecumam (l+dz 50 minktm) 05104 (11.22 Eur) - Visprj mas~a brniem no triju l+dz 18 gadu vecumam (l+dz 60 minktm) 06003 (1.63 Eur) - Elektrokardiogrammas ar 12 novad+jumiem pieraksts 06004 (5.28 Eur) - Elektrokardiogrammas ar 12 novad+jumiem apraksts 06005 (0.20 Eur) - Elektrokardiogrammas pieraksts ar mazk par 12 novad+jumiem no ekstremittm un/vai krkau kurvja 06006 (2.67 Eur) - Elektrokardiogrammas ar mazk par 12 novad+jumiem apraksts 06007 (2.67 Eur) - Elektrokardiogrammas ar 12 novad+jumiem pieraksts brniem l+dz triju gadu vecumam 06008 (8.19 Eur) - Elektrokardiogrammas apraksts, sal+dzinot ar ne mazk k piecm ieprieka pierakst+tm elektrokardiogrammm. Nenord+t kop ar manipulcijm 06004 un 06006 06011 (7.70 Eur) - Elektrokardiogramma 12 novad+jumos ar medikamentozm provm, zles ievadot per os 06012 (7.93 Eur) - Elektrokardiogramma 12 novad+jumos ar medikamentozm provm, zles ievadot i/v 06013 (6.86 Eur) - Elektrokardiogrammas pieraksts ar portat+vo apartu pie slimnieka mjs 06014 (23.29 Eur) - Miokarda perfkzijas scintigrfija (MPS) ar elektrokardiogrammu 12 novad+jumos un medikamentozm provm 06015 (32.33 Eur) - Holtera monitoraana no 18 l+dz 24 stundm 06016 (32.28 Eur) - Miokarda perfkzijas scintigrfijas kardiolo#isk da<a ar slodzes testu, ar rezulttu izvrtaanu un arhivciju darba stacij. Nenord+t kop ar manipulciju 06021 06017 (54.74 Eur) - Miokarda perfkzijas scintigrfijas kardiolo#isk da<a, kombinjot slodzes testu ar medikamentozm provm, ar rezulttu izvrtaanu un arhivciju darba stacij. Nenord+t kop ar manipulciju 06021 06021 (23.27 Eur) - Veloergometrijas slodzes tests 06032 (17.29 Eur) - Ehokardiogrfija ar hemodinamikas rd+tju noteikaanu 06033 (45.58 Eur) - Ehokardiogrfija ar doplerogrfiju 06034 (76.77 Eur) - Stresehokardiogrfija ar fizisku slodzi vai medic+niskm provm. Nenord+t kop ar manipulcijm 06011, 06012 un 06021 06035 (26.83 Eur) - Skr+ningehokardiogrfija 06040 (73.53 Eur) - Stresehokardiogrfija, lietojot sinusa mezgla kairinjumu 06041 (54.91 Eur) - Transezofagela ehokardiogrfija M un B re~+mos ar krsas doplerogrfiju, spektra anal+zi un hemodinamikas rd+tju noteikaana 06042 (13.37 Eur) - Doplerogrfisks manipulcijas grktnieces un aug<a izmeklaan 06050 (27.04 Eur) - Transezofagels elektrokardiostimulcijas slodzes tests 06051 (27.04 Eur) - Transezofagela elektrofiziolo#iska izmeklaana aritmiju diagnostikai 06052 (28.52 Eur) - Transezofagela elektrokardiostimulcija aritmijas terapijai 06053 (53.11 Eur) - Piemaksa manipulcijm 06050, 06051 par elektrodiem transezofagelai elektrofiziolo#iskai izmeklaanai 06054 (161.83 Eur) - Piemaksa manipulcijai 06052 par elektrodu (zondi) 06056 (50.01 Eur) - *slaic+ga, transvenoza sirds elektrostimulcija, ieskaitot vnu punkciju, elektrodu ievad+aanu krkau kurvja rentgena kontrol 06057 (77.11 Eur) - Piemaksa manipulcijai 06056 par zondi transvenozai sirds elektrostimulcijai 06060 (130.63 Eur) - Pagaidu EKS sistmas korekcija 06061 (51.20 Eur) - Intrakardila elektrofiziolo#iska izmeklaana aritmiju diagnostikai 06062 (402.66 Eur) - Radiofrekvent katetra ablcija ar tr+sdimensiju potencilu re#istrcijas lietoaanu 06063 (727.44 Eur) - Piemaksa par elektroda endokardilai izmeklaanai un katetra ablcijai lietoaanu 06064 (91.41 Eur) - Piemaksa par specilas pagarintas radiofrekvences ablcijas elektrodu ievades un stabilizcijas sistmas lietoaanu 06065 (174.35 Eur) - Piemaksa pie manipulcijm 06061, 06062 par elektrodu endokardilai izmeklaanai 06066 (252.00 Eur) - Piemaksa pie manipulcijm 06061, 06062 par koronr sinusa elektrodu (CSL) 06067 (15.29 Eur) - Piemaksa par ievades komplekta radiofrekvences ablcijai un invaz+viem elektrofiziolo#iskiem izmekljumiem lietoaanu 06068 (23.72 Eur) - Elektroimpulsu plnveida terapija (defibrilcija) 06069 (13.05 Eur) - Elektroimpulsu neatliekam terapija (defibrilcija) 06070 (47.35 Eur) - Invaz+v elektroimpulsu terapija (defibrilcija) 06071 (153.67 Eur) - Piemaksa manipulcijai 06070 par specilo defibrilcijas zondi 06075 (8.47 Eur) - Centrl venoz spiediena mr+aana 06076 (16.95 Eur) - Piemaksa manipulcijai 06075 par katetra lietoaanu 06080 (16.53 Eur) - Ekstremitau ma#istrlo artriju funkcionl stvok<a neinvaz+va pletismogrfiska novrtaana 06081 (2.49 Eur) - Pulsa vi<Fa izplat+aans truma noteikaana ma#istrlaj artrij 06082 (6.13 Eur) - Ma#istrlo artriju oblitercijas l+meFa un pakpes noteikaana pc re#ionl spiediena gradienta 06085 (3.58 Eur) - Digitlo artriju pulsa pierakst+aana vai spiediena mr+aana 06086 (14.05 Eur) - Digitlo artriju pulsa pierakst+aana vai spiediena mr+aana pirms un pc aukstuma ekspoz+cijas vai medic+niskm provm 06087 (6.14 Eur) - Ekstremitau vnu funkcionl stvok<a neinvaz+va pletismogrfiska novrtaana 06100 (11.38 Eur) - Brahioceflo asinsvadu doplerogrfija ar spektra anal+zi un funkcionlm provm 06101 (11.38 Eur) - Transkranila asinsvadu doplerogrfija un spektra anal+ze 06102 (25.82 Eur) - Brahioceflo asinsvadu dupleksskenaana ar krsas doplerogrfiju un spektra anal+zi 06103 (16.45 Eur) - Pot+tes indeksa noteikaana ar seaiem mr+jumiem 06104 (18.68 Eur) - Abu apakajo ekstremitau segmentl doplerogrfija ar 12 mr+jumiem 06105 (9.83 Eur) - Abu augajo ekstremitau ma#istrlo asinsvadu doplerogrfija un spektra anal+ze 06106 (18.69 Eur) - Abu apakajo ekstremitau ma#istrlo asinsvadu doplerogrfija un spektra anal+ze 06107 (7.46 Eur) - Abu augajo ekstremitau segmentla doplerogrfija ar 8 mr+jumiem 06109 (6.97 Eur) - Abu apakajo ekstremitau das mikroasinsvadu lzera doplerogrfijas pieraksts 06110 (4.73 Eur) - Abu apakajo ekstremitau das mikroasinsvadu lzera doplerogrammas apraksts 06111 (12.66 Eur) - Abu apakajo ekstremitau das mikroasinsvadu postokluz+vs hipermijas lzera doplerogrfijas pieraksts 06112 (11.54 Eur) - Abu apakajo ekstremitau das mikroasinsvadu postokluz+vs hipermijas lzera doplerogrammas apraksts 06115 (30.15 Eur) - Vdera aortas un visu ts zaru krskodta dupleksskenaana 06116 (15.82 Eur) - Aortas loka un descendjoas da<as krskodta dupleksskenaana 06117 (12.93 Eur) - Abu roku artriju krskodta dupleksskenaana 06118 (24.80 Eur) - Abu kju artriju krskodta dupleksskenaana 06119 (35.51 Eur) - Transkranila krskodta dupleksskenaana (ar+ jaundzimuaajiem) 06121 (110.00 Eur) - Transkranila krskodta dupleksskenaana ar kontrastvielu 06122 (19.89 Eur) - Abu roku vnu krskodta dupleksskenaana 06123 (28.13 Eur) - Abu kju vnu krskodta dupleksskenaana 06124 (33.42 Eur) - Vdera dobuma vnu krskodta dupleksskenaana 06125 (29.26 Eur) - Hiperbr oksigencija, par katru pilnu stundu 06130 (331.40 Eur) - Vienkameras elektrokardiostimulatora implantcijas opercija bez elektrokardiostimulatora vrt+bas 06131 (467.60 Eur) - Divkameru pastv+g elektrokardiostimulatora implantcija bez elektrokardiostimulatora un endokardilo elektrodu vrt+bas 06132 (27.86 Eur) - Vienkameras elektrokardiostimulatora darb+bas prbaude un programmaana 06133 (41.36 Eur) - Divkameru elektrokardiostimulatora darb+bas prbaude un programmaana 06134 (41.36 Eur) - Vienkameras ventrikulr ICD prbaude un programmaana 06135 (51.57 Eur) - Divkameru (DDD) ICD prbaude un programmaana 06136 (466.67 Eur) - ICD implantcija bez ICD un endokardilo elektrodu vrt+bas 06137 (331.39 Eur) - Pastv+gas EKS sistmas rekonstrukcija, sistmas korekcija bez EKS elektroda un elektroda adaptera vrt+bas 06138 (331.39 Eur) - Endokardil elektroda maiFa 06139 (331.39 Eur) - Elektrokardiostimulatora lo~as maiFa 06140 (331.39 Eur) - Elektrokardiostimulatora ekstirpcija 06141 (201.08 Eur) - Ilgstoas elektrokardiogrammas monitoraanas iekrtas implantcija bez iekrtas vrt+bas 06150 (1155.22 Eur) - Elektrokardiostimulatora miokardil implantcija 06151 (317.68 Eur) - Piemaksa par vienkameras elektrokardiostimulatora SSI tipa bez papildu funkcijm un SSIR tipa ar slodzes adapt+vo funkciju lietoaanu 06152 (720.24 Eur) - Piemaksa par vienkameras elektrokardiostimulatora SSIR tipa ar slodzes adapt+vo funkciju un automtisko stimulcijas sliekaFa mr+aanas sistmu lietoaanu 06153 (764.98 Eur) - Piemaksa par divkameru elektrokardiostimulatoru VDD un DDD tipa bez papildu funkcijm lietoaanu 06154 (981.61 Eur) - Piemaksa par divkameru elektrokardiostimulatoru DDDR tipa ar slodzes adapt+vo funkciju lietoaanu 06155 (2958.76 Eur) - Piemaksa manipulcijai 06131 par divkameru sare~#+to elektrokardiostimulatoru lietoaanu antitahikard+tisko, biatrilo vai biventrikulro sirds kambaru resinhronizcijai (CRT) 06156 (4044.95 Eur) - Piemaksa manipulcijai 06136 par vienkameras intrakardil defibrilatora (ICD) lietoaanu 06157 (9515.84 Eur) - Piemaksa manipulcijai 06136 par divkameru intrakardil defibrilatora vai implantjamiem kambaru kardioverteriem-defibrilatoriem ar triju un biventrikulrs stimulcijas funkcijm lietoaanu 06158 (2047.17 Eur) - Piemaksa manipulcijai 06141 par implantjams ilgstoaas elektrokardiogrammas monitoraanas diagnostisks iekrtas "REVALT" lietoaanu 06160 (425.91 Eur) - Miokarda biopsija k patstv+ga manipulcija 06165 (3106.06 Eur) - Piemaksa par elektrokardiostimulatora ar fizisks slodzes adapt+vo funkciju un telemetrijas iespjm ar diviem bipolriem elektrodiem lietoaanu 06166 (559.09 Eur) - Piemaksa par elektroda koronram sinusam biventrikulrajai vai biartrilai stimulcijai lietoaanu 06167 (598.63 Eur) - Piemaksa par ievades komplekta sinus coronarius elektrodu ievadei lietoaanu 06168 (231.51 Eur) - Piemaksa par akt+vs fikscijas bipolr elektroda pastv+gai elektrokardiostimulcijai lietoaanu 06169 (314.77 Eur) - Piemaksa par miokardili bipolr elektroda pastv+gai elektrokardiostimulatoru miokardilai implantcijai lietoaanu 06170 (49.42 Eur) - Piemaksa par pastv+g implantjam elektroda adaptera lietoaanu 06171 (16.19 Eur) - Piemaksa par ievadu sistmu pastv+g elektroda implantcijai lietoaanu 06172 (52.79 Eur) - Piemaksa par pagaidu elektrokardiostimulatora elektroda ievades ier+ces ar ievadsistmu un pagaidu elektrostimulcijas elektrodu lietoaanu 06173 (70.59 Eur) - Piemaksa par pagaidu rjs stimulcijas vadiem intraoperat+viem mr+jumiem lietoaanu 06174 (252.15 Eur) - Piemaksa par pagaidu elektrokardiostimulatora akt+vs fikscijas bipolr elektroda lietoaanu 06175 (21.45 Eur) - Piemaksa par pieauguao kardiostimulcijas-defibrilcijas kontaktspilventiFu lietoaanu 06176 (281.30 Eur) - Piemaksa par savienojoaas ier+ces pierakstam no katetrablcijas elektroda AMAZR lietoaanu 06177 (97.43 Eur) - Piemaksa par ar Localisa 9670590 savienojama pas+v elektroda lietoaanu 06178 (254.13 Eur) - Piemaksa par transezofagils elektrokardiostimulcijas seapolra elektroda lietoaanu 06179 (28.23 Eur) - Piemaksa par vienas sirds kameras stimulcijai lietojam rj pagaidu elektrokardiostimulatora lietoaanu 06201 (990.43 Eur) - Intravaskulr ultrasonogrfija (IVUS) ar materilu vrt+bm. Nenord+t kop ar manipulcijm 60072, 60073, 60074 06202 (5261.90 Eur) - Iedzimtu un iegktu sirds defektu korekcija ar invaz+vs kardiolo#ijas metodi 06203 (0.00 Eur) - Perkutna koronr intervence ar zlm pild+tu stentu implantciju stacionr un dienas stacionr 06204 (24726.67 Eur) - Transkatetrl aortas vrstu<a implantcija (iek<auti anesteziologa pakalpojumi) 06210 (15409.14 Eur) - Ekstrakorporl membrnu oksigencija (EKMO) implantcija 06211 (2177.22 Eur) - Ekstrakorporl membrnu oksigencija (EKMO) eksplantcija 06212 (1688.89 Eur) - Ekstrakorporl membrnu oksigencija (EKMO), uzturaanas vienas dienas izmaksas 07002 (2.19 Eur) - Izelpas maksimumplksmas (IMP) noteikaana (PEF-metrija) 07004 (6.47 Eur) - rjs elpoaanas pamatrd+tju noteikaana un anal+ze, izmantojot portat+vu spirogrfu (pneimotahogrfu) 07017 (7.60 Eur) - Spirogrfija (pneimotahogrfija) ar automtisku datoranal+zi 07018 (10.70 Eur) - Spirogrfija (pneimotahogrfija) ar automtisku datoranal+zi un bronhodilatcijas testu 07023 (36.96 Eur) - Elpce<u nespecifisks reaktivittes noteikaana ar metahol+na inhalcijm 07024 (9.96 Eur) - Automatizts seau minkau staigaanas tests 07025 (16.14 Eur) - Visa 7ermeFa pletizmogrfija 07026 (18.54 Eur) - Visa 7ermeFa pletizmogrfija ar bronhodilatcijas testu 07028 (16.15 Eur) - Plauau difkzijas spju noteikaana 07029 (3.11 Eur) - Piemaksa manipulcijai 07002 par brna l+dz 10 gadu vecumam apmc+bu (apmc+bu veic medic+nas darbinieks 15-30 minktes pirms testa veikaanas) 07030 (4.93 Eur) - Piemaksa manipulcijm 07004, 07017, 07018 par brnu l+dz 10 gadu vecumam apmc+bu spirogrfijas (pneimotahogrfijas) izdar+aanai (apmc+bu veic medic+nas darbinieks 20-30 minktes pirms testa veikaanas) 07043 (29.00 Eur) - Sviedru proves skr+ninga izdar+aana ar cistisks fibrozes (CF) indikatoru 07044 (39.27 Eur) - Sviedru proves skr+ninga izdar+aana ar sviedru anal+zes sistmu (NANODUCT) (ar+ rezulttu novrtaana) 07045 (31.44 Eur) - Kardiopulmonlais slod~u tests 07046 (40.02 Eur) - Sviedru kolekcija, izmantojot Macroduct iekrtu. Nenord+t kop ar manipulciju 07044 07060 (0.00 Eur) - Inhalatora pareizas lietoaanas apmc+ba, ar+ atkrtota 08001 (65.01 Eur) - 24 stundu bar+bas vada un/vai kuF#a pH-metrija pieauguaajiem ar vienelektroda zondi vairkkrtjai lietoaanai 08002 (138.79 Eur) - 24 stundu bar+bas vada un/vai kuF#a pH-metrija brniem ar vienelektroda zondi vairkkrtjai lietoaanai (skbju refluksa noteikaanai) 08003 (90.73 Eur) - 24 stundu bar+bas vada un/vai kuF#a pH-metrija pieauguaajiem ar divu elektrodu zondi vairkkrtjai lietoaanai 08005 (85.43 Eur) - Oddi sfinktera manometrija ar kdens perfkzijas vienkanla katetru vairkkrtjai lietoaanai 08006 (68.29 Eur) - Anorektla manometrija ar kdens perfkzijas etrkanlu katetru vairkkrtjai lietoaanai 08007 (48.50 Eur) - Laktozes malabsorbcijas diagnostika ar kdeFra~a elptestu 08008 (54.42 Eur) - Zarnu disbakteriozes diagnostika ar kdeFra~a elptestu 08009 (54.42 Eur) - Orli cekl tranz+ta laika diagnostika ar kdeFra~a elptestu 08010 (71.87 Eur) - Bar+bas vada manometrija ar daudzkanlu augstas iza7irtspjas kdens perfkzijas katetru 08011 (63.40 Eur) - Anorektla manometrija ar astoFkanlu kdens perfkzijas katetru 08012 (98.74 Eur) - 24 stundu bar+bas vada un/vai kun#a pH-metrija pieauguaajiem ar etrelektrodu zondi vairkkrtjai lietoaanai 08013 (95.20 Eur) - 24 stundu bar+bas vada un/vai kun#a pH-metrija pieauguaajiem ar tr+selektrodu zondi vairkkrtjai lietoaanai 08014 (86.07 Eur) - Portat+v elektrogastrogrfija 08015 (39.70 Eur) - Anorektl sfinktera vektoru tilpumanal+ze ar astoFkanlu katetru 08016 (26.17 Eur) - Gastroskopija ar pH-metriju vienlaikus 08017 (15.53 Eur) - Piemaksa manipulcijm 08061, 08062, 08111, 08112, 08113, 08136 par zondes ievad+aanu ar endoskopu 08019 (253.37 Eur) - 24 stundu pH-metrija un bar+bas vada pretest+bas mr+jums brniem ar vienreizlietojamo 1,5 mm zondi. Nenord+t kop ar manipulciju 08036 08020 (203.17 Eur) - 24 stundu pH-metrija un bar+bas vada pretest+bas mr+jums brniem ar vienreizlietojamo 2,0 mm zondi. Nenord+t kop ar manipulciju 08036 08030 (23.60 Eur) - KuF#a pH-metrija vienam pacientam 08035 (23.37 Eur) - Endoskopisk pH-metrija 08036 (23.96 Eur) - KuF#a-bar+bas vada refluksa izmeklaana 08037 (25.65 Eur) - Automatizt kuF#a pH-metrija vienam pacientam 08050 (13.79 Eur) - Duodenl zondaana 08051 (19.35 Eur) - Piemaksa manipulcijm 08059, 08062 par bar+bas vada bu~aanu kombinti ar ezofagoskopiju 08052 (19.63 Eur) - Piemaksa manipulcijm 08059, 08062 par bar+bas vada bu~aanu brniem 08053 (34.95 Eur) - Bar+bas vada endoprotzes ielikaana bez endoprotzes vrt+bas. Var nord+t kop ar manipulciju 08059 08054 (945.93 Eur) - Piemaksa manipulcijai 08053 par bar+bas vada metlisko stentu ar poliestera apvalku un plat+na mar7ieriem 08058 (34.80 Eur) - Gastroskopija un/vai parcila duodenoskopija bez parauga eksc+zijas un/vai punkcijas 08059 (13.37 Eur) - Ezofagoskopija bez parauga eksc+zijas un/vai punkcijas 08060 (29.80 Eur) - Ezofagoskopija ar parauga eksc+ziju un/vai punkciju 08061 (47.05 Eur) - Gastroskopija un/vai parcila duodenoskopija ar parauga eksc+ziju un/vai punkciju un urezes nord+aanu 08062 (47.76 Eur) - Neatliekam ezofagoskopija un/vai gastroskopija un/vai parcil duodenoskopija 08063 (36.63 Eur) - Hemostze neatliekams augajs vai apakajs endoskopijas laik bez vienreizjs lietoaanas materilu vrt+bm. Var nord+t kop ar manipulcijm 08061, 08062, 08111, 08112, 08113 08065 (17.91 Eur) - Piemaksa par hemostzes klipaa lietoaanu 08066 (66.20 Eur) - Piemaksa par endocilpas lietoaanu 08070 (24.49 Eur) - Bar+bas vada struktkras lzera koagulcija 08071 (52.77 Eur) - Svea7ermeFa izFemaana no bar+bas vada, kuF#a un divpadsmitpirkstu zarnas. Var nord+t kop ar manipulcijm 08061 un 08062 08072 (58.20 Eur) - Endoskopiska varikozu vnu terapija augaj un apakaj gremoaanas sistm bez variko~u klipau un ligatkru izmaksm neatliekam situcij asiFojoau vnu gad+jum. Var nord+t kop ar manipulcijm 08061, 08062, 08111, 08112, 08113 08074 (21.19 Eur) - Piemaksa par vienreizlietojams cilpas lietoaanu varikozo vnu li#aanai 08075 (0.94 Eur) - Piemaksa par endoskopa distl gala vairkreizlietojamo uzmavu loklai aspircijai vienai procedkrai 08076 (39.22 Eur) - Endoskopiska kuF#a un duodena klas rstaana vien seans. Nenord+t kop ar manipulciju 08135 08077 (91.34 Eur) - Papillae Vateri endoskopiska kanulcija ar kontrastvielas ievad+aanu un/vai sekrta Femaanu (ERHP) bez vienreizjs lietoaanas vad+tju, dilatcijas balonu un katetru vrt+bm 08078 (185.10 Eur) - Piemaksa par vienreizlietojam ~ultsce<u dilatcijas balona lietoaanu 08079 (139.62 Eur) - Piemaksa par vienreizlietojam ~ultsce<u balonkatetra lietoaanu 08080 (9.89 Eur) - Piemaksa manipulcijai 08077 par stenta izFemaanu no ~ultsce<iem 08081 (55.30 Eur) - L+dz galam neveikta manipulcija 08077 neparedztu apstk<u d<. Nenord+t kop ar manipulciju 08077 08085 (7.79 Eur) - Pacienta sedcija endoskopisku izmekljumu laik 08086 (1359.83 Eur) - Selekt+va granuloc+tu, monoc+tu, makrofgu aferze ar Adacolumn sistmu 08090 (125.28 Eur) - Endoskopiska papilosfinkterotomija bez vienreizjs lietoaanas vad+tju, dilatcijas balonu un katetru vrt+bm 08091 (127.07 Eur) - Piemaksa manipulcijai 08090 par vienreizjs lietoaanas katetra un vad+tja lietoaanu 08093 (109.54 Eur) - Endoskopisk papilosfinkterotomija ar konkrementu litotripsiju un/vai ekstrakciju 08094 (63.54 Eur) - Piemaksa manipulcijai 08093 par balonkatetra lietoaanu 08095 (228.72 Eur) - Piemaksa manipulcijai 08093 par groziFveida ekstraktora lietoaanu 08096 (310.61 Eur) - Piemaksa manipulcijai 08093 par mehnisk litotriptora lietoaanu ar viena mainm groziFa vrt+bu 08097 (120.16 Eur) - Endoskopisk papilosfinkterotomija un stenta ievietoaana ~ults vai aizkuF#a dziedzera vados bez endoprot~u vrt+bas 08098 (172.56 Eur) - Piemaksa par vienreizlietojam plastikta drenas komplekta lietoaanu 08099 (109.81 Eur) - Piemaksa par vienreizlietojams nazobilirs drenas komplekta lietoaanu 08100 (53.15 Eur) - Perkutn endoskopisk gastrostomija 08101 (141.18 Eur) - Piemaksa manipulcijai 08100 par perkutns endoskopisks gastrostomijas (PEG) komplektu 08102 (16.15 Eur) - Zondes tipa gastrostomas un zema profila (pogveida) gastrostomas nomaiFa (bez gastrostomas vrt+bas) 08103 (54.55 Eur) - Piemaksa par zondes tipa gastrostomu 08104 (281.06 Eur) - Piemaksa par zema profila (pogveida) gastrostomijas komplektu 08105 (281.06 Eur) - Piemaksa par zema profila (pogveida) gastrostomijas zondes pirmreizjo ievietoaanas komplektu 08108 (572.85 Eur) - Kapsulas endoskopija 08109 (81.15 Eur) - Kapsulas endoskopijas datu apstrde 08110 (8.51 Eur) - Rektoskopija 08111 (33.31 Eur) - Sigmoidoskopija ar elast+giem instrumentiem, ieskaitot rektoskopiju 08112 (54.16 Eur) - Resns zarnas izmeklaana ar elast+giem instrumentiem, ieskaitot rektoskopiju l+dz liesas leF7im 08113 (126.88 Eur) - Resns zarnas izmeklaana ar elast+giem endoskopiem, ieskaitot rektoskopiju un sigmoidoskopiju, parauga eksc+ziju un/vai punkciju 08114 (58.07 Eur) - Piemaksa manipulcijm 08060, 08061, 08062, 08063, 08110, 08111, 08112, 08113 par l+dz divu g<otdas paraugu Femaanu sakar ar polipu izgrieaanu un/vai mezglu biopsijm, lietojot augstfrekvences elektroinstrumentu 08115 (64.43 Eur) - Piemaksa pie manipulcijm 08060, 08061, 08062, 08063, 08110, 08111, 08112, 08113 par vairk nek divu g<otdas paraugu Femaanu sakar ar polipu izgrieaanu un/vai mezglu biopsijm, lietojot augstfrekvences elektroinstrumentu 08120 (34.64 Eur) - Endosonogrfija, lietojot elast+gos endoskopus 08121 (134.88 Eur) - Terapeitisk endoskopisk ultrasonogrfija ar sektorla detektora endoskopu 08122 (117.13 Eur) - Diagnostisk endoskopisk ultrasonogrfija ar sektorla detektora endoskopu 08125 (258.72 Eur) - Piemaksa par ultraskaFas aspircijas un histolo#ijas biopsijas adatas komplekta lietoaanu 08128 (313.74 Eur) - Piemaksa par Plexus coeliacus neirol+zes adatas komplekta lietoaanu 08130 (46.28 Eur) - Piemaksa par vienreizjs lietoaanas injektora lietoaanu endoskopijs 08132 (776.52 Eur) - Piemaksa manipulcijai 08097 par endoprotzes - ~ultsce<u metlisko stentu ar plat+na mar7ieriem - lietoaanu 08133 (8.10 Eur) - Piemaksa manipulcijm 08058, 08059, 08060, 08061, 08062, 08077, 08081, 08090, 08111, 08112, 08113, 08121, 08122 par videoendoskopijas aparatkras lietoaanu 08134 (91.37 Eur) - Piemaksa par argonplazmas koagulcijas iekrtas izmantoaanu 08135 (18.69 Eur) - Lzera koagulcija caur endoskopu, viens seanss. Nenord+t kop ar manipulciju 08070 08136 (5.62 Eur) - Endoskopu automtisk apstrde (ieskaitot dezinfekcijas l+dzek<us) 08140 (50.50 Eur) - C13 elptests Helicobacter pylori noteikaanai 08141 (75.65 Eur) - C13 metacet+na elptests aknu funkcijas noteikaanai 08142 (65.77 Eur) - C13 eti7skbes elptests kuF#a evakucijas funkcijas noteikaanai 08143 (9.87 Eur) - Resno zarnu t+r+aanas metode pacienta sagatavoaanai resno zarnu endoskopiskai izmeklaanai vai irigoskopijai ar klizmm 08144 (95.38 Eur) - C13 jaukto triglicer+du elptests lipzes defic+ta noteikaanai 08155 (3503.38 Eur) - Perorla endoskopiska tieaas vizualizcijas holangiopankreatoskopija 08156 (4095.01 Eur) - Mehniska litotripsija perorlas endoskopiskas tieaas vizualizcijas holangiopankreatoskopijas laik 09004 (8.29 Eur) - Pdu noslogojuma noteikaana ar podogrfu (statisk) 09005 (13.41 Eur) - Pdu noslogojuma noteikaana ar podogrfu (dinamisk un posturl) 09182 (39.10 Eur) - Hormonlo diagnostisko testu izdar+aana ? STH stimulcijas prove bez stimulatora 09183 (33.48 Eur) - Hormonlo diagnostisko testu izdar+aana ? Synacthen prove 09184 (34.84 Eur) - Hormonlo diagnostisko testu izdar+aana ? GnRH (analogi ar+ TRH, ACTH, GHRH) proves 09185 (31.91 Eur) - Hormonlo diagnostisko testu izdar+aana ? insul+na un/vai C-pept+da l+meFa noteikaana perorl glikozes tolerances testa laik 09186 (11.39 Eur) - Hormonlo diagnostisko testu izdar+aana ? horionisk gonadotrop+na tests 09187 (0.71 Eur) - Piemaksa manipulcijai 09182 par stimulatora ? Insulin (human) lietoaanu 09188 (14.12 Eur) - Piemaksa manipulcijai 09182 par stimulatora ? GHRH lietoaanu (Somatropin un somatropin agonists) 09189 (16.95 Eur) - Piemaksa manipulcijai 09182 par stimulatora ? glikagona (Glicagon) lietoaanu 10008 (5.38 Eur) - das dkriena raudze (prick tests) ar vienu alergnu 10009 (2.12 Eur) - das dkriena raudze (prick tests), par katru nkamo alergnu 10010 (15.26 Eur) - das dkriena raudze (prick tests) ar vienu biau, lapseFu indes alergna devu 10011 (7.96 Eur) - das dkriena raudze (prick tests), par katru nkamo biau, lapseFu indes alergna devu 10012 (4.04 Eur) - das dkriena?dkriena raudze (prick?prick tests) ar vienu alergnu 10013 (0.85 Eur) - das dkriena?dkriena raudze (prick?prick tests), par katru nkamo alergnu 10020 (9.94 Eur) - Intrakutn testa izdar+aana ar vienu alergnu 10021 (2.59 Eur) - Intrakutn testa izdar+aana, par katru nkamo alergnu 10022 (13.02 Eur) - Intrakutn testa izdar+aana ar vienu biau, lapseFu indes devu 10023 (6.54 Eur) - Par katru nkamo biau, lapseFu indes devas ievad+aanu 10025 (2.53 Eur) - Specifiska imknterapija ar alergna injekciju (hiposensibilizcija) par katru injekciju 10026 (17.23 Eur) - Specifisk imknterapija ar alergna injekciju (hiposensibilizcija) ar biau, lapseFu indi, ieskaitot alergna vrt+bu 10033 (14.47 Eur) - das aplikcijas testa sagatavoaana un veikaana ar trim alergniem, ieskaitot alergna vrt+bu 10034 (1.83 Eur) - das aplikcijas testa veikaana, par katru nkamo alergnu 10037 (87.18 Eur) - das aplikcijas tests ar UV apstaroaanu fotosensibilizcijas diagnostikai vienam pacientam 10038 (8.79 Eur) - Pneimotahogrfija ar automtisko datoranal+zi bronhils astmas slimniekiem pirms un pc imknterapijas atkrtotas injekcijas 10041 (31.05 Eur) - Intranazls provokcijas tests ar alergna ekstraktu, kl+nisku novrtjumu un rinomanometriju 10042 (149.89 Eur) - Bronhu provokcijas tests ar alergna ekstraktu, izmantojot pneimotahogrfu un alergna ekstraktu 10043 (66.17 Eur) - Orlas provokcijas tests ar prtikas vai medikamentu alergniem 10044 (29.21 Eur) - Inducto krpu iegkaana un sagatavoaana anal+zei 11001 (7.91 Eur) - Lumblpunkcija ar anestziju 11002 (19.01 Eur) - Lumblpunkcija brniem ar anestziju 11003 (7.41 Eur) - Piemaksa manipulcijm 11001, 11002 par likvora dinamisko provju prbaudi 11004 (23.02 Eur) - Klasisk elektromiogrfija un datu izvrtaana 11005 (74.29 Eur) - Neirogrfija un kvantitat+v elektromiogrfija ar adatu elektrodiem un datoriztu datu apstrdi 11006 (28.86 Eur) - Atsevia7u musku<u a7iedru elektromiogrfija ar adatu elektrodiem 11007 (44.64 Eur) - Neirogrfija ar datoriztu datu apstrdi 11008 (22.70 Eur) - Tremora anal+ze un ekstrapiramidls sistmas izmeklaana 11009 (27.04 Eur) - Ve#etat+vs nervu sistmas izmeklaanas testi 11010 (13.88 Eur) - Miastnisks reakcijas noteikaana 11011 (12.88 Eur) - Trijzaru nerva (n. trigeminus) un sejas nerva (n. facialis) izmeklaanas tests 11021 (23.19 Eur) - Galvas smadzeFu snu vderiFu punkcija caur lielo avotiFu z+daiFiem 11022 (13.13 Eur) - Brna izmeklaana pc Vojta metodikas, lietojot Landau, collis verticalis, collis horisontalis, Peiper-Labert proves 11025 (2.67 Eur) - Orientjoaa redzes lauka prbaude un datu anal+ze 11028 (8.29 Eur) - O~as un garaas sajktu prbaude 11030 (32.84 Eur) - Spju kl+nisk izmeklaana un novrtaana (neuzrda kop ar manipulciju 11031) 11031 (25.00 Eur) - Pirmreizja vai atkrtota hronisko spju dinamisk aprkpe (neuzrda kop ar manipulciju 11030) 11032 (30.85 Eur) - Specializts kons+lijs spju pacienta aprkpei (uzrda katrs kons+lij iesaist+tais specilists) 11035 (8.19 Eur) - Musku<u spka izvrtjums un prbaude ar speciliem sare~#+tiem un instrumentliem testiem pa musku<u grupm 11036 (5.34 Eur) - Kust+bu koordincijas un l+dzsvara prbaude ar testiem (citi testi, izFemot Romberga, pirksta?degungala, pap~a?ce<gala, adiodohokinzes m#injumus) 11037 (6.59 Eur) - Vibrcijas sajktas prbaude ar kamertoFiem 11038 (3.58 Eur) - Stereognozes un citu sare~#+to juaanas veidu prbaude ar pal+gier+cm 11040 (3.01 Eur) - Augstks nervu sistmas funkciju mr7tiec+ga prbaude, izmantojot specilus testus 11041 (5.14 Eur) - Kompresijas neiroptiju kl+nisko testu prbaude vienam l+menim 11051 (84.52 Eur) - Elektroencefalogrfija ar indicto miegu 11052 (65.84 Eur) - Elektroencefalogrfija ar papildu funkcionlajiem un medikamentozajiem testiem 11053 (65.27 Eur) - Elektroencefalogrfija ar prvietojamo iekrtu 11054 (29.23 Eur) - Elektroencefalogrfija ar standarta funkcionlajiem testiem brniem, veckiem par septiFiem gadiem, un pieauguaajiem 11055 (69.47 Eur) - Elektroencefalogrfija ar standarta funkcionlajiem testiem brniem l+dz triju gadu vecumam 11056 (47.30 Eur) - Elektroencefalogrfija ar standarta funkcionlajiem testiem brniem no triju l+dz septiFu gadu vecumam 11057 (64.00 Eur) - Datorizta encefalogrfija ar biopotencilu kartaanu ar krsainajiem attliem 11058 (163.26 Eur) - Datorizta elektroencefalogrfija ar video sinhronu monitoraanu (pirms 12 stundas) pieauguaajam 11059 (124.23 Eur) - Piemaksa pie manipulcijas 11058 par katrm nkamajm 12 stundm 11060 (98.56 Eur) - Datoriztas elektroencefalogrfijas ar video sinhrono monitoraanu datu apstrde darba stacij (pirmo 12 stundu pierakstam) pieauguaajiem 11061 (49.30 Eur) - Datoriztas elektroencefalogrfijas ar video sinhrono monitoraanu datu apstrde darba stacij (nkamo 12 stundu pierakstam) pieauguaajiem 11065 (12.64 Eur) - Nervu sensoro a7iedru izmeklaana 11066 (27.96 Eur) - Redzes izsaukto potencilu noteikaana 11067 (27.83 Eur) - Dzirdes izsaukto potencilu noteikaana 11068 (18.25 Eur) - Somatosensori izsaukto potencilu noteikaana 11069 (200.27 Eur) - Datorizta elektroencefalogrfija ar video sinhronu monitoraanu (pirms 12 stundas) brnam 11070 (159.73 Eur) - Piemaksa pie manipulcijas 11069 par katrm nkamajm 12 stundm 11071 (137.00 Eur) - Brna datorizta elektroencefalogrfija ar video sinhrono monitoraanu, datu apstrde darba stacij (pirmo 12 stundu pierakstam) 11072 (117.42 Eur) - Brna datorizta elektroencefalogrfija ar video sinhrono monitoraanu, datu apstrde darba stacij (nkamo 12 stundu pierakstam) 11073 (12.62 Eur) - Piemaksa pie manipulcijas 11069 par vienu stundu 11074 (9